Notizie
Prof. Fabrizio Conti
Dipartimento di Scienze Cliniche Internistiche, Anestesiologiche e Cardiovascolari
Sapienza Università di Roma
Viale del Policlinico 155, 00161, Rome, Italy
Tel. +39-06-49974661 (office)
Fax: +39-06-49974670
email: fabrizio.conti@uniroma1.it
Office: VII Pav, III floor
- Full Professor of Rheumatology and Director of the post-graduate School of Rheumatology, at Sapienza University of Rome, Italy.
- Head of Rheumatology Unit at AOU Policlinico Umberto I University Hospital, Rome, Italy.
- PhD qualification in Experimental Immunology from the Magna Graecia University of Catanzaro, Italy.
- Member of the scientific board of the International PhD Program "INNOVATION IN IMMUNO-MEDIATED AND HEMATOLOGICAL DISORDERS", Sapienza University of Rome, Italy.
- Coordinator of “Course Pathology Integrated IV” CCLM "C", IV year, II semester,
Faculty of Medicina e Odontoiatria, Sapienza University of Rome, Italy.
- Coordinator CCLM "C", IV year, II semester,
Faculty of Medicina e Odontoiatria, Sapienza University of Rome, Italy.
- Coordinator of “path of excellence” CCLM "C", Faculty of “Medicina e Odontoiatria”, Sapienza University of Rome, Italy.
- Coordinator of “Applied pathology IV, diseases of the blood hematopoietic organs, immune system and rheumatology”, V year, I semester, Faculty of Medicine and Surgery "F" (Master degree program in English), Sapienza University of Rome, Italy.
- Senior research fellow at Sapienza School for Advanced Studies (SSAS), Academic Class: Life sciences.
- Member of the ethics committee of INMI L. Spallanzani in Rome.
- Council member of the Italian Society of Rheumatology (SIR).
- Member of the Standing Committee for the study of biological treatments in systemic lupus erythematosus (SLE) (LIRE) of the Italian Society of Rheumatology (SIR), member of the Standing Committee for the study of neuropsychiatric lupus of SIR, and member of the Standing Committee for the study of Anti-phospholipid Syndrome (APS) of SIR.
Author of over 360 ISI publications (H-index 54, citations 11311, SCOPUS). Research has focused on ethiopathogenesis, clinical features and treatment of antiphospholipid syndrome, systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune rheumatic diseases. Wide experience on clinical studies (phases II and III) carried out using new biological drugs.
From June 2014 to December 2014 Visiting Professor at the Arthritis Research UK Centre for Excellence in Epidemiology, University of Manchester (UK).
Principal investigator in several clinical studies (phase II and III) carried out using new biological products.
He organized several congresses on autoimmune rheumatic diseases.
Professor Conti has gained wide experience in clinical management of patients with autoimmune rheumatic diseases including peadiatric patients with juvenile idiopathic arthritis.
In 2008 he established the “Sapienza Lupus Clinic”. Currently, more than 1000 SLE out-patients are followed-up.
Publications
- Valesini G, Conti F, Priori R, Balsano F. Gilbert’s syndrome and chronic fatigue syndrome. Lancet 341:1162-1163; 1993.
- R Priori, F Conti, FL Luan, C Arpino, G Valesini.Chronic fatigue: a peculiar evolution of eosinopholia-myalgia syndrome following treatment with L-tryptophane in four Italian adolescents.Eur J Pediatrics 153:344-346; 1994
- F Conti, R Priori, G De Petrillo, AC Rusconi, C Arpino, G Valesini. Prevalence of chronic fatigue syndrome in Italian patients with persistent fatigue.Ann Ital Med Int 9:219-222; 1994
- G Valesini, R Priori, F Conti. Chronic Fatigue Syndrome: what factors trigger it off?Clin Exp Rheumatol 12:473-476; 1994
- Valesini G, Priori R, Conti F.Saddle nose in relapsing polichondritis: a problem of differential diagnosis. N Eng J Med 333:525-526; 1995
- F Conti, L Magrini, R Priori, P Rotiroti, G Valesini, S Bonini.Eosinophil cationic protein serum levels and allergy in chronic fatigue syndrome.Allergy 51:124-127; 1996
- S Morelli, C Barbieri, A Sgreccia, L Ferrante, V Pittoni, F Conti, G Gualdi, E Polettini, O Carlesimo, S Calvieri.Relationship between cutaneous and pulmonary involvement in Systemic Sclerosis.J Rheumatol 25:85-89; 1997.
- Priori R, Conti F, Pittoni V, Valesini G.Relapsing polichondritis: a syndrome rather than a distinct clinical entity.Clin Exp Rheumatol 15:334-335; 1997.
- M Sorice, V Pittoni, A Circella, R Misasi, F Conti, A Longo, GM Pontieri, G Valesi. Anti-prothrombin but not “pure” anticardiolipin antibodies are associated with the clinical features of the Antiphospholipid Antibodies SyndromeThromb Haemost 80:713-715; 1998.
- B Caronti, C Calderaro, C Alessandri, F Conti, R Tinghino, C Pini, G Palladini, G Valesini.Serum anti-b2-glycoprotein I antibodies from patients with antiphospholipid antibodies syndrome bind central nervous systemJ Autoimmun 11:425-429; 1998.
11. R Priori, M Tomassini, L Magrini, F Conti, G Valesini.
Churg-Strauss syndrome during pregnancy after steroid withdrawal.
Lancet 352:1499-1500; 1998.
12. F Conti, V Pittoni, P Sacerdote, R Priori, PL Meroni, G Valesini.
Decreased immunoreactive beta-endorphin in mononuclear leucocytes from patients with Chronic Fatigue Syndrome.
Clin Exp Rheumatol 16:729-732; 1998.
13. B Caronti, C Calderaro, C Alessandri, F Conti, R Tinghino, G Palladini, G Valesini.
Beta2-glycoprotein I (β2-GPI) mRNA is expressed by several cell types involved in antiphospholipid syndrome-related tissue damage.
Clin Exp Immunol 115:214-219; 1999.
14. Praticò D, Ferro D, Iuliano L, Rokach J, Conti F, Valesini G, FitzGerald GA, Violi F.
Ongoing prothrombotic state in patients with antiphospholipid antibodies: a role for increased lipid peroxidation.
Blood 93:3401-3407; 1999.
15. F Conti, R Priori, V Pittoni, P Pivetti-Pezzi, G Valesini.
Antiphospholipid antibody syndrome in Behçet’s disease.
Lancet 354:73; 1999.
16. Arpino C, Carrieri MP, Valesini G, Pizzigallo E, Rovere P, Tirelli U, Conti F, Dialmi P, Barberio A, Rusconi N, Bosco O, Lazzarin A, Saracco A, Moro ML, Vlahov D.
Idiopathic chronic fatigue and chronic fatigue syndrome: a comparison of two case-definitions.
Ann Ist Super Sanità 35:435-441; 1999.
17. R Priori, F Conti, V Pittoni, T Garofalo, M Sorice, G Valesini.
Is there a role for anti-phospholipid-binding protein antibodies in the pathogenesis of thrombosis in Behçet’s disease?
Thromb Haemost 83:173-174; 2000.
18. U Ramenghi, S Bonissoni, G Migliaretti, S De Franco, F Bottarel, D Buonfiglio, C Gambaruto, R Priori, F Conti, I Dianzani, G Valesini, F Merletti, U Dianzani.
Deficiency of the FAS apoptosis pathway without gene mutations is a familial trait predisposing to the development of autoimmune disease and cancer.
Blood 95:3176-3182; 2000.
19. F Conti, R Priori, C Alessandri, FR Spinelli, E Medda, G Valesini.
Safety profile and causes of withdrawal due to adverse events in Systemic Lupus Erythematosus patients treated long-term with Cyclosporine A.
Lupus 9:676-680; 2000.
20. S Morelli, AM Gurgo Di Castelmenardo, F Conti, A Sgreccia, C Alessandri, ML Bernardo, G Valesini.
Cardiac involvement in patients with Wegener’s granulomatosis.
Rheumatol Int 19:209-212; 2000.
21. F Conti, FR Spinelli, A Ossandon, G Valesini.
Selective cyclooxygenase-2 inhibition: biological and clinical effects.
Isr Med Assoc J 2:841-847; 2000.
22. RS Shacterle, F Conti, L Magrini, AL Komaroff, G Valesini.
Increased Eosinophil Protein X levels in Chronic Fatigue Syndrome.
Journal of Chronic Fatigue Syndrome 9:21-30; 2001.
23. Pittoni V, Bombardieri M, Spinelli FR, Scrivo R, Alessandri C, Conti F, Spadaro A, Valesini G.
Anti-tumour necrosis factor (TNF) alpha treatment of rheumatoid arthritis (infliximab) selectively down regulates the production of interleukin (IL) 18 but not of IL12 and IL13.
Ann Rheum Dis 61:723-725; 2002.
24. Ferro D, Iuliano L, Violi F, Valesini G, Conti F.
Antioxidant treatment decreases the titer of circulating anticardiolipin antibodies: comment on the article by Sambo et al.
Arthritis Rheum 46:3110-3112; 2002.
25. Conti F, Sorice M, Circella A, Alessandri C, Pittoni V, Caronti B, Calderaro C, Griggi T, Misasi R, Valesini G.
Beta-2-glycoprotein I expression on monocytes is increased in anti-phospholipid antibody syndrome and correlates with tissue factor expression.
Clin Exp Immunol 132:509-516; 2003.
26. Alessandri C, Bombardieri M, Scrivo R, Viganego F, Conti F, De Luca N, Riccieri V, Valesini G.
Anti-carbonic anhydrase II antibodies in systemic sclerosis: association with lung involvement.
Autoimmunity 36:85-89; 2003.
27. Priori R, Medda E, Conti F, Cassarà EA, Danieli MG, Gerli R, Giacomelli R, Franceschini F, Manfredi A, Pietrogrande M, Stazi MA, Valesini G.
Familial autoimmunity as a risk factor for systemic lupus erythematosus and vice versa: a case-control study.
Lupus 12:735-740; 2003.
28. Magrini L, Rotiroti G, Conti F, Viganego F, Alessandri C, Picardo V, Valesini G.
Orbital myositis in a patient with primary biliary cirrhosis: successful treatment with methotrexate and corticosteroids.
Isr Med Assoc J 5:825-826; 2003.
29. Morelli S, Bernardo ML, Viganego F, Sgreccia A, De Marzio P, Conti F, Priori R, Valesini G.
Left-sided heart valve abnormalities and risk of ischemic cerebrovascular accidents in patients with systemic lupus erythematosus.
Lupus 12:805-812; 2003.
30. Ferro D, Pignatelli P, Loffredo L, Conti F, Valesini G, D'Angelo A, Violi F.
Soluble CD154 plasma levels in patients with systemic lupus erythematosus: modulation by antiphospholipid antibodies.
Arthritis Rheum 50:1693-1694; 2004.
31. Alessandri C, Conti F, Valesini G.
Role of anti-glial fibrillary acidic protein antibodies in the pathogenesis of neuropsychiatric systemic lupus erythematosus should be clarified: comment on the article by Trysberg et al.
Arthritis Rheum 50:1698-1699; 2004.
32. Conti F, Alessandri C, Bompane D, Bombardieri M, Spinelli FR, Rusconi AC, Valesini G.
Autoantibody profile in systemic lupus erythematosus with psychiatric
manifestations: a role for anti-endothelial-cell antibodies.
Arthritis Res Ther 6:R366-72. Jun 17; 2004.
33. Iagnocco A, Ossandon A, Coari G, Conti F, Priori R, Alessandri C, Valesini G.
Wrist joint involvement in systemic lupus erythematosus. An ultrasonographic study.
Clin Exp Rheumatol 22:621-624; 2004.
34. Alessandri C, Bombardieri M, Di Prospero L, Conigliaro P, Conti F, Labbadia G, Misasi R, Sorice M, Valesini G.
Anti-lysobisphosphatidic acid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus.
Clin Exp Immunol 140:173-180; 2005.
35. F Conti, R Priori, M S Chimenti, G Coari, A Annovazzi, G Valesini, A Signore.
Successful intrarticular infliximab for resistant knee monoarthritis in a patient with spondyloarthropathy: a role for scintigraphy with 99mTc- infliximab.
Arthritis Rheum 52:1224-1226; 2005.
36. Margutti P, Sorice M, Conti F, Delunardo F, Racaniello M, Alessandri C, Siracusano A, Riganò R, Profumo E, Valesini G, Ortona E.
Screening of an endothelial cDNA library identifies the C-terminal region of Nedd5 as a novel autoantigen in systemic lupus erythematosus with psychiatric manifestations.
Arthritis Res Ther 7:R896-903; 2005.
37. Conti F, Borrelli O, Anania C, Marocchi E, Romeo EF, Paganelli M, Valesini G, Cucchiara S.
Chronic intestinal inflammation and seronegative spondyloarthropathy in children.
Dig Liver Dis 37:761-767; 2005.
38. Delunardo F, Conti F, Margutti P, Alessandri C, Priori R, Siracusano A, Rigano
R, Profumo E, Valesini G, Sorice M, Ortona E.
Identification and characterization of the carboxy-terminal region of Sip-1, a
novel autoantigen in Behçet's disease.
Arthritis Res Ther 8:R71; 2006.
39. Ossandon A, Bompane D, Alessandri C, Marocchi E, Conti F, Valesini G.
Leishmania in SLE mimicking an exacerbation.
Clin Exp Rheumatol 24:186-190: 2006.
40. Valesini G, Alessandri C, Celestino D, Conti F.
Anti-endothelial antibodies and neuropsychiatric systemic lupus erythematosus.
Ann N Y Acad Sci 1069:118-128; 2006.
41. Chianelli M, D'Alessandria C, Conti F, Priori R, Valesini G, Annovazzi A,
Signore A.
New radiopharmaceuticals for imaging rheumatoid arthritis.
Q J Nucl Med Mol Imaging 50:217-225; 2006.
42. Alessandri C, Sorice M, Bombardieri M, Conigliaro P, Longo A, Garofalo T,
Manganelli V, Conti F, Esposti MD, Valesini G.
Antiphospholipid reactivity against cardiolipin metabolites occurring during
endothelial cell apoptosis.
Arthritis Res Ther 8:R180; 2006.
43. F Conti, S Rezai, G Valesini.
Vaccination and rheumatic diseases: is there still a dilemma?
Curr Rheumatol Review 13:79-91; 2007.
44. Priori R, Medda E, Conti F, Cassarà EA, Sabbadini MG, Antonioli CM, Gerli R,
Danieli MG, Giacomelli R, Pietrogrande M, Valesini G, Stazi MA.
Risk factors for Sjogren's syndrome: a case-control study.
Clin Exp Rheumatol 25:378-384; 2007.
45. Margutti P, Delunardo F, Colasanti T, Piro E, Profumo E, Riganò R, Siracusano A, Buttari B, Conti F, Alessandri C, Capozzi A, Sorice M, Ortona E.
Screening of endothelial expression libraries for the identification of novel
autoantigens involved in distinct autoimmune diseases characterized by
endothelial dysfunction.
Ann N Y Acad Sci 1109:178-184; 2007.
46. Sorice M, Longo A, Capozzi A, Garofalo T, Misasi R, Alessandri C, Conti F,
Buttari B, Riganò R, Ortona E, Valesini G.
Anti-beta2-glycoprotein I antibodies induce monocyte release of tumor necrosis
factor alpha and tissue factor by signal transduction pathways involving lipid
rafts.
Arthritis Rheum 56:2687-2697; 2007.
47. Conti F, Ceccarelli F, Marocchi E, Magrini L, Spinelli FR, Spadaro A, Scrivo R,
Valesini G.
Switching tumour necrosis factor α antagonists in patients with ankylosing
spondylitis and psoriatic arthritis: an observational study over a 5-year period.
Ann Rheum Dis 66:1393-1397; 2007.
48. Accorinti M, Pirraglia MP, Paroli MP, Priori R, Conti F, Pivetti-Pezzi P.
Infliximab treatment for ocular and extraocular manifestations of Behcet's
disease.
Jpn J Ophthalmol 51:191-196; 2007.
49. Delunardo F, Margutti P, Pontecorvo S, Colasanti T, Conti F, Rigano R, Profumo
E, Siracusano A, Capozzi A, Prencipe M, Sorice M, Francia A, Ortona E.
Screening of a microvascular endothelial cDNA library identifies rabaptin 5 as a
novel autoantigen in Alzheimer's disease.
J Neuroimmunol 192:105-112; 2007.
50. Margutti P, Matarrese P, Conti F, Colasanti T, Delunardo F, Capozzi A,
Garofalo T, Profumo E, Rigano R, Siracusano A, Alessandri C, Salvati B, Valesini
G, Malorni W, Sorice M, Ortona E.
Autoantibodies to the C-terminal subunit of RLIP76 induce oxidative stress and
endothelial cell apoptosis in immune-mediated vascular diseases and
atherosclerosis.
Blood 111:4559-4570; 2008.
51. Atzeni F, Bendtzen K, Bobbio-Pallavicini F, Conti F, Cutolo M, Montecucco C,
Sulli A, Valesini G, Sarzi-Puttini P.
Infections and treatment of patients with rheumatic diseases.
Clin Exp Rheumatol 26 (1 Suppl 48):S67-73; 2008.
52. F Conti, F Ceccarelli, R Priori, A Iagnocco, A Signore, G Valesini.
Intraarticular infliximab in patients with rheumatoid arthritis and psoriatic arthritis with monoarthritis resistant to local glucocorticoids. Clinical efficacy extended to patients on systemic anti-TNFα.
Ann Rheum Dis 67:1787-1790; 2008.
53. Conti F, Rezai S, Valesini G.
Vaccination and autoimmune rheumatic diseases.
Autoimmun Rev 8:124-128; 2008.
54. A Ossandon, A Iagnocco, C. Alessandri, R Priori, F Conti, G Valesini.
Clin Ultrasonographic depiction of knee joint alterations in systemic lupus erythematosus.
Clin Exp Rheumatol 27:329-32; 2009.
55. C Alessandri, F Conti, P Conigliaro, R Mancini, L Massaro, G Valesini.
Seronegative autoimmune disease.
Ann NY Acad Sci 1173:52-9; 2009.
56. Conti F, Scrivo R, Spinelli FR, Truglia S, Magrini L, Di Franco M, Ceccarelli F,
Valesini G.
Outcome in patients with rheumatoid arthritis switching TNF-alpha antagonists: a
single center, observational study over an 8-year period.
Clin Exp Rheumatol 27:540-1; 2009.
57. Scrivo R, Conti F, Spinelli FR, Truglia S, Magrini L, Di Franco M, Ceccarelli F,
Valesini G.
Switching between TNFalpha antagonists in rheumatoid arthritis: personal
experience and review of the literature.
Reumatismo 61:107-17; 2009.
58. Malviya G, Conti F, Chianelli M, Scopinaro F, Dierckx RA, Signore A.
Molecular imaging of rheumatoid arthritis by radiolabelled monoclonal antibodies:
new imaging strategies to guide molecular therapies.
Eur J Nucl Med Mol Imaging 37:386-398; 2010.
59. Profumo E, Buttari B, Alessandri C, Conti F, Capoano R, Valesini G, Salvati B,
Riganò R.
Beta2-glycoprotein I is a target of T cell reactivity in patients with advanced carotid atherosclerotic plaques.
Int J Immunopathol Pharmacol 23:73-80; 2010.
60. Conti F, Ceccarelli F, Perricone C, Massaro L, Spinelli FR, Valesini G.
Low incidence of flare and persistent active disease in a cohort of Italian patients with systemic lupus erythematosus: comment on the article by Nikpour et al.
Arthritis Care Res 62:899–900; 2010.
61. Ortona E, Capozzi A, Colasanti T, Conti F, Alessandri C, Longo A, Garofalo T,
Margutti P, Misasi R, Khamashta MA, Hughes GR, Valesini G, Sorice M.
Vimentin/cardiolipin complex as a new antigenic target of the antiphospholipid
syndrome.
Blood 116:2960-7; 2010.
62. MA Khamashta, GRV Hughes, E Ortona, A Capozzi, T Colasanti, F Conti, C Alessandri, A Longo, T Garofalo, P Margutti, R Misasi, G Valesini, M Sorice.
Anti-vimentin/cardiolipin antibodies in “seronegative” Antiphospholipid syndrome
Blood e-Letters (17 September 2010).
63. Conti F, Perricone C, Ceccarelli F, Valesini G.
Rituximab treatment of systemic lupus erythematosus in controlled trials and in clinical practice: Two sides of the same coin.
Autoimmun Rev 9:716-20; 2010.
64. Valesini G, Conti F.
The Persistent Challenge of Lupus Nephritis.
Clin Rev Allergy Immunol 40:135-7; 2011.
65. Conti F, Spinelli FR, Alessandri C, Valesini G.
Toll-like Receptors and Lupus Nephritis.
Clin Rev Allergy Immunol 40:192-8; 2011.
66. Conti F, Ceccarelli F, Perricone C, Alessandri C, Conti V, Massaro L, Truglia S, Spinelli F R, Spadaro A, Valesini G.
Rituximab infusion-related adverse event rates are lower in patients with systemic lupus erythematosus than in those with rheumatoid arthritis.
Rheumatology (Oxford) 50:1148-52; 2011.
67. Mosca M, Govoni M, Tomietto P, Aringer M, Boumpas D, Cervera R, Conti F, D'Cruz D, Doria A, De La Fuente D, Galeazzi M, Houssiau F, Huizinga TW, Khamashta MA, Ines L, Catia D, Couto M, Meroni P, Montecucco C, Norkuviene E, Riemekasten G, Rios V, Schneider M, Shoenfeld Y, Steup-Beekman G, Szmyrka-Kaczmarek M, Tani C, Tincani A, Tzioufas A, Voll R, Bencivelli W, Salaffi F, Bombardieri S.
The development of a simple questionnaire to screen SLE patients for the presence of neuropsychiatric (NP) symptoms in routine clinical practice.
Lupus 20:485-92; 2011.
68. Alessandri C, Conti F, Pendolino M, Mancini R, Valesini G.
New autoantigens in the antiphospholipid syndrome.
Autoimmun Rev 10:609-16; 2011.
69. Matarrese P, Colasanti T, Ascione B, Margutti P, Franconi F, Alessandri C, Conti F, Riccieri V, Rosano G, Ortona E, Malorni W.
Gender disparity in susceptibility to oxidative stress and apoptosis induced by autoantibodies specific to RLIP76 in vascular cells.
Antioxid Redox Signal 15:2825-36; 2011.
70. Caporali R, Conti F, Alivernini S, Atzeni F, Seriolo B, Cutolo M, Valesini G, Ferraccioli G, Sarzi-Puttini P, Salvarani C, Guiducci S, Zampogna G, Gremese E, Pipitone N, Scrivo R, Bugatti S, Montecucco C, Matucci-Cerinic M; Italian Society for Rheumatology.
Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology I. Efficacy.
Clin Exp Rheumatol 29 (3 Suppl 66):S7-14; 2011.
71. Cervera R, Conti F, Doria A, Iaccarino L, Valesini G.
Does seronegative antiphospholipid syndrome really exist?
Autoimmun Rev 11(8):581-4; 2012.
72. Colasanti T, Maselli A, Conti F, Sanchez M, Alessandri C, Barbati C, Vacirca D,
Tinari A, Chiarotti F, Giovannetti A, Franconi F, Valesini G, Malorni W,
Pierdominici M, Ortona E.
Autoantibodies to estrogen receptor α interfere with T lymphocyte homeostasis and are associated with disease activity in systemic lupus erythematosus.
Arthritis Rheum 64:778-87; 2012.
73. M Govoni, S Bombardieri, A Bortoluzzi, L Caniatti, C Casu, F Conti, S De
Vita, A Doria, I Farina, G Ferraccioli, E Gremese, E Mansutti, M Mosca, M
Padovan, M Piga, A Tincani, MR Tola, P Tomietto, M Taglietti, F Trotta, G
Valesini, M Zen, A Mathieu.
Factors and comorbidities associated with first neuropsychiatric event in
systemic lupus erythematosus: does a risk profile exist? A large multicentre
retrospective cross-sectional study on 959 Italian patients.
Rheumatology (Oxford) 51:157-68; 2012.
74. Conti F, Alessandri C, Sorice M, Capozzi A, Longo A, Garofalo T, Misasi R, Bompane D, Hughes GRV, Khamashta MA, Valesini G.
Thin-layer chromatography immunostaining in detecting anti-phospholipid antibodies in seronegative anti-phospholipid syndrome.
Clin Exp Immunol 167:429-437; 2012.
75. Conti F, Alessandri C, Perricone C, Scrivo R, Rezai S, Ceccarelli F, Spinelli FR, Ortona E, Marianetti M, Mina C, Valesini G.
Neurocognitive dysfunction in systemic lupus erythematosus: association with antiphospholipid antibodies, disease activity and chronic damage.
PLoS ONE 7 e33824; 2012.
76. Conti F, Malviya G, Ceccarelli F, Priori R, Iagnocco A, Valesini G, Signore A.
Role of scintigraphy with (99m)Tc-infliximab in predicting the response of
intraarticular infliximab treatment in patients with refractory monoarthritis.
Eur J Nucl Med Mol Imaging 39:1339-47; 2012.
77. De Angelis F, Di Rocco A, Minotti C, Valesini G, Cartoni C, Riminucci M, Conti F,
Finolezzi E, Armiento D, Grammatico S, Massaro L, Fama A, Colafigli G, Viccarone C, Foà R, Martelli M.
Atypical presentation of anaplastic large T-cell lymphoma mimicking an articular
relapse of rheumatoid arthritis in a patient treated with etanercept. A case
report and literature review.
Leuk Res 36:e199-201; 2012.
78. Conti F, Ceccarelli F, Perricone C, Miranda F, Truglia S, Massaro L, Pacucci V A, Conti V, Bartosiewicz I, Spinelli F R, Alessandri C, Valesini G.
Flare, Persistently Active Disease, and Serologically Active Clinically Quiescent Disease in Systemic Lupus Erythematosus: A 2-Year Follow-Up Study.
PLoS ONE 7:e45934; 2012.
79. Alessandri C, Barbati C, Vacirca D, Piscopo P, Confaloni A, Sanchez M, Maselli A, Colasanti T, Conti F, Truglia S, Perl A, Valesini G, Malorni W, Ortona E,
Pierdominici M.
T lymphocytes from patients with systemic lupus erythematosus are resistant to
induction of autophagy.
FASEB J 26:4722-32; 2012.
80. Colasanti T, Alessandri C, Capozzi A, Sorice M, Delunardo F, Longo A,
Pierdominici M, Conti F, Truglia S, Siracusano A, Valesini G, Ortona E, Margutti P.
Autoantibodies specific to a peptide of β2-glycoprotein I cross-react with
TLR4 inducing a pro-inflammatory phenotype in endothelial cells and monocytes.
Blood 120:3360-70; 2012.
81. Iannuccelli C, Spinelli FR, Guzzo MP, Priori R, Conti F, Ceccarelli F, Pietropaolo M, Olivieri M, Minniti A, Alessandri C, Gattamelata A, Valesini G, Di Franco M.
Fatigue and widespread pain in Systemic Lupus Erythematosus and Sjogren's Syndrome: symptoms of the inflammatory disease or associated Fibromyalgia?
Clin Exp Rheumatol 2012; 30 (Suppl. 74): S117-S121.
82. Perricone C, Ciccacci C, Ceccarelli F, Di Fusco D, Spinelli FR, Cipriano E,
Novelli G, Valesini G, Conti F, Borgiani P.
TRAF3IP2 gene and systemic lupus erythematosus: association with disease
susceptibility and pericarditis development.
Immunogenetics 65:703-9; 2013.
83. F Conti, F Ceccarelli, L Massaro, V A Pacucci, F Miranda, S Truglia, E Cipriano, F Martinelli, I Leccese, F R Spinelli, C Alessandri, C Perricone, G Valesini.
Evaluation of the patient acceptable symptom state (pass) in Italian patients affected by Systemic Lupus Erythematosus: association with disease activity indices.
PLoS ONE 8:e73517; 2013.
84. Conti F, Ceccarelli F, Massaro L, Cipriano E, Di Franco M, Alessandri C, Spinelli
FR, Scrivo R, Valesini G.
Biological therapies in rheumatic diseases.
Clin Ter 164:e413-28; 2013.
85. Iagnocco A, Ceccarelli F, Rizzo C, Truglia S, Massaro L, Spinelli F R, Vavala C, Valesini G, Conti F.
Ultrasound evaluation of hand, wrist and foot joint synovitis in systemic lupus erythematosus.
Rheumatology (Oxford) 53:465-72; 2014. First published online: November 14, 2013.
86. Conti F, Spinelli FR, Alessandri C, Pacelli M, Ceccarelli F, Marocchi E, Montali
A, Capozzi A, Buttari B, Profumo E, Sorice M, Arca M, Valesini G, Riganò R. Subclinical Atherosclerosis in Systemic Lupus Erythematosus and Antiphospholipid Syndrome: focus on β2GPI-specific T cell response.
Arterioscler Thromb Vasc Biol 34:661-8; 2014.
87. Conti F, Alessandri C, Spinelli F R, Capozzi A, Martinelli F, Recalchi S, Misasi R, Valesini G, Sorice M.
TLC immunostaining for the detection of “anti-phospholipid antibodies”.
Methods Mol Biol 1134:95-101; 2014.
88. Segni M, Pucarelli I, Truglia S, Turriziani I, Serafinelli C, Conti F.
High prevalence of antinuclear antibodies in children with thyroid autoimmunity.
J Immunol Res 2014:150239; 2014.
89. Conti F, Perricone C, Reboldi G, Gawlicki M, Bartosiewicz I, Pacucci V, Massaro L, Miranda F, Truglia S, Alessandri C, Spinelli F, Teh LS, Ceccarelli F, Valesini G.
Validation of a disease-specific health-related quality of life measure in adult Italian patients with systemic lupus erythematosus: LupusQoL-IT.
Lupus 23:743–751; 2014.
90. Di Franco M, Gerardi MC, Lucchino B, Conti F.
Mavrilimumab: an evidence based review of its potential in the treatment of rheumatoid arthritis.
Core Evid 9:41–48; 2014.
91. Conti F, Capozzi A, Truglia S, Lococo E, Longo A, Misasi R, Alessandri C, Valesini G, Sorice M.
The mosaic of “seronegative” antiphospholipid syndrome
J Immunol Res 2014:389601; 2014.
92. Cervera R, Rodríguez-Pintó I, Colafrancesco S, Conti F, Valesini G, Rosário C, Agmon-Levin N, Shoenfeld Y, Ferrão C, Faria R, Vasconcelos C, Signorelli F, Espinosa G.
14th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome.
Autoimmun Rev 13:699-707; 2014.
93. T Colasanti, M Vomero, C Alessandri, C Barbati, A Maselli, C Camperio, F Conti, A Tinari, C Carlostella, L Tuosto, G Valesini, W Malorni, M Pierdominici, E Ortona, D Benincasa.
Role of α-synuclein in autophagy modulation of primary human T lymphocytes.
Cell Death Dis 5:e1265; 2014.
94. Di Franco M, Guzzo MP, Spinelli FR, Atzeni F, Sarzi-Puttini P, Conti F,
Iannuccelli C.
Pain and systemic lupus erythematosus.
Reumatismo 66:33-38; 2014.
95. Caporali R, Conti F, Covelli M, Govoni M, Salaffi F, Ventriglia G.
Treating rheumatoid arthritis to target: an Italian rheumatologists' survey on the acceptance of the treat-to-target recommendations.
Clin Exp Rheumatol 32:471-6; 2014.
96. Conti F, Ceccarelli F, Gigante A, Barbano B, Perricone C, Massaro
L, Martinelli F, Spinelli FR, Giannakakis K, Valesini G, Cianci R.
Ultrasonographic Evaluation of Renal Resistive Index in Patients with Lupus
Nephritis: Correlation with Histologic Findings.
Ultrasound Med Biol 40:2573-80; 2014.
97. Bortoluzzi A, Scirè CA, Bombardieri S, Caniatti L, Conti F, De
Vita S, Doria A, Ferraccioli G, Gremese E, Mansutti E, Mathieu
A, Mosca M, Padovan M, Piga M, Tincani A, Tola MR, Tomietto
P, Valesini G, Zen M, Govoni M; on behalf of the Study Group on
Neuropsychiatric Systemic Lupus Erythematosus of the Italian Society of
Rheumatology.
Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus.
Rheumatology (Oxford) 54:891-8; 2015. Epub 2014 Oct 21
98. Perricone C, Rinkevich-Shop S, Blank M, Landa-Rouben N, Alessandri C,
Conti F, Leor J, Shoenfeld Y, Valesini G.
The Autoimmune Side of Rheumatic Fever.
IMAJ 16:654–655; 2014.
99. Ceccarelli F, Perricone C, Massaro L, Pacucci VA, Cipriano E, Truglia S, Miranda F, Spinelli FR, Alessandri C, Valesini G, Conti F.
The role of Disease Activity Score 28 in the evaluation of articular involvement in systemic lupus erythematosus.
ScientificWorldJournal Volume 2014, Article ID 236842, 6 pages; 2014.
100. Ciccacci C, Perricone C, Ceccarelli F, Rufini S, Di Fusco D, Alessandri C,
Spinelli FR, Cipriano E, Novelli G, Valesini G, Borgiani P, Conti F.
A multilocus genetic study in a cohort of Italian SLE patients confirms the association with STAT4 gene and describes a new association with HCP5 gene. PLoS One Nov 4;9(11):e111991; 2014.
101. Conti F, Spinelli FR, Colafrancesco S, Truglia S, Ceccarelli F, Fattapposta F, Sorice M, Capozzi A, Ferretti G, Priori R, Martinelli F, Pirone C, Alessandri C, Valesini G.
Acute longitudinal myelitis following Cryptococcus laurentii pneumonia in a
patient with systemic lupus erythematosus.
Lupus 24:94-7; 2015. Epub 2014 Oct 8.
102. Spinelli FR, Di Franco M, Metere A, Conti F, Iannuccelli C, Agati L, Valesini
G.
Decrease of asymmetric dimethyl arginine after anti-TNF therapy in patients with
rheumatoid arthritis.
Drug Dev Res. 2014 Nov;75 Suppl 1:S67-9.
103. Chimenti MS, Spinelli FR, Giunta A, Martinelli F, Saraceno R, Conti F,
Perricone R, Valesini G.
Emergence of antinuclear antibodies in psoriatic patients treated with
infliximab: personal experience and literature review.
Drug Dev Res. 2014 Nov;75 Suppl 1:S61-3.
104. Perricone C, Ceccarelli F, Nesher G, Borella E, Odeh Q, Conti F, Shoenfeld Y,
Valesini G.
Immune thrombocytopenic purpura (ITP) associated with vaccinations: a review of reported cases.
Immunol Res 60:226-35; 2014.
105. Conti F, Ceccarelli F, Perricone C, Massaro L, Cipriano E, Pacucci VA, Truglia
S, Miranda F, Morello F, Alessandri C, Spinelli FR, Valesini G.
Mycophenolate mofetil in systemic lupus erythematosus: results from a
retrospective study in a large monocentric cohort and review of the literature.
Immunol Res 60:270-6; 2014.
106. Artenjak A, Locatelli I, Brelih H, Simonič DM, Ulcova-Gallova Z, Swadzba J,
Musial J, Iwaniec T, Stojanovich L, Conti F, Valesini G, Avčin T, Cohen Tervaert
JW, Shoenfeld Y, Blank M, Ambrožič A, Sodin-Semrl S, Božič B, Cučnik S.
Immunoreactivity and avidity of IgG anti-β2-glycoprotein I antibodies from
patients with autoimmune diseases to different peptide clusters of
β2-glycoprotein I.
Immunol Res 61:35-44; 2015.
107. Barbati C, Alessandri C, Vomero M, Vona R, Colasanti T, Vacirca D, Camerini S, Crescenzi M, Pendolino M, Truglia S, Conti F, Garofalo T, Sorice M, Pierdominici M, Valesini G, Malorni W, Ortona E.
Autoantibodies specific to D4GDI modulate Rho GTPase mediated cytoskeleton remodeling and induce autophagy in T lymphocytes.
J Autoimmun 58:78-89; 2015.
108. Ceccarelli F, Perricone C, Massaro L, Cipriano E, Alessandri C, Spinelli FR, Valesini G, Conti F.
Assessment of disease activity in Systemic Lupus Erythematosus: lights and
shadows.
Autoimmun Rev 14:601-8; 2015.
109. Misasi R, Capozzi A, Longo A, Recalchi S, Emanuela Lococo E, Alessandri C, Conti F, Valesini G, Sorice M.
“New” antigenic targets and methodological approaches for refining laboratory diagnosis of antiphospholipid syndrome.
J Immunol Res 2015:858542; 2015.
110. Perricone C, Pendolino M, Olivieri M, Conti F, Valesini G, Alessandri C. Neuropsychiatric manifestations associated with anti-endothelial cell antibodies
in systemic lupus erythematosus.
Isr Med Assoc J 17:171-8; 2015.
111. Conti F, Ceccarelli F, Gigante A, Perricone C, Barbano B, Massaro L, Spinelli FR, Alessandri C, Valesini G, Cianci R.
Ultrasonographic evaluation of resistive index and renal artery stenosis in
patients with anti-phospholipid syndrome: two distinct mechanisms?
Ultrasound Med Biol 41:1814-20; 2015.
112. Mastrangelo A, Colasanti T, Barbati C, Pecani A, Sabatinelli D, Pendolino M,
Truglia S, Massaro L, Mancini R, Miranda F, Spinelli FR, Conti F, Alessandri C.
The role of posttranslational protein modifications in rheumatological diseases: focus on Rheumatoid Arthritis.
J Immunol Res 2015:712490; 2015.
113. Spinelli FR, Pecani A, Ceccarelli F, Alessandri C, Conti F.
Effect of Etanercept on Anti-Carbamylated Protein Antibodies in Patients with Rheumatoid Arthritis.
J Rheum Dis Treat 1:013; 2015.
114. Iaccarino L, Bartoloni E, Carli L, Ceccarelli F, Conti F, De Vita
S, Ferraccioli G, Galeazzi M, Gatto M, Gerli R, Govoni M, Gremese E, Iuliano A, Mansutti E, Moroni G, Mosca M, Nalli C, Naretto C, Padovan M, Palma , Raffiotta F, Roccatello D, Tincani A, Valesini G, Zen M, Doria A.
Efficacy and safety of off-label use of rituximab in refractory lupus: data from The Italian Multicentre Registry.
Clin Exp Rheumatol 33:449-56; 2015.
115. Conti F, Ceccarelli F, Perricone C, Massaro L, Marocchi E, Miranda F, Spinelli FR, Truglia S, Alessandri C, Valesini G.
Systemic Lupus Erythematosus with and without anti-dsDNA antibodies: analysis
from a large monocentric cohort.
Mediators Inflamm 2015:328078; 2015.
116. Foltyn Zadura A, Memon AA, Stojanovich L, Perricone C, Conti F, Valesini G,
Bogdanovic G, Hillarp A, Shoenfeld Y, Sundquist J, Leffler J, Svensson PJ, Trouw LA, Blom AM.
Factor H Autoantibodies in Patients with Antiphospholipid Syndrome
and Thrombosis.
J Rheumatol 42:1786-93; 2015.
117. Alessandri C, Bartosiewicz I, Pendolino M, Mancini R, Colasanti T, Pecani A, Morello F, Mastrangelo A, Sabatinelli D, Riccieri V, Di Franco M, Ceccarelli F, Perricone C, Conti F, Valesini G.
Anti-carbamylated protein antibodies in unaffected first-degree relatives of rheumatoid arthritis patients: lack of correlation with anti-cyclic citrullinated protein antibodies and rheumatoid factor.
Clin Exp Rheumatol 33:824-30; 2015.
118. Cipriano E, Ceccarelli F, Massaro L, Spinelli FR, Alessandri C, Perricone C,
Valesini G, Conti F.
Joint involvement in patients affected by systemic lupus erythematosus: application of the swollen to tender joint count ratio.
Reumatismo 67:62-7; 2015.
119. Spinelli FR, Ceccarelli F, Alessandri C, Sili Scavalli A, Conti F, Valesini G.
Developing new evaluation methods in systemic lupus erythematosus.
International Journal of Clinical Rheumatology 10:479-488; 2015.
120. Ceccarelli F, Perricone C, Borgiani P, Ciccacci C, Rufini S, Cipriano E, Alessandri C, Spinelli FR, Sili Scavalli A, Novelli G, Valesini G, Conti F.
Genetic Factors in Systemic Lupus Erythematosus: Contribution to Disease Phenotype.
J Immunol Res 2015:745647; 2015.
121. Sorice M, Buttari B, Capozzi A, Profumo E, Facchiano F, Truglia S, Recalchi S, Alessandri C, Conti F, Misasi R, Valesini G, Riganò R.
Antibodies to age-β2 glycoprotein i in patients with antiphospholipid antibody
syndrome.
Clin Exp Immunol 184:174-82; 2016. Epub 2016 Feb 15.
122. Maselli A, Conti F, Alessandri C, Colasanti T, Barbati C, Vomero M, Ciarlo L, Patrizio M, Spinelli FR, Ortona E, Valesini G, Pierdominici M.
Low expression of estrogen receptor β in T lymphocytes and high serum levels of
anti-estrogen receptor α antibodies impact disease activity in female patients
with systemic lupus erythematosus.
Biol Sex Differ 12;7:3. 2016.
123. Vadasz Z, Goldeberg Y, Halasz K, Rosner I, Valesini G, Conti F, Perricone C, Sthoeger Z, Bezalel SR, Tzioufas AG, Levin N, Shoenfeld Y, Toubi E.
Increased soluble CD72 in systemic lupus erythematosus is in association with
disease activity and lupus nephritis.
Clin Immunol 13;164:114-8; 2016.
124. Perricone C, Versini M, Ben-Ami D, Gertel S, Watad A, Segel MJ, Ceccarelli F, Conti F, Cantarini L, Bogdanos DP, Antonelli A, Amital H, Valesini G, Shoenfeld Y.
Smoke and autoimmunity: The fire behind the disease.
Autoimmun Rev 15:354-74; 2016.
125. Conti F, Ceccarelli F, Perricone C, Leccese I, Massaro L, Pacucci VA, Truglia S, Miranda F, Spinelli FR, Alessandri C, Valesini G.
The chronic damage in systemic lupus erythematosus is driven by flares,
glucocorticoids and antiphospholipid antibodies: results from a monocentric
cohort.
Lupus 25:719-26; 2016.
126. Gigante A, Barbano B, Di Mario F, Rosato E, Simonelli M, Rocca
AR, Conti F, Ceccarelli F, Giannakakis K, Valesini G, Cianci R.
Renal parenchymal resistance in patients with biopsy proven glomerulonephritis:
correlation with histological findings.
Int J Immunopathol Pharmacol 29:469-74; 2016.
127. Delunardo F, Soldati D, Bellisario V, Berry A, Camerini S, Crescenzi M, Alessandri C, Conti F, Ceccarelli F, Francia A, Valesini G, Cirulli F, Siracusano A, Siracusano A, Niolu C, Alex Rubino I, Ortona E, Margutti P.
Anti-GAPDH autoantibodies as a pathogenic determinant and potential biomarker of neuropsychiatric diseases.
Arthritis Rheumatol 68:2708-16; 2016.
128. Conti F, Ceccarelli F, Iaiani G, Perricone C, Giordano A, Amori L, Miranda F, Massaro L, Pacucci VA, Truglia S, Girelli G, Fakeri A, Taliani G, Temperoni C, Spinelli FR, Alessandri C, Valesini G.
Association between Staphylococcus aureus nasal carriage and disease phenotype in patients affected by systemic lupus erythematosus.
Arthritis Res Ther 30;18:177; 2016.
129. F Conti, FR Spinelli, S Truglia, F Miranda, C Alessandri, F Ceccarelli, M Bombardieri, K Giannakakis, G Valesini.
Kidney expression of Toll Like Receptors in lupus nephritis: quantification and clinicopathological correlations.
Mediators Inflamm 2016:7697592; 2016.
130. Spinelli FR, Pecani A, Conti F, Mancini R, Alessandri C, Valesini G.
Post-translational modifications in rheumatoid arthritis and atherosclerosis:
Focus on citrullination and carbamylation.
J Int Med Res 44(1 suppl):81-84; 2016.
131. Ciccacci C, Perricone C, Politi C, Rufini S, Ceccarelli F, Cipriano E, Alessandri C, Latini A, Valesini G, Novelli G, Conti F, Borgiani P.
A polymorphism upstream MIR1279 gene is associated with pericarditis development in Systemic Lupus Erythematosus and contributes to definition of a genetic risk profile for this complication.
Lupus 26:841-848; 2017. Epub 2016 Nov 23.
132. Pecani A, Alessandri C, Spinelli FR, Priori R, Riccieri V, Di Franco M, Ceccarelli F, Colasanti T, Pendolino M, Mancini R, Truglia S, Barbati C, Vomero M, Sabatinelli D, Morello F, Valesini G, Conti F.
Prevalence, sensitivity and specificity of antibodies against carbamylated
proteins in a monocentric cohort of patients with rheumatoid arthritis and other
autoimmune rheumatic diseases.
Arthritis Res Ther 25;18:276; 2016.
133. Alessandri C, Agmon-Levin N, Conti F, Perricone C, Ortona E, Pendolino M, Capozzi A, Delunardo F, Mancini R, Truglia S, Spinelli FR, Ceccarelli F, Sorice M, Shoenfeld Y, Valesini G.
Anti-mutated citrullinated vimentin antibodies in antiphospholipid syndrome:
diagnostic value and relationship with clinical features.
Immunol Res 65:524-531; 2017.
134. Caporali R, Carletto A, Conti F, D'Angelo S, Foti R, Gremese E, Govoni M, Iannone F, Pellerito R, Sinigaglia L.
Using a modified Delphi process to establish clinical consensus for the
diagnosis, risk assessment and abatacept treatment in patients with aggressive
rheumatoid arthritis.
Clin Exp Rheumatol 35:772-776; 2017.
135. Ceccarelli F, Sciandrone M, Perricone C, Galvan G, Morelli F, Vicente LN, Leccese I, Massaro L, Cipriano E, Spinelli FR, Alessandri C, Valesini G, Conti F.
Prediction of chronic damage in systemic lupus erythematosus by using
machine-learning models.
PLoS One 12(3):e0174200; 2017.
136. Ceccarelli F, Massaro L, Perricone C, Pendolino M, Cipriano E, Truglia S, Miranda, F, Spinelli FR, Alessandri C, Valesini G, Conti F.
Jaccoud's arthropathy in systemic lupus erythematosus: clinical, laboratory and
ultrasonographic features.
Clin Exp Rheumatol 35:674-677; 2017.
137. Ceccarelli F, Perricone C, Cipriano E, Massaro L, Natalucci F, Capalbo G, Leccese I, Bogdanos D, Spinelli FR, Alessandri C, Valesini G, Conti F.
Joint involvement in systemic lupus erythematosus: From pathogenesis to clinical
assessment.
Semin Arthritis Rheum 47:53-64; 2017.
138. Bartalesi F, Scirè C, Requena-Méndez A, Abad MA, Buonfrate D, Caporali R, Conti F, Diaz-Gonzalez F, Fernández-Espartero C, Martinez-Fernandez C, Mascarello M, Generali E, Minisola G, Morrone A, Muñoz J, Richi P, Sakellariou G, Salas Coronas J, Spinicci M, Castelli F, Bartoloni A, Bisoffi Z, Gimenez-Sanchez F, Muñoz-Fernandez S, Matucci-Cerinic M
Recommendations for infectious disease screening in migrants to Western Europe with inflammatory arthropathies before starting biologic agents. Results from a multidisciplinary task force of four European societies (SIR, SER, SIMET, SEMTSI) facing the largest impact of the flow of migrants today.
Clin Exp Rheumatol 35:752-765; 2017.
139. Conti F, Priori R, Alessandri C, Misasi R, Capozzi A, Pendolino M, Truglia S, Frisenda S, Sorice M, Valesini G
Diagnosis of catastrophic anti-phospholipid syndrome in a patient tested negative
for conventional tests.
Clin Exp Rheumatol 35:678-680; 2017.
140. Spinelli FR, Pecani A, Ciciarello F, Colasanti T, Di Franco M, Miranda F, Conti F, Valesini G, Alessandri C
Association between antibodies to carbamylated proteins and subclinical
atherosclerosis in rheumatoid arthritis patients.
BMC Musculoskelet Disord 18:214; 2017.
141 Massaro L, Ceccarelli F, Colasanti T, Pendolino M, Perricone C, Cipriano E, Natalucci F, Capalbo G, Lucchetti R, Pecani A, Vomero M, Mancini R, Spinelli FR, Alessandri C, Valesini G, Conti F.
Anti-carbamylated protein antibodies in systemic lupus erythematosus patients
with articular involvement.
Lupus 27:105-111; 2018. Epub 2017 Jun 7.
142. Alessandri C, Ciccia F, Priori R, Astorri E, Guggino G, Alessandro R, Rizzo A, Conti F, Minniti A, Barbati C, Vomero M, Pendolino M, Finucci A, Ortona E, Colasanti T, Pierdominici M, Malorni W, Triolo G, Valesini G.
CD4 T lymphocyte autophagy is upregulated in the salivary glands of primary Sjögren's syndrome patients and correlates with focus score and disease activity.
Arthritis Res Ther 19:178; 2017.
143. Giacomelli R, Afeltra A, Alunno A, Baldini C, Bartoloni-Bocci E, Berardicurti O, Carubbi F, Cauli A, Cervera R, Ciccia F, Cipriani P, Conti F, De Vita S, Di Benedetto P, Doria A, Drosos AA, Favalli EG, Gandolfo S, Gatto M, Grembiale RD, Liakouli V, Lories R, Lubrano E, Lunardi C, Margiotta DPE, Massaro L, Meroni P, Minniti A, Navarini L, Pendolino M, Perosa F, Pers
JO, Prete M, Priori R, Puppo F, Quartuccio L, Ruffatti A, Ruscitti P, Russo B, Sarzi-Puttini P, Shoenfeld Y, Somarakis GA, Spinelli FR, Tinazzi E, Triolo G, Ursini F, Valentini G, Valesini G, Vettori S, Vitali C, Tzioufas AG.
International consensus: what else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management.
Autoimmun Rev 16:911-924; 2017.
144. González-Gay MA, Montecucco C, Selva-O'Callaghan A, Trallero-Araguas E, Molberg O, Andersson H, Rojas-Serrano J, Perez-Roman DI, Bauhammer J, Fiehn C, Neri R, Barsotti S, Lorenz HM, Doria A, Ghirardello A, Iannone F, Giannini M, Franceschini F, Cavazzana I, Triantafyllias K, Benucci M, Infantino M, Manfredi M, Conti F, Schwarting A, Sebastiani G, Iuliano A, Emmi G, Silvestri E, Govoni M, Scirè CA, Furini F, Lopez-Longo FJ, Martínez-Barrio J, Sebastiani M, Manfredi A, Bachiller-Corral J, Sifuentes Giraldo WA, Cimmino MA, Cosso C, Belotti Masserini A, Cagnotto G, Codullo V, Romano M, Paolazzi G, Pellerito R, Saketkoo LA, Ortego-Centeno N, Quartuccio L, Batticciotto A, Bartoloni Bocci E, Gerli R, Specker C, Bravi E, Selmi C, Parisi S, Salaffi F, Meloni F, Marchioni E, Pesci A, Dei G, Confalonieri M, Tomietto P, Nuno L, Bonella F, Pipitone N, Mera-Valera A, Perez-Gomez N, Gerzeli S, Lopez-Mejias R, Matos-Costa CJ, Pereira da Silva JA, Cifrian J, Alpini C, Olivieri I, Blázquez Cañamero MÁ, Rodriguez Cambrón AB, Castañeda S, Cavagna L; AENEAS (American and European NEtwork of Antisynthetase Syndrome) collaborative group. Timing of onset affects arthritis presentation pattern in antisyntethase syndrome.
Clin Exp Rheumatol 36:44-49; 2018. Epub 2017 Jul 26.
145. Scrivo R, Massaro L, Barbati C, Vomero M, Ceccarelli F, Spinelli FR, Riccieri V, Spagnoli A, Alessandri C, Desideri G, Conti F, Valesini G.
The role of dietary sodium intake on the modulation of T helper 17 cells and regulatory T cells in patients with rheumatoid arthritis and systemic lupus erythematosus.
PLoS One 6;12(9):e0184449; 2017.
146. Iaccarino L, Andreoli L, Bocci EB, Bortoluzzi A, Ceccarelli F, Conti F, De Angelis R, De Marchi G, De Vita S, Di Matteo A, Emmi G, Emmi L, Gatto M, Gerli R, Gerosa M, Govoni M, Larosa M, Meroni PL, Mosca M, Pazzola G, Reggia R, Saccon F, Salvarani C, Tani C, Zen M, Frigo AC, Tincani A, Doria A.
Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide study.
J Autoimmun 86:1-8; 2018. Epub 2017 Sep 19.
147. Arnaud L, Conti F, Massaro L, Denas G, Chasset F, Pengo V.
Primary thromboprophylaxis with low-dose aspirin and antiphospholipid antibodies: Pro's and Con's.
Autoimmun Rev 16:1103-1108; 2017.
148. Del Giudice E, Dilillo A, Tromba L, La Torre G, Blasi S, Conti F, Viola F, Cucchiara S, Duse M.
Aortic, carotid intima-media thickness and flow-mediated dilation as markers of early atherosclerosis in a cohort of pediatric patients with rheumatic diseases.
Clin Rheumatol 37:1675-1682; 2018. Epub 2017 Oct 12.
149. Manganelli V, Capozzi A, Truglia S, Alessandri C, Lococo E, Garofalo T, De Carolis C, Conti F, Valesini G, Sorice M, Longo A, Misasi R.
Elevated Serum Level of HMGB1 in Patients with the Antiphospholipid Syndrome.
J Immunol Res 2017:4570715; 2017.
150. Di Franco M, Lucchino B, Conti F, Valesini G, Spinelli FR.
Asymmetric Dimethyl Arginine as a Biomarker of Atherosclerosis in Rheumatoid Arthritis.
Mediators Inflamm 2018:3897295; 2018.
151. Conti F, Pontikaki I, D'Andrea M, Ravelli A, De Benedetti F.
Patients with juvenile idiopathic arthritis become adults: the role of transitional care.
Clin Exp Rheumatol 36:1086-1094; 2018. Epub 2018 Apr 13.
152. Ceccarelli F, Perricone C, Pirone C, Massaro L, Alessandri C, Mina C, Marianetti M, Spinelli FR, Valesini G, Conti F.
Cognitive dysfunction improves in systemic lupus erythematosus: Results of a 10 years prospective study.
PLoS One 3;13(5):e0196103; 2018.
153. Scrivo R, Gerardi MC, Rutigliano I, Sessa P, Mipatrini D, Stricchiola GMG, Pacella E, Altobelli A, Castellani C, Alessandri C, Ceccarelli F, Di Franco M, Priori R, Riccieri V, Sili Scavalli A, Spinelli FR, La Torre G, Conti F, Valesini G.
Polymyalgia rheumatica and diverticular disease: just two distinct age-related disorders or more? Results from a case-control study.
Clin Rheumatol 37:2573-2577; 2018.
154. Ciccacci C, Perricone C, Alessandri C, Latini A, Politi C, Delunardo F, Pierdominici M, Conti F, Novelli G, Ortona E, Borgiani P.
Evaluation of ATG5 polymorphisms in Italian patients with systemic lupus erythematosus: contribution to disease susceptibility and clinical phenotypes.
Lupus 27:1464-1469; 2018
155. Sebastiani GD, Prevete I, Iuliano A, Piga M, Iannone F, Coladonato L, Govoni M, Bortoluzzi A, Mosca M, Tani C, Doria A, Iaccarino L, Tincani A, Fredi M, Conti F, Spinelli FR, Galeazzi M, Bellisai F, Zanetti A, Carrara G, Scirè CA, Mathieu A.
Early Lupus Project: one-year follow-up of an Italian cohort of patients with
systemic lupus erythematosus of recent onset.
Lupus 27:1479-1488; 2018
156. Ceccarelli F, Lucchetti R, Spinelli FR, Perricone C, Truglia S, Miranda F, Scrivo R, Alessandri C, Valesini G, Conti F.
Early response to apremilast treatment in psoriatic arthritis: a real-life ultrasonographic follow-up study.
Rheumatology (Oxford) 1;57:1490-1491; 2018.
157. Ceccarelli F, Perricone C, Colasanti T, Massaro L, Cipriano E, Pendolino M, Natalucci F, Mancini R, Spinelli FR, Valesini G, Conti F, Alessandri C.
Anti-carbamylated protein antibodies as a new biomarker of erosive joint damage in systemic lupus erythematosus.
Arthritis Res Ther 14;20:126; 2018.
158. Spinelli FR, Moscarelli E, Ceccarelli F, Miranda F, Perricone C, Truglia S, Garufi C, Massaro L, Morello F, Alessandri C, Valesini G, Conti F.
Treating lupus patients with antimalarials: analysis of safety profile in a single-center cohort.
Lupus 27:1616-1623; 2018.
159. Ceccarelli F, Orrù G, Pilloni A, Bartosiewicz I, Perricone C, Martino E, Lucchetti R, Fais S, Vomero M, Olivieri M, di Franco M, Priori R, Riccieri V, Scrivo R, Shoenfeld Y, Alessandri C, Conti F, Polimeni A, Valesini G.
Porphyromonas gingivalis in the tongue biofilm is associated with the clinical outcome in rheumatoid arthritis patients.
Clin Exp Immunol 194:244-252; 2018.
160. Favalli EG, Conti F, Atzeni F, Selmi C, D'Angelo S, Caporali R, Iannone F.
COMMENTS ON "Short-term reasons for withdrawal and adverse events associated with apremilast therapy for psoriasis in real-world practice compared with in clinical trials: A multicenter retrospective study".
J Am Acad Dermatol 9:e119-e120; 2018.
161. Dupuis ML, Conti F, Maselli A, Pagano MT, Ruggieri A, Anticoli S, Fragale A, Gabriele L, Gagliardi MC, Sanchez M, Ceccarelli F, Alessandri C, Valesini G, Ortona E, Pierdominici M.
The Natural Agonist of Estrogen Receptor β Silibinin Plays an Immunosuppressive Role Representing a Potential Therapeutic Tool in Rheumatoid Arthritis.
Front Immunol 17;9:1903; 2018.
162. Vomero M, Barbati C, Colasanti T, Perricone C, Novelli L, Ceccarelli F, Spinelli FR, Di Franco M, Conti F, Valesini G, Alessandri C.
Autophagy and Rheumatoid Arthritis: Current Knowledges and Future Perspectives.
Front Immunol 18;9:1577; 2018.
163. Truglia S, Capozzi A, Mancuso S, Recalchi S, Spinelli FR, Perricone C, De Carolis C, Manganelli V, Riitano G, Garofalo T, Longo A, De Carolis S, Alessandri C, Misasi R, Valesini G, Sorice M, Conti F.
A Monocentric Cohort of Obstetric Seronegative Anti-Phospholipid Syndrome.
Front Immunol Jul 20;9:1678; 2018.
164. Mackay M, Dall'Era M, Fishbein J, Kalunian K, Lesser M, Sanchez Guerrero J, Levy DM, Silverman E, Petri M, Arriens C, Lewis EJ, Korbet SM, Conti F, Tesar V, Hruskova Z, Borba EF, Bonfa E, Chan TM, Rathi M, Gupta KL, Jha V, Hasni S, West MR, Silverman E, Solomons N, Houssiau FA, Romera Diaz J, Mejia-Vilet J, Rovin BH.
Establishing Surrogate Kidney Endpoints for Lupus Nephritis Clinical Trials: Development and Validation of a Novel Approach to Predict Future Kidney Outcomes.
Arthritis Rheumatol 71:411-419; 2019. 2018 Sep 17. [Epub ahead of print]
165. Frasca L, Palazzo R, Chimenti MS, Alivernini S, Tolusso B, Bui L, Botti E, Giunta A, Bianchi L, Petricca L, Auteri SE, Spadaro F, Fonti GL, Falchi M, Evangelista A, Marinari B, Pietraforte I, Spinelli FR, Colasanti T, Alessandri C, Conti F, Gremese E, Costanzo A, Valesini G, Perricone R, Lande R.
Anti-LL37 Antibodies Are Present in Psoriatic Arthritis (PsA) Patients: New Biomarkers in PsA.
Front Immunol 12;9:1936; 2018.
166. Ceccarelli F, Orrù G, Pilloni A, Bartosiewicz I, Perricone C, Martino E, Lucchetti R, Fais S, Vomero M, Olivieri M, di Franco M, Priori R, Riccieri V, Scrivo R, Shoenfeld Y, Alessandri C, Conti F, Polimeni A, Valesini G.
Porphyromonas gingivalis in the tongue biofilm is associated with clinical outcome in rheumatoid arthritis patients.
Clin Exp Immunol 194:244-252; 2018.
167. Colasanti T, Fiorito S, Alessandri C, Serafino A, Andreola F, Barbati C, Morello F, Alfè M, Di Blasio G, Gargiulo V, Vomero M, Conti F, Valesini G.
Diesel exhaust particles induce autophagy and citrullination in Normal Human Bronchial Epithelial cells.
Cell Death Dis 19;9:1073; 2018.
168. Barbati C, Vomero M, Colasanti T, Ceccarelli F, Marcosano M, Miranda F, Novelli L, Pecani A, Perricone C, Spinelli FR, Truglia S, Conti F, Valesini G, Alessandri C.
Microparticles and autophagy: a new frontier in the understanding of atherosclerosis in rheumatoid arthritis.
Immunol Res 7;20:273; 2018.
169. Conti F, Atzeni F, Massaro L, Chiara Gerardi M, Gremese E, Passiu G, Carletto A, Malavolta N, Foti R, Ramonda R, Sarzi-Puttini P.
The influence of comorbidities on the efficacy of tumour necrosis factor inhibitors, and the effect of tumour necrosis factor inhibitors on comorbidities in rheumatoid arthritis: report from a National Consensus Conference.
Rheumatology (Oxford) 1;57(57 Suppl 7):vii11-vii22; 2018.
170. Ceccarelli F, Sciandrone M, Perricone C, Galvan G, Cipriano E, Galligari A, Levato T, Colasanti T, Massaro L, Natalucci F, Spinelli FR, Alessandri C, Valesini G, Conti F.
Biomarkers of erosive arthritis in systemic lupus erythematosus: Application of machine learning models.
PLoS One 13(12):e0207926; 2018.
171. Barbati C, Vomero M, Colasanti T, Diociaiuti M, Ceccarelli F, Ferrigno S, Finucci A, Miranda F, Novelli L, Perricone C, Spinelli FR, Truglia S, Conti F, Valesini G, Alessandri C.
TNFα expressed on the surface of microparticles modulates endothelial cell fate in rheumatoid arthritis.
Arthritis Res Ther 20:273; 2018.
172. Tamirou F, Arnaud L, Talarico R, Scirè CA, Alexander T, Amoura Z, Avcin T, Bortoluzzi A, Cervera R, Conti F, Cornet A, Devilliers H, Doria A, Frassi M, Fredi M, Govoni M, Houssiau F, Lladò A, Macieira C, Martin T, Massaro L, Moraes-Fontes MF, Pamfili C, Paolino S, Tani C, Tas SW, Tektonidou M, Tincani A, Van Vollenhoven RF, Bombardieri S, Burmester G, Eurico FJ, Galetti I, Hachulla E, Mueller-Ladner U, Schneider M, Smith V, Cutolo M, Mosca M, Costedoat-Chalumeau N.
Systemic lupus erythematosus: state of the art on clinical practice guidelines.
RMD Open 4(2):e000793; 2018.
173. Giacomelli R, Afeltra A, Alunno A, Bartoloni-Bocci E, Berardicurti O, Bombardieri M, Bortoluzzi A, Caporali R, Caso F, Cervera R, Chimenti MS, Cipriani P, Coloma E, Conti F, D'Angelo S, De Vita S, Di Bartolomeo S, Distler O, Doria A, Feist E, Fisher BA, Gerosa M, Gilio M, Guggino G, Liakouli V, Margiotta DPE, Meroni P, Moroncini G, Perosa F, Prete M, Priori R, Rebuffi C, Ruscitti P, Scarpa R, Shoenfeld Y, Todoerti M, Ursini F, Valesini G, Vettori S, Vitali C, Tzioufas AG.
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis.
Autoimmun Rev 18:93-106; 2019.
174. Vomero M, Manganelli V, Barbati C, Colasanti T, Capozzi A, Finucci A, Spinelli FR, Ceccarelli F, Perricone C, Truglia S, Morrone S, Maggio R, Misasi R, Bombardieri M, Di Franco M, Conti F, Sorice M, Valesini G, Alessandri C.
Reduction of autophagy and increase in apoptosis correlates with a favorable clinical outcome in patients with rheumatoid arthritis treated with anti-TNF drugs.
Arthritis Res Ther 21:39; 2019.
175. Capozzi A, Manganelli V, Riitano G, Recalchi S, Truglia S, Alessandri C, Longo A, Garofalo T, Misasi R, Valesini G, Conti F, Sorice M.
Tissue Factor overexpression in platelets of patients with Antiphospholipid Syndrome: induction role of anti-β2-GPI antibodies
Clin Exp Immunol 196:59-66; 2019.
176. Manganelli V, Truglia S, Capozzi A, Alessandri C, Riitano G, Spinelli FR, Ceccarelli F, Mancuso S, Garofalo T, Longo A, Valesini G, Sorice M, Conti F, Misasi R.
Alarmin HMGB1 and Soluble RAGE as New Tools to Evaluate the Risk Stratification in Patients With the Antiphospholipid Syndrome.
Front Immunol 14;10:460; 2019.
177. Novelli L, Barbati C, Ceccarelli F, Perricone C, Spinelli FR, Alessandri C, Valesini G, Perricone R, Conti F.
CD44v3 and CD44v6 isoforms on T cells are able to discriminate different disease activity degrees and phenotypes in systemic lupus erythematosus patients.
Lupus 28:621-628; 2019.
178. Ceccarelli F, Perricone C, Cipriano E, Massaro L, Natalucci F, Spinelli FR, Alessandri C, Valesini G, Conti F.
Usefulness of composite indices in the assessment of joint involvement in systemic lupus erythematosus patients: correlation with ultrasonographic score.
Lupus 28:383-388; 2019.
179. Perricone C, Ceccarelli F, Matteo S, Di Carlo G, Bogdanos DP, Lucchetti R, Pilloni A, Valesini G, Polimeni A, Conti F.
Porphyromonas gingivalis and rheumatoid arthritis.
Curr Opin Rheumatol 31:517-524; 2019.
180. Barbati C, Stefanini L, Colasanti T, Cipriano E, Celia A, Gabriele G, Vomero M, Ceccarelli F, Spinelli FR, Finucci A, Speziali M, Orso G, Margiotta DPE, Conti F, Violi F, Afeltra A, Valesini G, Alessandri C.
Anti-D4GDI antibodies activate platelets in vitro: a possible link with thrombocytopenia in primary antiphospholipid syndrome.
Arthritis Res Ther 21:161; 2019.
181. Favalli EG, Becciolini A, Carletto A, Conti F, Amato G, Fusaro E, Quartuccio L, Egan CG, Lo Monaco A, Benucci M, Salaffi F, Semeraro A, Parisi S, Ceccarelli F, Piazza I, Foti R.
Efficacy and retention rate of adalimumab in rheumatoid arthritis and psoriatic arthritis patients after first-line etanercept failure: the FEARLESS cohort.
Rheumatol Int. 2019 Aug 21. doi: 10.1007/s00296-019-04416-3. [Epub ahead of print].
182. Reggia R, Andreoli L, Sebbar H, Canti V, Ceccarelli F, Favaro M, Hoxha A, Inversetti A, Larosa M, Ramoni V, Caporali R, Conti F, Doria A, Montecucco C, Rovere-Querini P, Ruffatti A, Valesini G, Zatti S, Fallo L, Lojacono A, Tincani A.
An observational multicentre study on the efficacy and safety of assisted reproductive technologies in women with rheumatic diseases.
Rheumatol Adv Pract. 2019 Feb 22;3(1):rkz005. doi: 10.1093/rap/rkz005. eCollection 2019.
183. Spinelli FR, Garufi C, Truglia S, Pacucci VA, Morello F, Miranda F, Perricone C, Ceccarelli F, Valesini G, Conti F.
The role of osteopontin as a candidate biomarker of renal involvement in systemic lupus erythematosus.
Clin Exp Rheumatol. 37:899-905; 2019.
184 Scrivo R, Perricone C, Altobelli A, Castellani C, Tinti L, Conti F, Valesini G.
Dietary Habits Bursting into the Complex Pathogenesis of Autoimmune Diseases: The Emerging Role of Salt from Experimental and Clinical Studies.
Nutrients 2019 May 5;11(5) pii: E1013.
185. Favalli EG, Conti F, Selmi C, Iannone F, Bucci R, D'Onofrio F, Carlino G, Santo L, Semeraro A, Zuccaro C, D'Angelo S, Atzeni F, Marino F, Monti S, Guidelli GM, Spinelli FR, Biggioggero M, Caporali R.
Retrospective evaluation of patient profiling and effectiveness of apremilast in an
Italian multicentric cohort of psoriatic arthritis patients.
Clin Exp Rheumatol. 38:19-26; 2020. Accepted in revised form on February 25, 2019.
186. Conti F, Ceccarelli F, Spinelli FR.
Comment on: 'Temporal relationships between systemic lupus erythematosus and comorbidities'.
Rheumatology (Oxford). 2019 Jul 10. pii: kez271. doi: 10.1093/rheumatology/kez271. [Epub ahead of print]
187. Ravelli A, Sinigaglia L, Cimaz R, Alessio M, Breda L, Cattalini M, Consolaro A, Conti F, Cortis E, D'Angelo S, De Benedetti F, Doria A, Ferrari C, Gallizzi R, Govoni M, Gremese E, Iannone F, La Torre F, Maggio MC, Perricone R, Pontikaki I, Rossi F, Salaffi F, Simonini G, Caporali R; Italian Paediatric Rheumatology Study Group and the Italian Society of Rheumatology.
Transitional care of young people with juvenile idiopathic arthritis in Italy: results of a Delphi consensus survey.
Clin Exp Rheumatol. 37:1084-1091; 2019.
188. Ceccarelli F, Lucchetti R, Perricone C, Spinelli FR, Cipriano E, Truglia S, Miranda F, Riccieri V, Di Franco M, Scrivo R, Alessandri C, Valesini G, Conti F.
Musculoskeletal ultrasound in monitoring response to apremilast in psoriatic arthritis patients: results from a longitudinal study.
Clin Rheumatol. 38:3145-3151; 2019.
189. F Ceccarelli, C Perricone, G Olivieri, E Cipriano, F R Spinelli, G Valesini, F Conti.
Staphylococcus aureus Nasal Carriage and Autoimmune Diseases: From Pathogenic Mechanisms to Disease Susceptibility and Phenotype.
Int J Mol Sci 20, 5624; 2019.
190. S Parisi, A Bortoluzzi, GD Sebastiani, F Conti, R Caporali, N Ughi, I Prevete, A Ariani, M. Manara, G Carrara, CA Scirè.
The Italian Society for Rheumatology clinical practice guidelines for rheumatoid arthritis.
Reumatismo. 71 S1:22-49; 2019.
191. Conti F, Andreoli L, Crisafulli F, Mancuso S, Truglia S, Tektonidou MG.
Does seronegative obstetric APS exist? "pro" and "cons".
Autoimmun Rev. 18:102407; 2019.
192. Ciccacci C, Latini A, Perricone C, Conigliaro P, Colafrancesco S, Ceccarelli F, Priori R, Conti F, Perricone R, Novelli G, Borgiani P.
TNFAIP3 Gene Polymorphisms in Three Common Autoimmune Diseases: Systemic Lupus Erythematosus, Rheumatoid Arthritis, and Primary Sjogren Syndrome-Association with Disease Susceptibility and Clinical Phenotypes in Italian Patients.
J Immunol Res. 2019:6728694; 2019.
193. Perricone C, Katz D, Ciccacci C, Ceccarelli F, Valesini G, Shoenfeld Y, Borgiani P, Conti F.
The Heart Matters: Contribution of Genetic Factors in Recurrent Pericarditis.
Isr Med Assoc J. 21:487-490; 2019. PMID: 31507126.
194. Cavagna L, Trallero-Araguás E, Meloni F, Cavazzana I, Rojas-Serrano J, Feist E, Zanframundo G, Morandi V, Meyer A, Pereira da Silva JA, Matos Costa CJ, Molberg O, Andersson H, Codullo V, Mosca M, Barsotti S, Neri R, Scirè C, Govoni M, Furini F, Lopez-Longo FJ, Martinez-Barrio J, Schneider U, Lorenz HM, Doria A, Ghirardello A, Ortego-Centeno N, Confalonieri M, Tomietto P, Pipitone N, Rodriguez Cambron AB, Blázquez Cañamero MÁ, Voll RE, Wendel S, Scarpato S, Maurier F, Limonta M, Colombelli P, Giannini M, Geny B, Arrigoni E, Bravi E, Migliorini P, Mathieu A, Piga M, Drott U, Delbrueck C, Bauhammer J, Cagnotto G, Vancheri C, Sambataro G, De Langhe E, Sainaghi PP, Monti C, Gigli Berzolari F, Romano M, Bonella F, Specker C, Schwarting A, Villa Blanco I, Selmi C, Ceribelli A, Nuno L, Mera-Varela A, Perez Gomez N, Fusaro E, Parisi S, Sinigaglia L, Del Papa N, Benucci M, Cimmino MA, Riccieri V, Conti F, Sebastiani GD, Iuliano A, Emmi G, Cammelli D, Sebastiani M, Manfredi A, Bachiller-Corral J, Sifuentes Giraldo WA, Paolazzi G, Saketkoo LA, Giorgi R, Salaffi F, Cifrian J, Caporali R, Locatelli F, Marchioni E, Pesci A, Dei G, Pozzi MR, Claudia L, Distler J, Knitza J, Schett G, Iannone F, Fornaro M, Franceschini F, Quartuccio L, Gerli R, Bartoloni E, Bellando Randone S, Zampogna G, Gonzalez Perez MI, Mejia M, Vicente E, Triantafyllias K, Lopez-Mejias R, Matucci-Cerinic M, Selva-O'Callaghan A, Castañeda S, Montecucco C, Gonzalez-Gay MA.
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course.
J Clin Med. 8(11):E2013; 2019.
195. Ceccarelli F, Pirone C, Mina C, Mascolo A, Perricone C, Massaro L, Spinelli FR, Alessandri C, Valesini G, Conti F.
Pragmatic language dysfunction in systemic lupus erythematosus patients: Results from a single center Italian study.
PLoS One. 14:e0224437; 2019.
196. Spinelli FR, Barbati C, Cecarelli F, Morello F, Colasanti T, Vomero M, Massaro L, Orefice V, Alessandri C, Valesini G, Conti F.
B lymphocyte stimulator modulates number and function of endothelial progenitor cells in systemic lupus erythematosus.
Arthritis Res Ther. 21:245; 2019.
197. Piga M, Floris A, Sebastiani GD, Prevete I, Iannone F, Coladonato L, Govoni M, Bortoluzzi A, Mosca M, Tani C, Doria A, Iaccarino L, Franceschini F, Fredi M, Conti F, Spinelli FR, Galeazzi M, Bellisai F, Zanetti A, Carrara G, Scirè CA, Mathieu A.
Risk factors of damage in early diagnosed systemic lupus erythematosus: results of the Italian multicentre Early Lupus Project inception cohort.
Rheumatology (Oxford). kez584; 2019.
198. Lucchino B, Spinelli FR, Iannuccelli C, Guzzo MP, Conti F, Di Franco M.
Mucosa-Environment Interactions in the Pathogenesis of Rheumatoid Arthritis.
Cells. 8(7):700; 2019.
199. Ceccarelli F, Botticelli A, Gelibter AJ, Leccese I, Lucchetti R, Cortesi E,
Valesini G, Marchetti P, Conti F.
'Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation' by Braaten et al: another point of view.
Ann Rheum Dis. 216867; 2020 doi: 10.1136/annrheumdis-2019-216867.
200. Quartuccio L, Bond M, Isola M, Monti S, Felicetti M, Furini F, Murgia S,
Berti A, Silvestri E, Pazzola G, Bozzolo E, Leccese P, Raffeiner B, Parisi S,
Leccese I, Cianci F, Bettio S, Sainaghi P, Ianniello A, Ravagnani V, Bellando
Randone S, Faggioli P, Lomater C, Stobbione P, Ferro F, Colaci M, Alfieri G,
Carubbi F, Erre GL, Giollo A, Franzolini N, Ditto MC, Balduzzi S, Padoan R,
Bortolotti R, Bortoluzzi A, Cariddi A, Padula A, Di Scala G, Gremese E, Conti F,
D'Angelo S, Matucci Cerinic M, Dagna L, Emmi G, Salvarani C, Paolazzi G,
Roccatello D, Govoni M, Schiavon F, Caporali R, De Vita S; Italian Study Group
on Lung Involvement in Rheumatic Diseases and the Italian Vasculitis Study
Group.
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and
mortality predictors.
J Autoimmun. 102397; 2020.
201. Prevete I, Espinosa G, Bellisai F, Bortoluzzi A, Conti F, Fredi M, Fonseca-
Aizpuru EM, García de Viedma V, González-García A, González-León R, Iaccarino L, Iannone F, Marín-Ballvé A, Mitjavila F, Pallarés L, Piga M, Ríos-Garcés R, Suárez S, Tani C, Zanetti A, Ruiz-Irastorza G, Sebastiani GD; Gruppo di Studio SIR sul Lupus Eritematoso Sistemico di recente insorgenza-Early Lupus and Registro Español de pacientes con Lupus Eritematoso Sistémico (RELES), Autoimmune Diseases Study Group (GEAS).
Comparative study between two European inception cohorts of patients with early systemic lupus erythematosus.
Clin Exp Rheumatol. 2020 Jan 20. Epub ahead of print. PMID: 31969225.
202. Ceccarelli F, Orefice V, Perrone G, Pirone C, Perricone C, Truglia S, Miranda
F, Pacucci VA, Spinelli FR, Galoppi P, Alessandri C, Valesini G, Conti F.
Premature ovarian failure in patients affected by systemic lupus erythematosus:
a cross-sectional case control study.
Clin Exp Rheumatol. 2020 Feb 14. Epub ahead of print. PMID: 32083540.
203. Lande R, Palazzo R, Gestermann N, Jandus C, Falchi M, Spadaro F, Riccieri V, James EA, Butera A, Boirivant M, Feldmeyer L, Surbeck I, Di Lucca J, Stuber F, Spinelli FR, Botti E, Marinari B, Bianchi L, Pica R, Cerbelli B, Giannakakis K, Auteri SE, Daniels I, Durrant LG, Horstman S, Costanzo A, Romero P, Alessandri C, Conti F, Valesini G, Gilliet M, Chizzolini C, Frasca L.
Native/citrullinated LL37-specific T-cells help autoantibody production in Systemic Lupus Erythematosus.
Sci Rep. 10:5851; 2020.
204. Spinelli FR, Ceccarelli F, Di Franco M, Conti F.
To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic.
Ann Rheum Dis. 2020 Apr 2:annrheumdis-2020-217367. doi: 10.1136/annrheumdis-2020-217367. Online ahead of print.
205. Spinelli FR, Ceccarelli F, Di Franco M, Conti F.
Response to 'Is there a future for hydroxychloroquine/chloroquine in prevention of SARS-CoV-2 infection (COVID-19)?' by Moiseev et al.
Ann Rheum Dis., annrheumdis-2020-217636 [April, 28]. https://doi.org/10.1136/annrheumdis-2020-217636
206. Spinelli FR, Ceccarelli F, Di Franco M, Conti F.
Response to 'To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic' by Parperis.
Ann Rheum Dis. 2020 May 4:annrheumdis-2020-217634. doi: 10.1136/annrheumdis-2020-217634. Online ahead of print.
207. Gatto M, Saccon F, Zen M, Regola F, Fredi M, Andreoli L, Tincani A, Urban ML, Emmi G, Ceccarelli F, Conti F, Bortoluzzi A, Govoni M, Tani C, Mosca M, Ubiali T, Gerosa M, Bozzolo E, Canti V, Cardinaletti P, Gabrielli A, Tanti G, Gremese E, De Marchi G, De Vita S, Fasano S, Ciccia F, Pazzola G, Salvarani C, Negrini S, Puppo F, Di Matteo A, De Angelis R, Orsolini G, Rossini M, Faggioli P, Laria A, Piga M, Mathieu A, Scarpato S, Rossi FW, de Paulis A, Brunetta E, Ceribelli A, Selmi C, Prete M, Racanelli V, Vacca A, Bartoloni E, Gerli R, Larosa M, Iaccarino L, Doria A.
Early disease and low baseline damage predict response to belimumab in
patients with systemic lupus erythematosus.
Arthritis Rheumatol. 2020 Apr 10. doi: 10.1002/art.41253. Online ahead of print
208. Spinelli FR, Conti F, Gadina M.
HiJAKing SARS-CoV-2? The potential role of JAK inhibitors in the management of COVID-19
Sci Immunol. 5, 10.1126/sciimmunol.abc5367 2020.
209. Lucchino B, Di Franco M, Conti F.
COVID-19: an unexpected indication for anti-rheumatic therapies?
Rheumatology (Oxford). 59:1200-1203; 2020.
209. Chimenti MS, Fonti GL, Conigliaro P, Sunzini F, Scrivo R, Navarini L, Triggianese P, Peluso G, Scolieri P, Caccavale R, Picchianti Diamanti A, De Martino E, Salemi S, Birra D, Altobelli A, Paroli M, Bruzzese V, Laganà B, Gremese E, Conti F, Afeltra A, Perricone R.
One-year effectiveness, retention rate, and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis: a real-life multicenter study.
Expert Opin Biol Ther. 2020 May 13:1-9. doi: 10.1080/14712598.2020.1761957.
[Epub ahead of print].
210. Colasanti T, Sabatinelli D, Mancone C, Giorgi A, Pecani A, Spinelli FR, Di Giamberardino A, Navarini L, Speziali M, Vomero M, Barbati C, Perricone C, Ceccarelli F, Finucci A, Celia AI, Currado D, Afeltra A, Schininà ME, Barnaba V, Conti F, Valesini G, Alessandri C.
Homocysteinylated alpha 1 antitrypsin as an antigenic target of autoantibodies in
seronegative rheumatoid arthritis patients.
J Autoimmun. 2020 May 27:102470.
211. Colafrancesco S, Alessandri C, Conti F, Priori R.
COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome?
Autoimmun Rev. 2020 Jul;19(7):102573. doi: 10.1016/j.autrev.2020.102573. Epub 2020 May 5.
212. Saccon F, Zen M, Gatto M, Margiotta DPE, Afeltra A, Ceccarelli F, Conti F, Bortoluzzi A, Govoni M, Frontini G, Moroni G, Dall'Ara F, Tincani A, Signorini V, Mosca M, Frigo AC, Iaccarino L, Doria A.
Remission in systemic lupus erythematosus: testing different definitions in a large multicentre cohort.
Ann Rheum Dis. 2020 Apr 22:annrheumdis-2020-217070. doi: 10.1136/annrheumdis-2020-217070. Online ahead of print.
213. Garufi C, Mancuso S, Spinelli FR, Truglia S, Ceccarelli F, Alessandri C, Conti F.
Janus kinases inhibitors for treating patients with rhupus.
Joint Bone Spine. 2020 Jun 10:S1297-319X(20)30106-8. doi: 10.1016/j.jbspin.2020.05.010. Online ahead of print.
214. Orefice V, Ceccarelli F, Perrone G, Perricone C, Galoppi P, Pacucci VA, Spinelli FR, Alessandri C, Brunelli R, Conti F.
Treatment with Gonadotropin Releasing Hormone Agonists in Systemic Lupus Erythematosus Patients Receiving Cyclophosphamide: A Long-term Follow-up Study.
Isr Med Assoc J. 2020 Jun;22(6):343-347.
215. Scrivo R, Silvestri V, Ciciarello F, Sessa P, Rutigliano I, Sestili C, La Torre G, Barbati C, Altobelli A, Alessandri C, Ceccarelli F, Di Franco M, Priori R, Riccieri V, Sili Scavalli A, Spinelli FR, Agati L, Fedele F, Gossetti B, Conti F, Valesini G.
An exploratory cross-sectional study of subclinical vascular damage in patients with polymyalgia rheumatica.
Sci Rep. 2020 Jul 9;10(1):11407.
216. Rosato E, Gigante A, Cianci R, Spinelli FR, Ceccarelli F, Conti F.
Evaluation of renal resistive index in different autoimmune diseases.
Clin Exp Rheumatol. 2020 Jun 4. Online ahead of print.
217. Piga M, Floris A, Sebastiani GD, Prevete I, Iannone F, Coladonato L, Govoni M, Bortoluzzi A, Mosca M, Tani C, Doria A, Iaccarino L, Franceschini F, Fredi M, Conti F, Spinelli FR, Galeazzi M, Bellisai F, Zanetti A, Carrara G, Scirè CA, Mathieu A.
Risk factors of damage in early diagnosed systemic lupus erythematosus: results of the Italian multicentre Early Lupus Project inception cohort.
Rheumatology (Oxford). 2020 Sep 1;59(9):2272-2281.
218. Ceccarelli F, Cipriano E, Natalucci F, Perricone C, Olivieri G, Orefice V, Morello F, Alessandri C, Spinelli FR, Conti F.
Belimumab is Able to Induce a Significant Improvement of Joint Activity Status in Patients Diagnosed with Systemic Lupus Erythematosus: Results From a 12-Month Longitudinal Study.
Isr Med Assoc J. 2020 Jul;7(22):349-353.
219. Ceccarelli F, Mancuso S, Lucchetti R, Conti F.
Systemic lupus erythematosus onset in patient receiving anti-PD1 treatment with pembrolizumab: a case report.
Rheumatology (Oxford). 2020 Aug 25:keaa389.
220. Iannone F, Favalli EG, Caporali R, D'Angelo S, Cantatore FP, Sarzi-Puttini P, Foti R, Conti F, Carletto A, Gremese E, Cauli A, Ramonda R, Palermo A, Epis O, Priora M, Bergossi F, Frediani B, Salaffi F, Lopalco G, Cacciapaglia F, Marchesoni A, Biggioggiero M, Bugatti S, Balduzzi S, Carriero A, Corrado A, Bongiovanni S, Benenati A, Miranda F, Fracassi E, Perra D, Ferraccioli G, Lapadula G.
Golimumab effectiveness in biologic inadequate responding patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis in real-life from the Italian registry GISEA.
Joint Bone Spine. 2020 Aug 2:S1297-319X(20)30147-0.
221. Orefice V, Ceccarelli F, Barbati C, Lucchetti R, Olivieri G, Cipriano E, Natalucci F, Perricone C, Spinelli FR, Alessandri C, Valesini G, Conti F.
Caffeine intake influences disease activity and clinical phenotype in systemic lupus erythematosus patients.
Lupus. 2020 Jul 23:961203320941920.
222. Gandolfo S, Fabro C, Kapsogeorgou E, Colafrancesco S, Ferro F, Bartoloni E, Quartuccio L, Goules A, Priori R, Alunno A, Conti F, Valesini G, Giacomelli R, Baldini C, Gerli R, Tzioufas AG, De Vita S.
Validation of thymic stromal lymphopoietin as a biomarker of primary Sjögren's syndrome and related lymphoproliferation: results in independent cohorts.
Clin Exp Rheumatol. 2020 Jul-Aug;38 Suppl 126(4):189-194. Epub 2020 Oct 23
223. Ceccarelli F, Presti AL, Olivieri G, Angeletti S, Perricone C, Garufi C, Iaiani G, De Florio L, Antonelli F, De Cesaris M, Giordano A, Amori L, Spinelli FR, Alessandri C, Valesini G, Ciccozzi M, Conti F.
Genetic diversity of Staphylococcus aureus influences disease phenotype of systemic lupus erythematosus.
Rheumatology (Oxford). 60:958-966; 2020.
224. Barbati C, Colasanti T, Vomero M, Ceccarelli F, Celia AI, Perricone C, Spinelli FR, Conti F, Valesini G, Alessandri C.
Up-regulation of autophagy by etanercept treatment results in TNF-induced apoptosis reduction in EA.hy926 endothelial cell line.
Clin Exp Rheumatol. 2020 Sep 3. Online ahead of print.
225. Vomero M, Finucci A, Barbati C, Colasanti T, Ceccarelli F, Novelli L, Massaro L, Truglia S, Pensa C, Mauro FR, Foà R, Valesini G, Conti F, Alessandri C.
Increased eryptosis in patients with primary antiphospholipid syndrome (APS): a new actor in the pathogenesis of APS.
Clin Exp Rheumatol. 2020 Oct 29. Online ahead of print.
226. Ugolini A, Zizzari IG, Ceccarelli F, Botticelli A, Colasanti T, Strigari L, Rughetti A, Rahimi H, Conti F, Valesini G, Marchetti P, Nuti M.
IgM-Rheumatoid factor confers primary resistance to anti-PD-1 immunotherapies in NSCLC patients by reducing CD137+T-cells.
EBioMedicine. 2020 Nov 6;62:103098. doi: 10.1016/j.ebiom.2020.103098. Online ahead of print.
227. Pellegrino G, Mohammad Reza Beigi D, Angelelli C, Stefanantoni K, Cadar M, Mancuso S, Conti F, Riccieri V.
COVID-19 and systemic sclerosis: analysis of lifestyle changes during the SARS-CoV-2 pandemic in an Italian single-center cohort.
Clin Rheumatol. 2020 Nov 14:1-5. doi: 10.1007/s10067-020-05504-7. Online ahead of print.
228. Vomero M, Barbati C, Colasanti T, Celia AI, Speziali M, Ucci FM, Ciancarella C, Conti F, Alessandri C.
Autophagy Modulation in Lymphocytes From COVID-19 Patients: New Therapeutic Target in SARS-COV-2 Infection.
Front Pharmacol. 2020 Nov 19;11:569849. doi: 10.3389/fphar.2020.569849. eCollection 2020.
229. Orefice V, Ceccarelli F, Barbati C, Perricone C, Alessandri C, Conti F.
The Impact of Caffeine Intake on Patients with Systemic Lupus Erythematosus: Protect Yourself, Drink More Coffee!
Mediterr J Rheumatol. 2020 Dec 28;31(4):374-375. doi: 10.31138/mjr.31.4.374. eCollection 2020 Dec.
230. Pacella I, Spinelli FR, Severa M, Timperi E, Tucci G, Zagaglioni M, Ceccarelli F, Rizzo F, Coccia EM, Patel RS, Martin-Fernandez M, Bogunovic D, Conti F, Barnaba V, Piconese S.
ISG15 protects human Tregs from interferon alpha-induced contraction in a cell-intrinsic fashion.
Clin Transl Immunology. 2020 Dec 23;9(12):e1221. doi: 10.1002/cti2.1221. eCollection 2020.
231. Spinelli FR, Ceccarelli F, Garufi C, Duca I, Mancuso S, Cipriano E, Dell'Unto E, Alessandri C, Di Franco M, Perricone C, Priori R, Riccieri V, Scrivo R, Sili Scavalli A, Truglia S, Valesini G, Conti F.
Effectiveness and safety of baricitinib in rheumatoid arthritis: a monocentric, longitudinal, real-life experience.
Clin Exp Rheumatol. 39:525-531; 2021.
232. Giacomelli R, Afeltra A, Bartoloni E, Berardicurti O, Bombardieri M, Bortoluzzi A, Carubbi F, Caso F, Cervera R, Ciccia F, Cipriani P, Coloma-Bazán E, Conti F, Costa L, D'Angelo S, Distler O, Feist E, Foulquier N, Gabini M, Gerber V, Gerli R, Grembiale RD, Guggino G, Hoxha A, Iagnocco A, Jordan S, Kahaleh B, Lauper K, Liakouli V, Lubrano E, Margiotta D, Naty S, Navarini L, Perosa F, Perricone C, Perricone R, Prete M, Pers JO, Pitzalis C, Priori R, Rivellese F, Ruffatti A, Ruscitti P, Scarpa R, Shoenfeld Y, Triolo G, Tzioufas A.
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts' Consensus.
Autoimmun Rev. 2021 Feb;20(2):102738. doi: 10.1016/j.autrev.2020.102738. Epub 2020 Dec 14
233. Natalucci F, Ceccarelli F, Cipriano E, Perricone C, Olivieri G, Pirone C, Mettola G, Truglia S, Spinelli FR, Alessandri C, Conti F.
Joint involvement influences quality of life in systemic lupus erythematosus patients.
Lupus. 2020 Dec 15:961203320979039. doi: 10.1177/0961203320979039. Online ahead of print.
234. Celia AI, Priori R, Cerbelli B, Diomedi-Camassei F, Leuzzi V, Scrivo R, Alessandri C, d'Amati G, Conti F.
"Protenuria in SLE: is it always lupus?".
Lupus. 2021 Jan 7:961203320983458. doi: 10.1177/0961203320983458. Online ahead of print.
235. Ceccarelli F, Olivieri G, Sortino A, Dominici L, Arefayne F, Celia AI, Cipriano E, Garufi C, Lapucci M, Mancuso S, Natalucci F, Orefice V, Perricone C, Pirone C, Pacucci VA, Spinelli FR, Truglia S, Alessandri C, Sciandrone M, Conti F.
Comprehensive disease control in systemic lupus erythematosus.
Semin Arthritis Rheum. 2021 Feb 19;51(2):404-408. doi: 10.1016/j.semarthrit.2021.02.005. Online ahead of print.
236. Klionsky DJ, … Conti F, … Tong CK.
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition).
Autophagy. 2021 Feb 8:1-382. doi: 10.1080/15548627.2020.1797280. Online ahead of print.
237. Priori R, Pellegrino G, Colafrancesco S, Alessandri C, Ceccarelli F, Di Franco M, Riccieri V, Scrivo R, Sili Scavalli A, Spinelli FR, Conti F.
SARS-CoV-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases: a message for rheumatologists.
Ann Rheum Dis. 2021 Feb 23:annrheumdis-2021-220059. doi: 10.1136/annrheumdis-2021-220059. Online ahead of print.
238. Spinelli FR, Garufi C, Mancuso S, Ceccarelli F, Conti F.
Comment on: Real-world single centre use of JAK inhibitors across the rheumatoid arthritis pathway.
Rheumatology (Oxford). 2021 Mar 2:keab195. doi: 10.1093/rheumatology/keab195. Online ahead of print.
239. Ceccarelli F, Botticelli A, Natalucci F, Olivieri G, Cirillo A, Alessandri C, Marchetti P, Conti F.
Immune checkpoint inhibitors and pre-existing antinuclear antibodies: the rheumatologist point of view.
Clin Transl Oncol. 2021 Mar 17. doi: 10.1007/s12094-021-02584-y. Online ahead of print.
240. Orefice V, Ceccarelli F, Pirone C, Galoppi P, Spinelli FR, Alessandri C, Brunelli R, Perrone G, Conti F.
Breastfeeding in women affected by systemic lupus erythematosus: Rate, duration and associated factors.
Lupus. 2021 May;30(6):913-920.
241. Ceccarelli F, Pirone C, Perricone C, Selntigia A, Orefice V, Pacucci VA, Truglia S, Spinelli FR, Galoppi P, Alessandri C, Valesini G, Brunelli R, Perrone G, Conti F.
Pregnancy outcome in systemic lupus erythematosus patients: a monocentric cohort analysis.
Rheumatology (Oxford). 2021 Apr 6;60(4):1747-1754.
242. Bettiol A, Sinico RA, Schiavon F, Monti S, Bozzolo EP, Franceschini F, Govoni M, Lunardi C, Guida G, Lopalco G, Paolazzi G, Vacca A, Gregorini G, Leccese P, Piga M, Conti F, Fraticelli P, Quartuccio L, Alberici F, Salvarani C, Bettio S, Negrini S, Selmi C, Sciascia S, Moroni G, Colla L, Manno C, Urban ML, Vannacci A, Pozzi MR, Fabbrini P, Polti S, Felicetti M, Marchi MR, Padoan R, Delvino P, Caporali R, Montecucco C, Dagna L, Cariddi A, Toniati P, Tamanini S, Furini F, Bortoluzzi A, Tinazzi E, Delfino L, Badiu I, Rolla G, Venerito V, Iannone F, Berti A, Bortolotti R, Racanelli V, Jeannin G, Padula A, Cauli A, Priori R, Gabrielli A, Bond M, Tedesco M, Pazzola G, Tomietto P, Pellecchio M, Marvisi C, Maritati F, Palmisano A, Dejaco C, Willeit J, Kiechl S, Olivotto I, Willeit P, Prisco D, Vaglio A, Emmi G; Italian EGPA Consortium.
Risk of acute arterial and venous thromboembolic events in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss syndrome).
Eur Respir J. 2021 Apr 8:2004158. doi: 10.1183/13993003.04158-2020. Online ahead of print.
243. Picchianti-Diamanti A, Spinelli FR, Rosado MM, Conti F, Laganà B.
Inhibition of Phosphodiesterase-4 in Psoriatic Arthritis and Inflammatory Bowel Diseases.
Int J Mol Sci. 2021 Mar 5;22(5):2638. doi: 10.3390/ijms22052638.
244. Capozzi A, Riitano G, Mancuso S, Recalchi S, Manganelli V, Garofalo T, Alessandri C, Longo A, Misasi R, Conti F, Truglia S, Sorice M.
Anti-vimentin/cardiolipin IgA in the Antiphospholipid Syndrome: a new tool for "seronegative" diagnosis.
Clin Exp Immunol. 205:326-332; 2021.
245. Truglia S, Mancuso S, Capozzi A, Recalchi S, Riitano G, Longo A, De Carolis S, Spinelli FR, Alessandri C, Ceccarelli F, De Carolis C, Misasi R, Sorice M, Conti F.
“Non-criteria antiphospholipid antibodies": bridging the gap between seropositive and seronegative Antiphospholipid Syndrome.
Rheumatology (Oxford). 61:826-833; 2022.
246. Sebastiani GD, Spinelli FR, Bartoloni E, Bortoluzzi A, Bozzolo E, Canofari C, Canti V, Conigliaro P, Ditto MC, Emmi G, Franceschini F, Frassi M, Iaccarino L, Iuliano A, Manfredi A, Pacucci V, Parisi S, Pazzola G, Perricone R, Prevete I, Ramirez GA, Scarpato S, Scirocco C, Silvagni E, Zen M, Zanetti A, Carrara G, Scirè CA, Conti F, Doria A.
Baseline characteristics of systemic lupus erythematosus patients included in the Lupus Italian Registry of the Italian Society for Rheumatology.
Lupus. 2021 Jul;30(8):1233-1243. doi: 10.1177/09612033211012470. Epub 2021 Apr 22.
247. Nalli C, Lini D, Andreoli L, Crisafulli F, Fredi M, Lazzaroni MG, Bitsadze V, Calligaro A, Canti V, Caporali R, Carubbi F, Chighizola CB, Conigliaro P, Conti F, De Carolis C, Del Ross T, Favaro M, Gerosa M, Iuliano A, Khizroeva J, Makatsariya A, Meroni PL, Mosca M, Padovan M, Perricone R, Rovere-Querini P, Sebastiani GD, Tani C, Tonello M, Truglia S, Zucchi D, Franceschini F, Tincani A.
Low Preconception Complement Levels Are Associated with Adverse Pregnancy Outcomes in a Multicenter Study of 260 Pregnancies in 197 Women with Antiphospholipid Syndrome or Carriers of Antiphospholipid Antibodies.
Biomedicines. 2021 Jun 11;9(6):671. doi: 10.3390/biomedicines9060671
248. Latini A, Novelli L, Ceccarelli F, Barbati C, Perricone C, De Benedittis G, Conti F, Novelli G, Ciccacci C, Borgiani P.
mRNA expression analysis confirms CD44 splicing impairment in systemic lupus erythematosus patients.
Lupus. 2021 Jun;30(7):1086-1093. doi: 10.1177/09612033211004725. Epub 2021 Apr 1
249. Carpino G, Cardinale V, Di Giamberardino A, Overi D, Donsante S, Colasanti T, Amato G, Mennini G, Franchitto M, Conti F, Rossi M, Riminucci M, Gaudio E, Alvaro D, Mancone C.
Thrombospondin 1 and 2 along with PEDF inhibit angiogenesis and promote lymphangiogenesis in intrahepatic cholangiocarcinoma.
J Hepatol. 2021 Jul 28:S0168-8278(21)01947-4. doi: 10.1016/j.jhep.2021.07.016. Online ahead of print.
250. Ceccarelli F, Spinelli FR, Garufi C, Mancuso S, Alessandri C, Di Franco M, Orefice V, Pacucci VA, Pirone C, Priori R, Riccieri V, Sili Scavalli A, Scrivo R, Truglia S, Conti F.
The role of musculoskeletal ultrasound in predicting the response to JAK inhibitors: results from a monocentric cohort.
Clin Exp Rheumatol. 2021 Jun 26. Online ahead of print.
251. Lucchetti R, Ceccarelli F, Cipriano E, Perricone C, Spinelli FR, Alessandri C, Conti F.
Application of Ultrasound in the Assessment of Oligoarticular Psoriatic Arthritis Subset: Results from Patients Treated with Apremilast.
Isr Med Assoc J. 2021 Jul;23(7):412-415.
252. Ceccarelli F, Covelli V, Olivieri G, Natalucci F, Conti F.
Systemic Lupus Erythematosus before and after COVID-19 Lockdown: How the Perception of Disease Changes through the Lenses of Narrative Medicine.
Healthcare (Basel). 2021 Jun 12;9(6):726. doi: 10.3390/healthcare9060726.
253. Ceccarelli F, Olivieri G, Natalucci F, Alessandri C, Conti F.
SARS-CoV-2 vaccination efficacy and B-cell depletion therapy in systemic lupus erythematosus: Description of a case.
Lupus. 2021 Jul 1:9612033211027940. doi: 10.1177/09612033211027940. Online ahead of print.
254. Olivieri G, Ceccarelli F, Natalucci F, Pirone C, Orefice V, Pacucci VA, Garufi C, Truglia S, Spinelli FR, Alessandri C, Conti F.
Five-years drug survival of mycophenolate mofetil therapy in patients with systemic lupus erythematosus: Comparison between renal and non-renal involvement.
Joint Bone Spine. 2021 Jun 24;88(6):105246. doi: 10.1016/j.jbspin.2021.105246. Online ahead of print.
255. Ceccarelli F, Lapucci M, Olivieri G, Sortino A, Natalucci F, Spinelli FR, Alessandri C, Sciandrone M, Conti F.
Can Machine Learning models support physicians in Systemic Lupus Erythematosus diagnosis? Results from a monocentric cohort.
Joint Bone Spine. 2021 Oct 13:105292.
256. Gatto M, Saccon F, Andreoli L, Bartoloni E, Benvenuti F, Bortoluzzi A, Bozzolo E, Brunetta E, Canti V, Cardinaletti P, Ceccarelli F, Ciccia F, Conti F, De Marchi G, de Paulis A, De Vita S, Emmi G, Faggioli P, Fasano S, Fredi M, Gabrielli A, Gasparotto M, Gerli R, Gerosa M, Govoni M, Gremese E, Laria A, Larosa M, Mosca M, Orsolini G, Pazzola G, Petricca L, Ramirez GA, Regola F, Rossi FW, Rossini M, Salvarani C, Scarpato S, Tani C, Tincani A, Ubiali T, Urban ML, Zen M, Doria A, Iaccarino L.
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort.
J Autoimmun. 2021 Nov;124:102729.
257. Ceccarelli F, Natalucci F, Olivieri G, Perricone C, Pirone C, Spinelli FR, Alessandri C, Conti F.
Erosive arthritis in systemic lupus erythematosus: not only Rhupus.
Lupus. 2021 Oct 19:9612033211051637. doi: 10.1177/09612033211051637. Online ahead of print.
258. Colafrancesco S, Barbati C, Priori R, Putro E, Giardina F, Gattamelata A, Monosi B, Colasanti T, Celia AI, Cerbelli B, Giordano C, Scarpa S, Fusconi M, Cavalli G, Berardicurti O, Gandolfo S, Nayar S, Barone F, Giacomelli R, De Vita S, Alessandri C, Conti F.
Maladaptive autophagy in the pathogenesis of autoimmune epithelitis in Sjӧgren's Syndrome.
Arthritis Rheumatol. 2022 74:654-664.
259. Duca I, Lucchino B, Spinelli FR, Altobelli A, Pirone C, Gioia C, Valesini G, Conti F, Di Franco M.
Perceived Disease Activity in Rheumatoid Arthritis: When the Physician's Gender Matters.
Isr Med Assoc J. 2021 Nov;23(11):693-698.
260. Cavalli G, Colafrancesco S, De Luca G, Rizzo N, Priori R, Conti F, Dagna L.
Cutaneous vasculitis following COVID-19 vaccination.
Lancet Rheumatol. 2021 Nov;3(11):e743-e744. doi: 10.1016/S2665-9913(21)00309-X. Epub 2021 Sep 30.
261. Latini A, De Benedittis G, Perricone C, Colafrancesco S, Conigliaro P, Ceccarelli F, Chimenti MS, Novelli L, Priori R, Conti F, Ciccacci C, Borgiani P.
VDR Polymorphisms in Autoimmune Connective Tissue Diseases: Focus on Italian Population.
J Immunol Res. 2021 Dec 23;2021:5812136. doi: 10.1155/2021/5812136. eCollection 2021.
262. Capozzi A, Truglia S, Buttari B, Recalchi S, Riitano G, Manganelli V, Mancuso S, Alessandri C, Longo A, Mattei V, Profumo E, Garofalo T, Misasi R, Conti F, Sorice M.
Carbamylation of β2-GPI generates new autoantigens for Antiphospholipid Syndrome: a new tool for diagnosis of "seronegative" patients.
Rheumatology (Oxford). 2022 Feb 2:keac045. doi: 10.1093/rheumatology/keac045. Online ahead of print. PMID: 35108369.
263. Scrivo R, D'Angelo S, Carriero A, Castellani C, Perrotta FM, Conti F, Vecellio M, Selmi C, Lubrano E.
The Conundrum of Psoriatic Arthritis: a Pathogenetic and Clinical Pattern at the Midpoint of Autoinflammation and Autoimmunity.
Clin Rev Allergy Immunol. 2022 Jan 18. doi: 10.1007/s12016-021-08914-w.
264. Spinelli FR, Favalli EG, Garufi C, Cornalba M, Colafrancesco S, Conti F*, Caporali R.
Low frequency of disease flare in patients with rheumatic musculoskeletal diseases who received SARS-CoV-2 mRNA vaccine.
Arthritis Res Ther. 2022 Jan 11;24(1):21. doi: 10.1186/s13075-021-02674-w.
265. Olivieri G, Ceccarelli F, Perricone C, Ciccacci C, Pirone C, Natalucci F, Spinelli FR, Alessandri C, Borgiani P, Conti F.
Fever in systemic lupus erythematosus: associated clinical features and genetic factors.
Clin Exp Rheumatol. 2022 Mar 23. doi: 10.55563/clinexprheumatol/7x37pf. Online ahead of print.
266. Nissen M, Delcoigne B, Di Giuseppe D, Jacobsson L, Hetland ML, Ciurea A, Nekvindova L, Iannone F, Akkoc N, Sokka-Isler T, Fagerli KM, Santos MJ, Codreanu C, Pombo-Suarez M, Rotar Z, Gudbjornsson B, van der Horst-Bruinsma I, Loft AG, Möller B, Mann H, Conti F, Yildirim Cetin G, Relas H, Michelsen B, Ribeiro PA, Ionescu R, Sanchez-Piedra C, Tomsic M, Geirsson ÁJ, Askling J, Glintborg B, Lindström U.
The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondylarthritis.
Rheumatology (Oxford). 2022 Mar 22:keac174. doi: 10.1093/rheumatology/keac174. Online ahead of print.
267. Iannuccelli C, Lucchino B, Gioia C, Dolcini G, Rabasco J, Venditto T, Ioppolo F, Santilli V, Conti F, Di Franco M.
Gender influence on clinical manifestations, depressive symptoms and brain-derived neurotrophic factor (BDNF) serum levels in patients affected by fibromyalgia.
Clin Rheumatol. 2022 Mar 28. doi: 10.1007/s10067-022-06133-y. Online ahead of print.
268. Scrivo R, Anastasi E, Castellani C, Conti F, Angeloni A, Granato T.
Ovarian reserve in patients with spondyloarthritis: impact of biological disease-modifying anti-rheumatic drugs on fertility status.
Clin Exp Rheumatol. 40:1738-1743; 2022.
269. Pellegrino G, Mancuso S, Colasanti T, Mieli S, Gioia C, Izzo R, Pignatelli P, Ciardi MR, Alessandri C, Conti F, Riccieri V.
Lack of cross-reactivity between rheumatoid factor IgM and anti-S1 receptor binding domain of SARS-CoV-2 IgM: a case-control study.
Clin Exp Rheumatol. 2022 Apr 29. doi: 10.55563/clinexprheumatol/irb45o. Online ahead of print.
270. Ceccarelli F, Saccucci M, Natalucci F, Olivieri G, Bruni E, Iacono R, Colasanti T, Di Carlo G, Alessandri C, Uccelletti D, Russo P, Pilloni A, Conti F, Polimeni A.
Porphyromonas gingivalis amount in the tongue biofilm is associated with erosive arthritis in systemic lupus erythematosus.
Lupus. 2022 Apr 28:9612033221098528. doi: 10.1177/09612033221098528. Online ahead of print.
271. Celia AI, Colafrancesco S, Barbati C, Alessandri C, Conti F.
Autophagy in Rheumatic Diseases: Role in the Pathogenesis and Therapeutic Approaches.
Cells. 2022 Apr 15;11(8):1359. doi: 10.3390/cells11081359.
272. Riitano G, Capozzi A, Recalchi S, Caissutti D, Longo A, Mattei V, Conti F, Misasi R, Garofalo T, Sorice M, Manganelli V.
Anti-β2-GPI Antibodies Induce Endothelial Cell Expression of Tissue Factor by LRP6 Signal Transduction Pathway Involving Lipid Rafts.
Cells. 2022 Apr 11;11(8):1288. doi: 10.3390/cells11081288.
273. Mancuso S, Spinelli FR, Agati L, Ciardi MR, Garufi C, Natalucci F, Molteni E, Truglia S, Riccieri V, Priori R, Mastroianni CM, Conti F.
Hydroxychloroquine cardiotoxicity: a case-control study comparing patients with COVID-19 and patients with systemic lupus erythematosus.
Clin Exp Rheumatol. 2022 May;40(5):890-896. doi: 10.55563/clinexprheumatol/7ullgb. Epub 2022 Mar 30.
274. Iannone F, Conti F, Cauli A, Farina A, Caporali R.
Subcutaneously-Administered Infliximab in the Management of Rheumatoid Arthritis: A Short Narrative Review of Current Clinical Evidence.
J Inflamm Res. 2022 Jun 1;15:3259-3267. doi: 10.2147/JIR.S240593. eCollection 2022.
275. Conticini E, d'Alessandro M, Grazzini S, Fornaro M, Sabella D, Lopalco G, Giardina F, Colafrancesco S, Rizzo C, Guggino G, Priori R, Conti F, Iannone F, Bargagli E, Cantarini L, Frediani B.
Relapses of idiopathic inflammatory myopathies after vaccination against COVID-19: a real-life multicenter Italian study.
Intern Emerg Med. 2022 Jun 26:1-8. doi: 10.1007/s11739-022-03028-3. Online ahead of print.
276. Ceccarelli F, Olivieri G, Pirone C, Ciccacci C, Picciariello L, Natalucci F, Perricone C, Spinelli FR, Alessandri C, Borgiani P, Conti F.
The Impacts of the Clinical and Genetic Factors on Chronic Damage in Caucasian Systemic Lupus Erythematosus Patients.
J Clin Med. 2022 Jun 12;11(12):3368. doi: 10.3390/jcm11123368.
277. Barbati C, Celia AI, Colasanti T, Vomero M, Speziali M, Putro E, Buoncuore G, Savino F, Colafrancesco S, Ucci FM, Ciancarella C, Balbinot E, Scarpa S, Natalucci F, Pellegrino G, Ceccarelli F, Spinelli FR, Mastroianni CM, Conti F, Alessandri C.
Autophagy Hijacking in PBMC From COVID-19 Patients Results in Lymphopenia.
Front Immunol. 2022 May 30;13:903498. doi: 10.3389/fimmu.2022.903498. eCollection
2022.
278. Scrivo R, Castellani C, Mancuso S, Sciarra G, Giardina F, Bevignani G, Ceccarelli F, Spinelli FR, Alessandri C, Di Franco M, Riccieri V, Priori R, Conti F.
Effectiveness of non-medical switch from adalimumab bio-originator to SB5 biosimilar and from ABP501 adalimumab biosimilar to SB5 biosimilar in patients with chronic inflammatory arthropathies: a monocentric observational study.
Clin Exp Rheumatol. 2022 Jul 28. doi: 10.55563/clinexprheumatol/bf00j9.
279. Prevete I, Iuliano A, Cauli A, Piga M, Iannone F, Coladonato L, Bortoluzzi A, Silvagni E, Tani C, Elefante E, Doria A, Iaccarino L, Franceschini F, Fredi M, Conti F, Spinelli FR, Frediani B, Gonzales Garcìa E, Scirè CA, Zanetti A, Rozza D, Carrara G, Sebastiani GD
Similarities and differences between younger and older disease onset patients with newly diagnosed systemic lupus erythematosus.
Clin Exp Rheumatol. 2022 Jul 26. doi: 10.55563/clinexprheumatol/oo5ymg. Online ahead of print.
280. Truglia S, Capozzi A, Mancuso S, Manganelli V, Rapino L, Riitano G, Recalchi S, Colafrancesco S, Ceccarelli F, Garofalo T, Alessandri C, Longo A, Misasi R, Conti F, Sorice M.
Relationship Between Gender Differences and Clinical Outcome in Patients With the Antiphospholipid Syndrome.
Front Immunol. 2022 Jul 4;13:932181. doi: 10.3389/fimmu.2022.932181. eCollection 2022.
281. Mohammad Reza Beigi D, Pellegrino G, Cadar M, Bisconti I, Di Ciommo FR, Stefanantoni K, Conti F, Riccieri V.
Psychological Fragility in an Italian Cohort of Systemic Sclerosis Patients During COVID-19 Pandemic Category: Short Communication.
Open Access Rheumatol. 2022 Jul 11;14:133-139. doi: 10.2147/OARRR.S367424. eCollection 2022.
282. Campagna G, Anzola LK, Varani M, Lauri C, Gentiloni Silveri G, Chiurchioni L, Spinelli FR, Priori R, Conti F, Signore A.
Imaging Activated-T-Lymphocytes in the Salivary Glands of Patients with Sjögren's Syndrome by 99mTc-Interleukin-2: Diagnostic and Therapeutic Implications.
J Clin Med. 2022 Jul 27;11(15):4368. doi: 10.3390/jcm11154368.
283. Colombo D, Frassi M, Pagano Mariano G, Fusaro E, Lomater C, Del Medico P, Iannone F, Foti R, Limonta M, Marchesoni A, Raffeiner B, Viapiana O, Grassi W, Grembiale RD, Guggino G, Mazzone A, Tirri E, Perricone R, Sarzi Puttini PC, De Vita S, Conti F, Ori A, Simoni L, Fiocchi M, Orsenigo R, Zagni E; and the CHRONOS Study Group.
Real-world evidence of biologic treatments in psoriatic arthritis in Italy: results of the CHRONOS (EffeCtiveness of biologic treatments for psoriatic artHRitis in Italy: an ObservatioNal lOngitudinal Study of real-life clinical practice) observational longitudinal study.
BMC Rheumatol. 2022 Sep 12;6(1):57. doi: 10.1186/s41927-022-00284-w.
284. Ceccarelli F, Covelli V, Olivieri G, Natalucci F, Alessandri C, Conti F.
Patients with systemic lupus erythematosus and their experience with vaccination against COVID-19: a descriptive and explanatory study.
Reumatismo. 2022 Sep 13;74(2). doi: 10.4081/reumatismo.2022.1491.
285. Scrivo R, Molteni E, Castellani C, Altobelli A, Alessandri C, Ceccarelli F, Di Franco M, Priori R, Riccieri V, Sili Scavalli A, Spinelli FR, Mastroianni CM, Conti F.
Are interferon-gamma release assays reliable to detect tuberculosis infection in patients with rheumatoid arthritis treated with Janus kinase inhibitors?
PLoS One. 2022 Sep 28;17(9):e0275329. doi: 10.1371/journal.pone.0275329. eCollection 2022.
286. Ferrara V, Perrone ME, Mina C, Ceccarelli F, Olivieri G, Fattapposta F, Conti F.
Science and visual Arts: Binomial or Dichotomy? A Pilot study in Systemic Lupus Erythematosus patients.
Lupus. 2022 Oct 2:9612033221131179. doi: 10.1177/09612033221131179. Online ahead of print.
287. Gremese E, Ciccia F, Selmi C, Cuomo G, Foti R, Matucci-Cerinic M, Conti F, Fusaro E, Guggino G, Iannone F, Delle Sedie A, Perricone R, Idolazzi L, Moscato P, Theander E, Noël W, Bergmans P, Marelli S, Gossec L, Smolen JS; Italian PsABio study.
Persistence, effectiveness and safety of ustekinumab compared to TNF inhibitors in psoriatic arthritis within the Italian PsABio cohort.
Clin Exp Rheumatol. 2022 Oct 12. doi: 10.55563/clinexprheumatol/j33pjt. Online ahead of print.
288. Vitale A, Alivernini S, Caporali R, Cassone G, Bruno D, Cantarini L, Lopalco G, Rossini M, Atzeni F, Favalli EG, Conti F, Gremese E, Iannone F, Ferraccioli GF, Lapadula G, Sebastiani M.
From Bench to Bedside in Rheumatoid Arthritis from the "2022 GISEA International Symposium".
J Clin Med. 2023 Jan 9;12(2):527. doi: 10.3390/jcm12020527.
289. Salaffi F, Siragusano C, Alciati A, Cassone G, D'Angelo S, Guiducci S, Favalli EG, Conti F, Gremese E, Iannone F, Caporali R, Sebastiani M, Ferraccioli GF, Lapadula G, Atzeni F.
Axial Spondyloarthritis: Reshape the Future-From the "2022 GISEA International Symposium".
J Clin Med. 2022 Dec 19;11(24):7537. doi: 10.3390/jcm11247537.
290. Floris A, Chessa E, Sebastiani GD, Prevete I, Iannone F, Coladonato L, Govoni M, Bortoluzzi A, Mosca M, Tani C, Doria A, Iaccarino L, Franceschini F, Fredi M, Conti F, Spinelli FR, Bellisai F, D'Alessandro R, Zanetti A, Carrara G, Scirè CA, Cauli A, Piga M; study group on Early SLE of the Italian Society of Rheumatology (SIR).
Glucocorticoid tapering and associated outcome in patients with newly diagnosed systemic lupus erythematosus: the real-world GULP prospective observational study.
RMD Open. 2022 Dec;8(2):e002701. doi: 10.1136/rmdopen-2022-002701.
291. Andreozzi V, Monaco E, Garufi C, Spinelli FR, Rossi G, Dagget M, Conti F, Ferretti A.
In-Office Needle Arthroscopic Synovial Biopsy Is an Effective Diagnostic Tool in Patients With Inflammatory Arthritis.
Arthrosc Sports Med Rehabil. 2022 Nov 29;4(6):e2099-e2106. doi: 10.1016/j.asmr.2022.10.003. eCollection 2022 Dec.
292. Priori R, Giardina F, Gioia C, Iannuccelli C, Villa M, Gattamelata A, Conti F, Di Franco M, Curcio G.
Cultural adaptation and preliminary validation of the Qualisex questionnaire for its use in patients with Sjögren's syndrome and fibromyalgia in Italy.
Clin Exp Rheumatol. 2022 Dec;40(12):2470-2471. doi: 10.55563/clinexprheumatol/9dva0x. Epub 2022 Dec 20.
293. Zagni E, Frassi M, Mariano GP, Fusaro E, Lomater C, Del Medico P, Iannone F, Foti R, Limonta M, Marchesoni A, Raffeiner B, Viapiana O, Grassi W, Grembiale RD, Guggino G, Mazzone A, Tirri E, Perricone R, Sarzi Puttini PC, De Vita S, Conti F, Zullo A, Simoni L, Fiocchi M, Orsenigo R, Colombo D.
A real-world economic analysis of biologic therapies for psoriatic arthritis in Italy: results of the CHRONOS observational longitudinal study.
BMC Health Serv Res. 2022 Dec 16;22(1):1537. doi: 10.1186/s12913-022-08954-8.
294. Ceccarelli F, Natalucci F, Pirone C, Olivieri G, Colasanti T, Picciariello L, Spinelli FR, Alessandri C, Conti F.
Erosive arthritis in systemic lupus erythematosus: application of cluster analysis.
Clin Exp Rheumatol. 2022 Nov;40(11):2175-2178. doi: 10.55563/clinexprheumatol/b8gaty. Epub 2022 Oct 28.
295. Ceccarelli F, Govoni M, Piga M, Cassone G, Cantatore FP, Olivieri G, Cauli A, Favalli EG, Atzeni F, Gremese E, Iannone F, Caporali R, Sebastiani M, Ferraccioli GF, Lapadula G, Conti F.
Arthritis in Systemic Lupus Erythematosus: From 2022 International GISEA/OEG Symposium.
J Clin Med. 2022 Oct 12;11(20):6016. doi: 10.3390/jcm11206016.
296. Ucci FM, Recalchi S, Barbati C, Manganelli V, Capozzi A, Riitano G, Buoncuore G, Garofalo T, Ceccarelli F, Spinelli FR, Balbinot E, Celia A, Longo A, Alessandri C, Misasi R, Sorice M, Conti F.
Citrullinated and carbamylated proteins in extracellular microvesicles from plasma of patients with Rheumatoid Arthritis.
Rheumatology (Oxford). 2022 Oct 18:keac598. doi: 10.1093/rheumatology/keac598. Online ahead of print.
297. Gremese E, Ciccia F, Selmi C, Cuomo G, Foti R, Matucci-Cerinic M, Conti F, Fusaro E, Guggino G, Iannone F, Delle Sedie A, Perricone R, Idolazzi L, Moscato P, Theander E, Noël W, Bergmans P, Marelli S, Gossec L, Smolen JS; Italian PsABio study.
Persistence, effectiveness and safety of ustekinumab compared to TNF inhibitors in psoriatic arthritis within the Italian PsABio cohort.
Clin Exp Rheumatol. 2022 Oct 12. doi: 10.55563/clinexprheumatol/j33pjt. Online ahead of print.
298. Schiavoni I, Olivetta E, Natalucci F, Olivieri G, Lo Presti A, Fedele G, Stefanelli P, Ceccarelli F, Conti F.
Evidence of immune response to BNT162b2 COVID-19 vaccine in systemic lupus erythematosus patients treated with Belimumab.
Lupus. 2023 Jan 6:9612033221151012. doi: 10.1177/09612033221151012. Online ahead of print.
299. Villano U, Mataj E, Dorrucci M, Farchi F, Pirone C, Valdarchi C, Equestre M, Madonna E, Bruni R, Pisani G, Martina A, Simeoni M, Iaiani G, Ciccozzi M, Ciccaglione AR, Conti F, Ceccarelli F, Lo Presti A.
Molecular Characterization of Hepatitis B Virus Infection in a Patient with Cutaneous Lupus Erythematosus.
Diagnostics (Basel). 2022 Nov 19;12(11):2866.
300. Zagni E, Frassi M, Mariano GP, Fusaro E, Lomater C, Del Medico P, Iannone F, Foti R, Limonta M, Marchesoni A, Raffeiner B, Viapiana O, Grassi W, Grembiale RD, Guggino G, Mazzone A, Tirri E, Perricone R, Sarzi Puttini PC, De Vita S, Conti F, Zullo A, Simoni L, Fiocchi M, Orsenigo R, Colombo D.
A real-world economic analysis of biologic therapies for psoriatic arthritis in Italy: results of the CHRONOS observational longitudinal study.
BMC Health Serv Res. 2022 Dec 16;22(1):1537.
301. Lo Presti A, Ceccarelli F, Dorrucci M, Farchi F, Pirone C, Garufi C, Valdarchi C, Spinelli FR, Alessandri C, Chionne P, Madonna E, Pisani G, Martina A, Simeoni M, Bruni R, Ciccozzi M, Iaiani G, Ciccaglione AR, Spada E, Conti F.
Hepatitis B and C virus infection in patients with Systemic and Cutaneous Lupus Erythematosus.
New Microbiol. 2022 Dec;45(4):296-303.
302. Novelli L, Barbati C, Capuano C, Recalchi S, Ceccarelli F, Vomero M, Alessandri C, Morrone S, Conti F.
KLRG1 is reduced on NK cells in SLE patients, inversely correlates with disease activity and is modulated by hydroxychloroquine in vitro.
Lupus. 2023 Mar 6:9612033231160979.
303. Ceccarelli F, Natalucci F, Picciariello L, Ciancarella C, Dolcini G, Gattamelata A, Alessandri C, Conti F.
Application of Machine Learning Models in Systemic Lupus Erythematosus.
Int J Mol Sci. 2023 Feb 24;24(5):4514.
304. Caporali R, Conti F, Iannone F.
Management of patients with inflammatory rheumatic diseases after treatment failure with a first TNF inhibitor: a narrative review.
Mod Rheumatol. 2023 Apr 6:road033. doi: 10.1093/mr/road033. Online ahead of print.
305. Monti S, Milanesi A, Klersy C, Tomelleri A, Dagna L, Campochiaro C, Farina N, Muratore F, Galli E, Marvisi C, Bond M, Berti A, Bortolotti R, Padoan R, Schiavon F, Felicetti M, Nannini C, Cantini F, Giollo A, Rossini M, Conticini E, Frediani B, Conti F, Priori R, Sebastiani M, Cassone G, Quartuccio L, Treppo E, Bettio S, Hoxha A, Lovisotto M, Emmi G, Mattioli I, Leccese P, Caporali R, Argolini LM, Foti R, Visalli E, Colaci M, Salvarani C, Montecucco C; Italian Society of Rheumatology Vasculitis Study Group.
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients.
Ann Rheum Dis. 2023 May 15:ard-2023-223895. doi: 10.1136/ard-2023-223895. Online ahead of print.
306. Salaffi F, Di Carlo M, Di Franco M, Bianchi G, Bazzichi L, Tirri R, Guiducci S, Gorla R, Atzeni F, Giacomelli R, Di Donato E, Guggino G, Fischetti F, Tirri E, Biasi G, Foti R, Dagna L, Carubbi F, Gremese E, Govoni M, Cutolo M, Iannone F, Lippolis I, Conti F, Tramontano G, Marino V, Farah S, Sarzi-Puttini P; Società Italiana di Reumatologia (SIR).
Determining the PASS cut-off points for the FIQR, FASmod and PSD in patients with fibromyalgia: a registry-based study.
Clin Exp Rheumatol. 2023 May 3. doi: 10.55563/clinexprheumatol/on8j9a. Online ahead of print.
307. Ceccarelli F, Natalucci F, Di Filippo A, Olivieri G, Napoletano C, Rughetti A, Nuti M, Zizzari IG, Conti F.
Membrane and Soluble CD137 in Systemic Lupus Erythematosus: Role as Biomarkers for Disease Activity.
J Immunol Res. 2023 Apr 18;2023:2344239. doi: 10.1155/2023/2344239. eCollection 2023.
308. Iagnocco A, Ciccia F, Conti F, D'Angelo S, Epis OM, Govoni M, Guiducci S, Iannone F, Mosca M, Salaffi F, Sebastiani GD, Sonnati M, Caporali RF.
Adherence to therapy in people with rheumatic and musculoskeletal diseases in Italy and the role of the digital health: results of an expert Delphi consensus survey.
Clin Exp Rheumatol. 2023 Jun 28. doi: 10.55563/clinexprheumatol/uip1u1. Online ahead of print.
309. Favretti M, Dolcini G, Iannuccelli C, Franculli D, Gioia C, Sarzi-Puttini P, Conti F, Di Franco M.
Gender differences in the revised Fibromyalgia Impact Questionnaire: a pilot study.
Clin Exp Rheumatol. 2023 Jun;41(6):1310-1316. doi: 10.55563/clinexprheumatol/4mlktj. Epub 2023 Jun 28.
310. Ceccarelli F, Perricone C, Natalucci F, Picciariello L, Olivieri G, Cafaro G, Bartoloni E, Roberto G, Conti F.
Organ damage in Systemic Lupus Erythematosus patients: A multifactorial phenomenon.
Autoimmun Rev. 2023 Aug;22(8):103374. doi: 10.1016/j.autrev.2023.103374. Epub 2023 Jun 9
311. Mohammad Reza Beigi D, Pellegrino G, Loconte M, Landini N, Mattone M, Paone G, Truglia S, Di Ciommo FR, Bisconti I, Cadar M, Stefanantoni K, Panebianco V, Conti F, Riccieri V.
Lung ultrasound compared to computed tomography detection and automated quantification of systemic sclerosis-associated interstitial lung disease: preliminary study.
Rheumatology (Oxford). 2023 Jul 3:kead324. doi: 10.1093/rheumatology/kead324. Online ahead of print.
312. Spinelli FR, Berti R, Farina G, Ceccarelli F, Conti F, Crescioli C.
Exercise-induced modulation of Interferon-signature: a therapeutic route toward management of Systemic Lupus Erythematosus.
Autoimmun Rev. 2023 Oct;22(10):103412. doi: 10.1016/j.autrev.2023.103412. Epub 2023 Aug 18.
313. Scagnellato L, Collesei A, Doria A, Cozzi G, Lorenzin M, Atzeni F, Bugatti S, Caporali R, Cauli A, Conti F, Corrado A, Carletto A, Chimenti MS, Foti R, Frediani B, Gerli R, Gorla R, Govoni M, Gremese E, Guiducci S, Iagnocco A, Iannone F, Parisi S, Rossini M, Salaffi F, Santo L, Sarzi Puttini P, Sebastiani M, Semerano A, Ferraccioli G, Lapadula G, Ramonda R; GISEA Study Group.
Comorbidities in the Spondyloarthritis GISEA Cohort: an average treatment effect analysis on patients treated with bDMARDs.
Clin Exp Rheumatol. 2023 Aug 30. doi: 10.55563/clinexprheumatol/q38lu0. Online ahead of print.
314. Ceccarelli F, Olivieri G, Orefice V, Picciariello L, Natalucci F, Conti F.
Fragility fractures in lupus patients: Associated factors and comparison of four fracture risk assessment tools.
Lupus. 2023 Sep 12:9612033231202701. doi: 10.1177/09612033231202701. Online ahead of print.
315. Hernández-Cruz B, Kiltz U, Avouac J, Treuer T, Haladyj E, Gerwien J, Gupta CD, Conti F.
Systematic Literature Review of Real-World Evidence on Baricitinib for the Treatment of Rheumatoid Arthritis.
Rheumatol Ther. 2023 Sep 16. doi: 10.1007/s40744-023-00591-9. Online ahead of print.
316. Spinelli FR, Garufi C, Mancuso S, Ceccarelli F, Truglia S, Conti F.
Tapering and discontinuation of glucocorticoids in patients with rheumatoid arthritis treated with tofacitinib.
Sci Rep. 2023 Sep 20;13(1):15537. doi: 10.1038/s41598-023-42371-z.
317. Zen M, Gatto M, Depascale R, Regola F, Fredi M, Andreoli L, Franceschini F, Urban ML, Emmi G, Ceccarelli F, Conti F, Bortoluzzi A, Govoni M, Tani C, Mosca M, Ubiali T, Gerosa M, Bozzolo EP, Canti V, Cardinaletti P, Gabrielli A, Tanti G, Gremese E, De Marchi G, De Vita S, Fasano S, Ciccia F, Pazzola G, Salvarani C, Negrini S, Di Matteo A, De Angelis R, Orsolini G, Rossini M, Faggioli P, Laria A, Piga M, Cauli A, Scarpato S, Rossi FW, De Paulis A, Brunetta E, Ceribelli A, Selmi C, Prete M, Racanelli V, Vacca A, Bartoloni E, Gerli R, Zanatta E, Larosa M, Saccon F, Doria A, Iaccarino L.
Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study-Joint and Skin (BeRLiSS-JS).
J Pers Med. 2023 Apr 20;13(4):691.
318. Bijl M, Westra J, Mancuso S, Bearzi P, Giacomelli R, Conti F.
Should we vaccinate during an active rheumatic disease?
Autoimmun Rev. 2023 Aug 25:103426. doi: 10.1016/j.autrev.2023.103426
319. Picchianti-Diamanti A, Navarra A, Aiello A, Laganà B, Cuzzi G, Salmi A, Vanini V, Maggi F, Meschi S, Matusali G, Notari S, Agrati C, Salemi S, Di Rosa R, Passarini D, Di Gioia V, Sesti G, Conti F, Spinelli FR, Corpolongo A, Chimenti MS, Ferraioli M, Sebastiani GD, Benucci M, Li Gobbi F, Santoro AP, Capri A, Puro V, Nicastri E, Goletti D.
Older Age, a High Titre of Neutralising Antibodies and Therapy with Conventional DMARDs Are Associated with Protection from Breakthrough Infection in Rheumatoid Arthritis Patients after the Booster Dose of Anti-SARS-CoV-2 Vaccine.
Vaccines (Basel). 2023 Nov 2;11(11):1684. doi: 10.3390/vaccines11111684.
320. Colasanti T, Conti F.
Autoantibody Recognition of Natural and Homocysteinylated Alpha-1 Antitrypsin: Indirect Enzyme-Linked Immunosorbent Assay (ELISA) Quantification in Sera.
Methods Mol Biol. 2024;2750:135-141. doi: 10.1007/978-1-0716-3605-3_13.
321. Spinelli FR, Conti F, Caporali R, Iannone F, Cacciapaglia F, Steering Committee Of The Italian Society Of Rheumatology OBOT.
Janus kinase inhibitors: between prescription authorization and reimbursability.
Reumatismo. 2023 Dec 19;75(4). doi: 10.4081/reumatismo.2023.1627.
322. Gioia C, Picchianti Diamanti A, Perricone R, Chimenti MS, Afeltra A, Navarini L, Migliore A, Massafra U, Bruzzese V, Scolieri P, Meschini C, Paroli M, Caccavale R, Scapato P, Scrivo R, Conti F, Laganà B, Di Franco M.
Anti-tumor necrosis factor α: originators versus biosimilars, comparison in clinical response assessment in a multicenter cohort of patients with inflammatory arthropathies.
Reumatismo. 2023 Dec 19;75(4). doi: 10.4081/reumatismo.2023.1602.
323. Riitano G, Capozzi A, Recalchi S, Augusto M, Conti F, Misasi R, Garofalo T, Sorice M, Manganelli V.
Role of Lipid Rafts on LRP8 Signaling Triggered by Anti-β2-GPI Antibodies in Endothelial Cells.
Biomedicines. 2023 Nov 24;11(12):3135. doi: 10.3390/biomedicines11123135.
324. Colafrancesco S, Celia AI, Baldini C, Quartuccio L, Bartoloni E, Carubbi F, Orlandi M, Barbati C, Pignataro MG, Cerbelli B, Giordano C, Ferro F, Gattamelata A, Giardina F, Izzo R, Longhino S, De Vita S, Gerli R, Giacomelli R, Conti F, Priori R.
Clinical and histological features of patients with primary Sjögren's syndrome and autoimmune thyroiditis: a national multicentre cross-sectional study.
Clin Exp Rheumatol. 2023 Dec;41(12):2389-2396. doi: 10.55563/clinexprheumatol/eh36vs. Epub 2023 Dec 23.
325. Gigante A, Cianci R, Villa A, Pellicano C, Giannakakis K, Rosato E, Spinelli FR, Basile U, Racco C, Di Virgilio EM, Cerbelli B, Conti F.
Kidney Biopsy and Immuno-Rheumatological Diseases: A Retrospective and Observational Study.
J Pers Med. 2024 Jan 13;14(1):92. doi: 10.3390/jpm14010092.
326. Riccieri V, Pellegrino G, Cipolletta E, Giuggioli D, Bajocchi G, Bellando-Randone S, Dagna L, Zanframundo G, Foti R, Cacciapaglia F, Cuomo G, Ariani A, Rosato E, Lepri G, Girelli F, Zanatta E, Bosello SL, Cavazzana I, Ingegnoli F, De Santis M, Murdaca G, Abignano G, Romeo N, Della Rossa A, Caminiti M, Iuliano A, Ciano G, Beretta L, Bagnato G, Lubrano E, De Andres I, Giollo A, Saracco M, Agnes C, Lumetti F, Spinella A, Magnani L, Campochiaro C, De Luca G, Codullo V, Visalli E, Di Vico C, Gigante A, Saccon F, Grazia Lazzaroni M, Franceschini F, Generali E, Mennillo G, Barsotti S, Pagano Mariano G, Calabrese F, Furini F, Vultaggio L, Parisi S, Peroni CL, Bianchi G, Conti F, Cozzi F, D'Angelo S, Doria A, Fusaro E, Govoni M, Guiducci S, Iannone F, Salvarani C, Sebastiani GD, Ferri C, Matucci-Cerinic M, De Angelis R.
Practice pattern for the use of intravenous iloprost for the treatment of peripheral vasculopathy in systemic sclerosis: A case-control study from the Italian national multicenter "SPRING" (Systemic Sclerosis Progression InvestiGation) Registry.
J Scleroderma Relat Disord. 2024 Feb;9(1):38-49. doi: 10.1177/23971983231209809. Epub 2024 Jan 11.
327. Bortoluzzi A, Fanouriakis A, Silvagni E, Appenzeller S, Carli L, Carrara G, Cauli A, Conti F, Costallat LTL, De Marchi G, Doria A, Fredi M, Franceschini F, Garaffoni C, Hanly JG, Mosca M, Murphy E, Piga M, Quartuccio L, Scirè CA, Tomietto P, Truglia S, Zanetti A, Zen M, Bertsias G, Govoni M.
Therapeutic Strategies and Outcomes in Neuropsychiatric Systemic Lupus
Erythematosus: An International Multicenter Retrospective Study.
Rheumatology (Oxford). 2024 Feb 24:keae119. doi: 10.1093/rheumatology/keae119. Online ahead of print.
328. Treppo E, Isola M, De Martino M, Padoan R, Giollo A, Urban ML, Monti S, Sartorelli S, Fassio A, Argolini LM, Marvisi C, Gattamelata A, Regola F, Ferro F, Cassone G, Motta F, Berti A, Conticini E, Guiducci S, Matucci-Cerinic M, Lo Gullo A, Manfredi A, Frediani B, Bortolotti R, Selmi C, Baldini C, Franceschini F, Conti F, Caporali R, Rossini M, Dagna L, Montecucco C, Emmi G, Schiavon F, Salvarani C, Quartuccio L.
Validation of the Italian version of the ANCA-associated vasculitis patient-reported outcome (AAV-PRO) questionnaire.
Rheumatol Adv Pract. 2024 Jan 22;8(1):rkae001.
329. Manfredi A, Fornaro M, Bazzani C, Perniola S, Cauli A, Rai A, Favalli EG, Bugatti S, Rossini M, Foti R, Conti F, Lopalco G, Scalvini A, Garufi C, Congia M, Gorla R, Gremese E, Atzeni F, Caporali R, Iannone F, Sebastiani M.
Retention rate of biologic and targeted synthetic anti-rheumatic drugs in elderly rheumatoid arthritis patients: data from GISEA registry.
Front Med (Lausanne). 2024 Mar 11;11:1349533.
330. Ceccarelli F, Natalucci F, Picciariello L, Cirillo A, Olivieri G, Veroli M, Pisegna S, Ciancarella C, Gelibter A, Picone V, Santini D, Botticelli A, Conti F.
Antinuclear antibodies may predict the development of immune-related adverse events in asymptomatic patients treated with immune checkpoint inhibitors: results from a single-center cohort.
Clin Exp Med. 2024 Apr 10;24(1):72.
331. Gioia C, Dolcini G, Iannuccelli C, Favretti M, Franculli D, Sarzi-Puttini P, Conti F, Priori R, Di Franco M.
Validation of Qualisex questionnaire to evaluate sexual dysfunction in women affected by fibromyalgia.
Clin Exp Rheumatol. 2024 Apr 8. doi: 10.55563/clinexprheumatol/a00yur. Online ahead of print.
332. Fornaro M, Caporali R, Biggioggero M, Bugatti S, De Stefano L, Cauli A, Congia M, Conti F, Chimenti MS, Bazzani C, Perniola S, Atzeni F, Lapadula G, Ferraccioli G, Iannone F; from the GISEA registry.
Effectiveness and safety of filgotinib in rheumatoid arthritis patients: data from the GISEA registry.
Clin Exp Rheumatol. 2024 Apr 17. doi: 10.55563/clinexprheumatol/b40rv4. Online ahead of print.
Rome, 10 Jul 2025
Fabrizio Conti
Orari di ricevimento
previo appuntamento e-mail
Curriculum
Fabrizio Conti
Lingue: Italiano, Inglese
INDIRIZZI
● Lavoro: Reumatologia, Dipartimento di Scienze Mediche e Cardiovascolari, Sapienza Università di Roma, Azienda Ospedaliero-Universitaria Policlinico Umberto I, Viale del Policlinico 155, 00161, Roma.
POSIZIONE ATTUALE
• Professore di I fascia
Settore: MED/16 REUMATOLOGIA
Settore concorsuale: 06/D3
Università degli Studi di Roma "La Sapienza"
Dipartimento di Scienze Cliniche Internistiche, Anestesiologiche e Cardiovascolari.
• Direttore della UOC di Reumatologia, DAI Medicina Interna e Specialità Mediche, Azienda Ospedaliero-Universitaria Policlinico Umberto I di Roma.
FORMAZIONE
• Laurea in Medicina e Chirurgia conseguita il 11/11/1991 presso l’Università degli Studi di Roma “La Sapienza” con votazione 110/110 e lode.
• Specializzazione in Medicina Interna conseguita il 2/11/1998 presso l’Università degli Studi di Roma “La Sapienza” con votazione 70/70 e lode.
• Dottorato di Ricerca in Immunologia Sperimentale - XIV ciclo, durata del corso quattro anni, sede amministrativa Università degli Studi Magna Graecia di Catanzaro. Conseguimento del titolo di dottore di ricerca in data 09/01/2003 con discussione della tesi dal titolo: “Meccanismi patogenetici della sindrome da anticorpi anti-fosfolipidi. Ruolo dei monociti”.
• Da Giugno 2014 a Dicembre 2014 visiting Professor presso Arthritis Research UK Centre for Excellence in Epidemiology, University of Manchester (UK).
• Stata Course 2014, Prof. Mark Lunt, Arthritis Research UK Centre for Excellence in Epidemiology, University of Manchester (UK).
Abilitazione scientifica nazionale a professore I fascia nel settore concorsuale 06/d3, malattie del sangue, oncologia e reumatologia, bando d.d. 1532/2016, abilitato dal 06/04/2017 al 06/04/2023.
ATTIVITA’ CLINICO-ASSISTENZIALE
• Nel 1992 ha iniziato a partecipare alle attività cliniche della cattedra di Allergologia e Immunologia Clinica III, Istituto di I Clinica Medica, Sapienza Università di Roma, quindi, dal 1999, presso la cattedra di Reumatologia, dapprima in qualità di medico frequentatore, quindi specializzando in Medicina Interna, dottorando di ricerca, dirigente medico e infine professore di II fascia di Reumatologia. In questi anni ha acquisito una vasta esperienza clinica nell’ambito della diagnosi e terapia delle malattie autoimmuni e auto infiammatorie di interesse reumatologico.
● Dal 1992 al 1999 ha svolto attività clinica ambulatoriale di Immunologia Clinica e, quindi, dal 1999 ad oggi di Reumatologia, presso l’Azienda Policlinico Umberto I di Roma.
● Dal 1992 al 1998 ha partecipato alle attività diagnostiche del laboratorio di immunologia clinica presso la I Clinica Medica.
• Da Novembre 1999 a Luglio 2000 ha svolto, inoltre, l’incarico di consulente ambulatoriale per la Reumatologia presso la Clinica Ematologica, Sapienza Università di Roma, direttore Prof. F. Mandelli.
• Negli anni 2000 e 2001 ha organizzato, coordinato e svolto corsi di educazione alla malattia rivolti ai pazienti affetti da Lupus Eritematoso Sistemico e ai loro familiari.
• Dal 08/08/2000 al 31/5/2001, dopo aver espletato concorso pubblico per Dirigente Medico di I livello con contratto a tempo indeterminato area Medicina Interna, ha ricoperto il ruolo di Dirigente Medico presso la Divisione di Medicina Generale dell’Ospedale San Giovanni Evangelista di Tivoli, Roma, Asl RMG. Durante tale periodo, oltre alla partecipazione quotidiana alle attività del reparto di degenza, ha attivato un ambulatorio specialistico di Reumatologia.
• Dal 01/06/2001 ricopre il ruolo di Dirigente Medico di I livello presso la UOC di Reumatologia del DAI Medicina Interna, Geriatria e Medicina Riabilitativa poi rinominato DAI Medicina Interna e Specialità Mediche, Azienda Ospedaliero-Universitaria Policlinico Umberto I, Sapienza Università di Roma.
● Dal 11.12.2019 Direttore (ff) della UOC di Reumatologia, Azienda Ospedaliero-Universitaria Policlinico Umberto I di Roma.
● Dal 9.03.2021 Direttore della UOC di Reumatologia, Azienda Ospedaliero-Universitaria Policlinico Umberto I di Roma.
• L’attività assistenziale include:
o attività assistenziale quotidiana, da Settembre 2001 ad oggi, presso il reparto di degenza della UOC di Reumatologia,
o attività ambulatoriale di reumatologia generale, inclusa la diagnosi e terapia delle malattie reumatologiche rare,
o fondatore nel 2008 e responsabile della Lupus Clinic Sapienza Università di Roma: ambulatorio dedicato alla diagnosi e terapia del lupus eritematoso sistemico e della sindrome da anticorpi antifosfolipidi,
o fondatore nel 2015 e responsabile Arthritis Center Sapienza Università di Roma: ambulatorio dedicato alla diagnosi e terapia delle artropatie infiammatorie,
● Dal 2001 al 2013 ha ricoperto il ruolo di consulente per la Reumatologia Pediatrica con attività ambulatoriale presso il Dipartimento di Pediatria, Sapienza Università di Roma. Dal 2013 si occupa del processo di transizione dei pazienti reumatologici pediatrici verso l’ambulatorio dell’adulto.
● Possiede, inoltre, un’ampia esperienza nel campo della medicina d'urgenza, della diabetologia e dietologia clinica, della cardiologia e in particolare della diagnostica elettrocardiografica.
ATTIVITÀ DIDATTICA
● Dal 2001 ad oggi: attività di supervisore dell’attività dei medici specializzandi in Reumatologia presso il reparto di degenza della UOC di Reumatologia.
● Negli anni accademici 2004/05, 2005/06, 2006/07, 2007/08 ha tenuto l’insegnamento “Manifestazioni a carico del SNC in corso di malattie autoimmuni sistemiche e vasculiti” per il II Modulo del Master di II Livello in Malattie Cerebrovascolari, direttore Prof. M. Prencipe, Dipartimento di Scienze Neurologiche, Sapienza Università di Roma.
● Nel 2008 ha tenuto l’insegnamento “Lupus eritematoso sistemico e sindrome da anticorpi anti-fosfolipidi” per il II Master di II Livello in Immunologia e Allergologia Pediatrica, direttore Prof. M. Duse, Dipartimento di Pediatria, Sapienza Università di Roma.
Il 30/12/2010 è stato nominato Professore di ruolo di II fascia, settore s/d MED/16 (Reumatologia), Facoltà di Medicina e Odontoiatria, Sapienza Università di Roma.
● Dall’aa 2010/11 all’aa 2011/12. C.d.L Infermieristica "Q", Sapienza Università di Roma: II anno, II semestre, Corso integrato Medicina e Chirurgia specialistiche, titolarità insegnamento di Reumatologia (MED/16).
● Dall’aa 2011/12 a oggi. Facoltà di Medicina e Odontoiatria, Sapienza Università di Roma: CCLM "C", IV anno, II semestre, Corso integrato Patologia Integrata IV, titolarità insegnamento di Reumatologia e attività formative professionalizzanti (MED/16).
● Dall’aa 2014/15 a oggi. Facoltà di Medicina e Odontoiatria, Sapienza Università di Roma: CCLM "C", IV anno, II semestre, coordinatore del Corso integrato Patologia Integrata IV.
● Dall’aa 2014/15 a oggi. Facoltà di Medicina e Odontoiatria, Sapienza Università di Roma: CCLM "C", coordinatore II semestre, IV anno.
● Dall’aa 2015/16 all’aa 2017-18. Facoltà di Medicina e Odontoiatria, Sapienza Università di Roma: CCLM "F" in lingua Inglese, Corso Movement disorders and Rheumatology, titolarità insegnamento di Reumatologia (MED/16), V anno, II semestre.
● Dall’aa 2017-18 a oggi. Facoltà di Medicina e Odontoiatria, Sapienza Università di Roma: CCLM "F" in lingua Inglese, Corso integrato Applied pathology IV, titolarità insegnamento di Reumatologia (MED/16), V anno, I semestre.
● Dall’aa 2019-20. Facoltà di Medicina e Odontoiatria, Sapienza Università di Roma: CCLM "F" in lingua Inglese, Coordinatore del Corso integrato Applied pathology IV, V anno, I semestre.
● Dall’aa 2012/13 a oggi. C.d.L in Tecniche di radiologia medica, per immagini e radioterapia (abilitante alla professione sanitaria di Tecnico di radiologia medica), Corso di Laurea G, Facoltà di Farmacia e Medicina, Sapienza Università di Roma,: Coordinatore Corso di Scienze Interdisciplinari – titolarità insegnamento di Reumatologia (MED/16).
● Dall’aa 2010/11 a oggi. Docente della Scuola di Specializzazione in Reumatologia, Sapienza Università di Roma.
● Dal 12/10/2015 al 06/12/2019. Membro del Comitato ordinatore della Scuola di Specializzazione in Reumatologia, Sapienza Università di Roma.
● Dal 06/12/2019 al 31.10.2025 oggi. Direttore della Scuola di Specializzazione in Reumatologia, Facoltà di Medicina e Odontoiatria, Sapienza Università di Roma.
● Dal 01.11.2025 Vice Direttore della Scuola di Specializzazione in Reumatologia, Facoltà di Medicina e Odontoiatria, Sapienza Università di Roma
● Da Maggio 2015 membro della CTP del CCLM C Sapienza Università di Roma e responsabile per il percorso d’eccellenza.
● Senior research fellow della SSAS (Scuola superiore di studi avanzati Sapienza) per la Classe Accademica SV per il triennio accademico 2019-22.
● Membro del collegio docenti di dottorato di ricerca " Innovation in immunomediated and hematological disorders"
[29524]
Ateneo proponente: Università degli Studi di ROMA "La Sapienza"
Anni accademici: dall’aa 2014/2015 all’aa 2016-2017.
● Membro del collegio docenti di dottorato di ricerca "INNOVATION IN IMMUNO-MEDIATED AND HEMATOLOGICAL DISORDERS" [DOT1326C63]
Ateneo proponente: Università degli Studi di ROMA "La Sapienza"
Dall’aa 2017/2018 a oggi.
● Dal 12.04.2021 componente della Commissione Nazionale per il Concorso Nazionale per l’ammissione dei medici alle Scuole di Specializzazione di area sanitaria.
● Dal 25.05.2021 al 30.06.2023 membro del Comitato Etico INMI L. Spallanzani di Roma.
● Da aprile 2025 Presidente del Collegio dei Reumatologi e dell’Associazione Unireuma.
ATTIVITA’ DI RICERCA
L’attività di ricerca è stata orientata verso una maggiore comprensione dei meccanismi eziopatogenetici delle malattie immuno-reumatiche con particolare riguardo al lupus eritematoso sistemico e alle altre connettiviti sistemiche, alla sindrome da anticorpi antifosfolipidi, alle artropatie infiammatorie, alle malattie auto-infiammatorie oltre che alla valutazione delle terapie innovative.
LINEE DI RICERCA
• Lupus Eritematoso Sistemico e altre connettiviti: aspetti eziopatogenetici, diagnostici, clinici e terapeutici.
• Sindrome da Anticorpi Antifosfolipidi: aspetti eziopatogenetici, diagnostici e nuove specificità autoanticorpali.
• Artrite reumatoide e artrite psoriasica: aspetti eziopatogenetici, diagnostici.
• Terapie innovative: utilizzo dei farmaci biologici antagonisti del TNF per via intra-articolare nei pazienti affetti da artrite reumatoide e artrite psoriasica con monoartrite refrattaria; utilizzo dell’infliximab nella sindrome di Behçet; utilizzo di farmaci biologici nel lupus eritematoso sistemico.
• Sindrome di Sjögren: aspetti eziopatogenetici, fattori di rischio e familiarità.
• Vasculiti sistemiche: aspetti eziopatogenetici, diagnostici e clinici.
• Sindrome da stanchezza cronica: aspetti epidemiologici, eziopatogenetici, clinici e terapeutici.
• Reumatologia pediatrica: artrite idiopatica giovanile.
RESPONSABILITA' SCIENTIFICA PER PROGETTI DI RICERCA AMMESSI AL FINANZIAMENTO SULLA BASE DI BANDI COMPETITIVI
● Responsabilita' scientifica del progetto di ricerca ammesso al finanziamento sulla base di bando competitivo che prevedeva la revisione tra pari: Ricerche Sapienza Università di Roma 2012. Titolo “Ruolo degli estrogeni e dei loro recettori nella patogenesi del Lupus Eritematoso Sistemico". Progetti Medi prot. C26A12YB7S.
● Responsabilita' scientifica del progetto di ricerca ammesso al finanziamento sulla base di bando competitivo che prevedeva la revisione tra pari: Ricerche Sapienza Università di Roma 2014. Titolo “CX3CL1 and CX3CR1 expression in Systemic Lupus Erythematosus glomerulonephritis: fractalkine as a new biomarker of disease activity and renal involvement”. Progetti Medi prot. C26A143ES7. Finanziamento per la ricerca e per un Assegno di ricerca.
● Responsabilita' scientifica del progetto di ricerca ammesso al finanziamento sulla base di bando competitivo che prevedeva la revisione tra pari: Ricerche Sapienza Università di Roma 2016. Titolo “Jak pathway role on autophagy and citrullinated peptides generation”. Progetti Medi prot. RM116154CA9B9CDF.
● Responsabilita' scientifica del progetto di ricerca ammesso al finanziamento sulla base di bando competitivo che prevedeva la revisione tra pari: Ricerche Sapienza Università di Roma 2018. Titolo “Characterization of regulatory T cells in psoriatic arthritis patients: role of type I interferons in restraining cAMP-mediated immune suppression, and implications for metabolic inflammation”. Progetti Medi prot. RM1181643284C70E.
● Responsabilita' scientifica del progetto di ricerca ammesso al finanziamento sulla base di bando competitivo che prevedeva la revisione tra pari: Ricerche Sapienza Università di Roma. Progetti di Ricerca Grandi - 2019: “Activation of salivary gland epithelial cells from different subset of patients with primary Sjögren syndrome: towards a personalized medicine”.
● Responsabilita' scientifica del progetto PNRR-MCNT2-2023-12377805 dal titolo “Moving more and sitting less: promoting physical exercise as adjuvant therapy in musculoskeletal rheumatic diseases” CUP MASTER E83C24001020006 nell’ambito del PNRR-M6C2.2 Investimento 2.1: Valorizzazione e potenziamento della ricerca biomedica del SSN , per un importo complessivo pari ad € 937.356,32.
RESPONSABILITA' DI STUDI CLINICI
● Sperimentatore principale dello studio: Studio di fase IIb, per caratterizzare l’efficacia e la sicurezza di Sifalimumab, a differenti dosaggi, in pazienti adulti con Lupus Eritematoso Sistemico, CD-IA-MEDI-545-1067/D2800L00004 MEDI-545-1067 (Astra Zeneca). Dal 28-10-2011 al 18-12-2012.
● Sperimentatore principale dello studio: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of BIIB023 in subjects with Lupus Nephritis, 211LE201 (Biogen). Dal 13-03-2013 al 28-05-2015.
● Sperimentatore principale dello studio: A multicenter, single-blind, randomized parallel-group study to assess the short- and long-term efficacy of certolizumab pegol plus methotrexate compared with adalimumab plus methotrexate in subjects with moderate to severe rheumatoid arthritis responding inadequately to methotrexate, RA0077 (UCB). Dal 22-03-2013 al 07-02-2014.
● Sperimentatore principale dello studio: A Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Neutralization of the Interferon Gene Signature and the Clinical Efficacy of IFNα-Kinoid in Adult Subjects with Systemic Lupus Erythematosus, IFN-K-002 (NEOVACS). Dal 15-03-2016 al 25-01-2019.
● Sperimentatore principale dello studio: Studio multicentrico, randomizzato, in doppio cieco, controllato con placebo, di fase 3, per la valutazione dell'efficacia e della sicurezza di due dosi di Anifrolumab in soggetti adulti con Lupus Eritematoso Sistemico attivo, AZULUP54-LUP545 / TULIP 1 (Astra Zeneca). Dal 20-04-2016 al 04/06/2018.
● Sperimentatore principale dello studio: A randomized, double-blind, placebo-controlled, multi-center study to evaluate the safety and efficacy of Obinutuzumab in patients with ISN/RPS 2003 class III or IV lupus nephritis, NOBILITY WA29748 (Roche). Dal 01-06-2016 a 29-03-2018.
● Sperimentatore principale dello studio: Studio clinico in doppio cieco, randomizzato, controllato verso placebo per valutare l’effetto di BI 655064, somministrato come iniezione sub-cutanea, sulla risposta renale dopo un anno di trattamento in pazienti con nefrite lupica attiva. BI 1293.10 (Boehringer Ingelheim). Dal 8-3-2017 al 20-06-2019.
● Sperimentatore principale dello studio: “CHRONOS “Effectiveness of biologic treatments for psoriatic arthritis in Italy: an observational longitudinal study of real-life clinical practice”. (Novartis). Dal 10-04-2019 a oggi.
● Sperimentatore principale dello studio: A Randomized, Double Blind, Placebo Controlled, Parallel Group, Phase 3 Study of Baricitinib in Patients with Systemic Lupus Erythematosus, I4V-MC-JAIA / SLE-BRAVE-II. (Eli Lilly). Dal 13-09-2019 a oggi.
COORDINAMENTO E PARTECIPAZIONE A PROGETTI DI RICERCA NAZIONALI E/O INTERNAZIONALI
● Partecipazione alle attività del gruppo di studio della Società Italiana di Reumatologia sul "Coinvolgimento neuropsichiatrico nel Lupus Eritematoso Sistemico". Dal 01-01-2008 a oggi.
● Responsabilità scientifica delle attività dei gruppi di ricerca Sapienza Lupus Clinic e Arthritis Center, Sapienza Università di Roma.
Tale gruppo si caratterizza per collaborazioni a livello nazionale, quali:
- Italian Multicentre Registry on Rituximab in SLE;
- Registro Italiano Belimumab;
- studio multicentrico sulla valutazione retrospettiva dell'esito e dell'influenza delle tecniche di procreazione medicalmente assistita applicate in donne affette da malattia autoimmune sistemica; studio multicentrico sull'associazione fra risposta al trattamento con farmaci immunosoppressori e polimorfismi dei geni coinvolti nella via di act1;
- dal 1998 con il Dipartimento di Medicina Sperimentale della Sapienza Università di Roma;
- dal 2005 con l'Istituto Superiore di Sanità;
- dal 2012 con il Dipartimento di Neurologia e ORL della Sapienza Università di Roma;
- dal 2013 con la sezione di Genetica del Dipartimento di Biomedicina e Prevenzione dell'Università di Roma "Tor Vergata";
- dal 2014 con il Dipartimento di Medicina Clinica della Sapienza Università di Roma. Collaborazioni a livello internazionale:
- dal 2008 al 2012 con The Rayne Institute, Guy’s, King’s and St Thomas’ School of Medicine, St Thomas’ Hospital, London, United Kingdom;
- dal 2012 con Lupus Nephritis Trials Network – LNTN;
- dal 2012 con Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Queen Mary University of London, United Kingdom;
- dal 2014 con The Zabludowicz Center for Autoimmune Diseases, Chaim Sheba Medical Center, Tel-Hashomer - Israel;
- dal 2014 con Arthritis Research UK Centre for Excellence in Epidemiology, University of Manchester, con il progetto di ricerca: “Inflammatory mechanisms and potential new biomarkers in lupus nephritis”.
● Membro del gruppo di ricerca vincitore del Bando AIFA 2012 per la ricerca indipendente sui farmaci con lo studio dal titolo “The role of anti TNF alpha agents in Behçet’s disease refractory to standard of care therapies: multicenter randomized controlled prospective parallel group single-blind trial to evaluate the 6-month effectiveness of either infliximab or adalimumab" FARM12LTAT. Dal 2016 a oggi.
● Co-responsabile del Progetto Strategico LIRE della Società Italiana di Reumatologia. Il progetto LIRE (Lupus Italian REgistry) prevede un registro italiano multicentrico dei pazienti affetti da LES. Dal 01-01-2015 a oggi.
● Partecipazione alle attività del gruppo di studio della Società Italiana di Reumatologia sul “Lupus Eritematoso Sistemico di recente Insorgenza – Early Lupus”. Dal 14-06-2016 a oggi.
● Coordinatore del gruppo di studio della Società Italiana di Reumatologia sulla "Sindrome da anticorpi antifosfolipidi". Da Novembre 2023 a oggi.
ORGANIZZATORE DI CONVEGNI NAZIONALI IN AMBITO REUMATOLOGICO
1. Componente del comitato scientifico del "50° Congresso Congresso Nazionale della Società Italiana di Reumatologia". Napoli - Mostra D’Oltremare, 27/30 Novembre 2013.
2. Componente del comitato scientifico del "51° Congresso Congresso Nazionale della Società Italiana di Reumatologia e 17° Congresso Nazionale CROI". Rimini 26-29 Novembre 2014.
3. Componente del comitato scientifico del convegno "Ten topics in rheumatology in Rome, reloaded". Roma 15-16 maggio 2015.
4. Componente del comitato scientifico del "52° Congresso Congresso Nazionale della Società Italiana di Reumatologia ". Rimini 23-26 Novembre 2015.
5. Responsabile scientifico del convegno "Ten topics in Rheumatology in Rome, reloaded". Roma 20-21 Maggio 2016.
6. Scientific Director: “Preceptorship in axial SpA.” Rome, 20-21 December 2016.
7. Responsabile scientifico del convegno "Ten topics in Rheumatology in Rome, reloaded". Roma, 19-20 Maggio 2016.
8. Responsabile scientifico del convegno “Fast forward. Nuovi orizzonti nella gestione del paziente con Artrite Reumatoide”. Roma, 12 Dicembre 2017.
9. Referente scientifico del convegno “Progetto MOMAR. Modelli Operativi di Management nell’Artrite Reumatoide". Roma, 20 Aprile 2018.
10. Responsabile scientifico del convegno “Ten topics in Rheumatology in Rome”. Roma, 25-26 Maggio 2018.
11. Responsabile scientifico del convegno “ExChange (Experience & Challenges) in PSA”. Roma, 6 Luglio 2018.
12. Responsabile scientifico dell’evento “Preceptorship sul lupus eritematoso sistemico focus sul lupus all’esordio e sulle manifestazioni lievi-moderate”. Roma, 11 Luglio 2018.
13. Responsabile scientifico del convegno “AReal life small molecules e pratica clinica nella gestione del paziente con Artrite Reumatoide”. Roma, 14 Settembre 2018.
14. Responsabile scientifico del convegno “The ultrasound days in rheumatology”. Roma, 19 Settembre 2018.
15. Responsabile scientifico del convegno “Experience the new - Il valore dell’esperienza per la qualità di vita dei pazienti con AR”. Roma, 21 Settembre 2018.
16. Responsabile scientifico del convegno “Reuma4Her. La gestione della donna in eta’ fertile affetta da artrite infiammatoria: il ruolo centrale del reumatologo”. Roma, 21 Maggio 2019.
17. Responsabile scientifico del convegno “Areal Life 2.0 JAK-inhibitors nella pratica clinica”, Roma, 21-22 Giugno 2019.
18. Responsabile scientifico del convegno “GEstione Multidisciplinare delle malattie infiammatorie immunomediate”. Roma, 12-13 Settembre 2019.
19. Responsabile scientifico del convegno “Reumatologic: pazienti, percorsi, progressi”. Roma, 11-12 Ottobre 2019.
20. Responsabile scientifico del convegno “L’artrite reumatoide: dalla diagnosi alla terapia”. Roma, 06 novembre 2019.
21. Responsabile scientifico del convegno “Medicina di precisione nelle artropatie infiammatorie per un migliore approccio diagnostico terapeutico”. Roma, 15 settembre 2020.
ATTIVITÀ DI COORDINAMENTO IN SOCIETÀ SCIENTIFICHE NAZIONALI IN AMBITO REUMATOLOGICO
● Membro del Consiglio Direttivo della Società Italiana di Reumatologia da Novembre 2012 a Novembre 2016 e da Novembre 2020 a Novembre 2024.
• Membro della Giunta Esecutiva e tesoriere di UNIREUMA (dal 2009 al 2012).
• Presidente del Collegio dei Reumatologi e di UNIREUMA da Aprile 2025.
● Co-responsabile del Progetto Strategico LIRE della Società Italiana di Reumatologia. Il progetto LIRE (Lupus Italian REgistry) prevede un registro italiano multicentrico dei pazienti affetti da LES. Dal 01-01-2015 a oggi.
● Membro della commissione promossa dalla Società Italiana di Reumatologia per l’elaborazione delle raccomandazioni relative al trattamento con farmaci biologici nei pazienti con artrite reumatoide (Raccomandazioni pubblicate su Clin Exp Rheumatol 29, 3 Suppl 66:S7-14; 2011).
Dal 29-03-2010 al 15-06-2011.
SOCIETÀ E GRUPPI SCIENTIFICI
● Società italiana di Reumatologia (SIR). Dal 2005 a oggi.
● Revisore per il Ministero dell'Istruzione, dell'Università e della Ricerca elenco REPRISE: Register of Expert Peer Reviewers for Italian Scientific Evaluation. Dal 29-09-2015 a oggi.
● Consulente dell’AIFA. Dal 19-10-2016 a oggi.
● Socio Ordinario dell’Accademia Medica di Roma. Dal 1.09.2017 a oggi.
ATTIVITÀ DI REFEREE PER RIVISTE SCIENTIFICHE
Referee:
Annals of Rheumatic Diseases; Arthritis Care & Research, Journal of Rheumatology, Plos One, Clinical and Experimental Rheumatology, Reumatismo, Seminars in Arthritis and Rheumatism, Lupus, Clinical Rheumatology. Metabolism & Cardiovascular Diseases, Atherosclerosis, Clinical Neurology and Neurosurgery, Journal of Postgraduate Medicine; Clinical and Experimental Medicine, Nutrition, Vaccine, Pediatric Drugs, Internal and Emergency Medicine, American Journal of Nephrology, Frontiers in Medicine.
● Partecipazione al comitato editoriale della rivista: Reumatismo, dal 01-01-2014 a oggi.
● Partecipazione al comitato editoriale della rivista: Journal of Rheumatic Diseases and Treatment, dal 29-11-2014 a oggi.
● Partecipazione al comitato editoriale della rivista: International Journal of Radiology & Medical Imaging, dal 06-01-2015 a oggi.
● Partecipazione al comitato editoriale della rivista: Case Reports in Medicine, dal 22-08-2016 a oggi.
● Partecipazione al comitato editoriale della rivista: The Scientific Pages of Orthopedics and Rheumatism, dal 07-09-2016 a oggi.
● Partecipazione al comitato editoriale della rivista: Austin Rheumatology, dal 19-09-2016 a oggi
● Partecipazione, come Review Editor, al comitato editoriale della rivista: Frontiers in Medicine, dal 13-11-2016 a oggi.
● Partecipazione comitato editoriale della rivista: International Journal of Molecular Sciences dal 27-02-2020 ad oggi.
ELENCO DELLE PUBBLICAZIONI
ARTICOLI IN LINGUA INGLESE
1. Valesini G, Conti F, Priori R, Balsano F.
Gilbert’s syndrome and chronic fatigue syndrome.
Lancet 341:1162-1163; 1993.
2. R Priori, F Conti, FL Luan, C Arpino, G Valesini.
Chronic fatigue: a peculiar evolution of eosinopholia-myalgia syndrome following treatment with L-tryptophane in four Italian adolescents.
Eur J Pediatrics 153:344-346; 1994.
3. F Conti, R Priori, G De Petrillo, AC Rusconi, C Arpino, G Valesini.
Prevalence of chronic fatigue syndrome in Italian patients with persistent fatigue.
Ann Ital Med Int 9:219-222; 1994.
4. G Valesini, R Priori, F Conti.
Chronic Fatigue Syndrome: what factors trigger it off?
Clin Exp Rheumatol 12:473-476; 1994.
5. Valesini G, Priori R, Conti F.
Saddle nose in relapsing polichondritis: a problem of differential diagnosis.
N Eng J Med 333:525-526; 1995.
6. F Conti, L Magrini, R Priori, P Rotiroti, G Valesini, S Bonini.
Eosinophil cationic protein serum levels and allergy in chronic fatigue syndrome.
Allergy 51:124-127; 1996.
7. S Morelli, C Barbieri, A Sgreccia, L Ferrante, V Pittoni, F Conti, G Gualdi, E Polettini, O Carlesimo, S Calvieri.
Relationship between cutaneous and pulmonary involvement in Systemic Sclerosis.
J Rheumatol 25:85-89; 1997.
8. Priori R, Conti F, Pittoni V, Valesini G.
Relapsing polichondritis: a syndrome rather than a distinct clinical entity.
Clin Exp Rheumatol 15:334-335; 1997.
9. M Sorice, V Pittoni, A Circella, R Misasi, F Conti, A Longo, GM Pontieri, G Valesini.
Anti-prothrombin but not “pure” anticardiolipin antibodies are associated with the clinical features of the Antiphospholipid Antibodies Syndrome.
Thromb Haemost 80:713-715; 1998.
10. B Caronti, C Calderaro, C Alessandri, F Conti, R Tinghino, C Pini, G Palladini, G Valesini.
Serum anti-β2-glycoprotein I antibodies from patients with antiphospholipid antibodies syndrome bind central nervous system.
J Autoimmun 11:425-429; 1998.
11. R Priori, M Tomassini, L Magrini, F Conti, G Valesini.
Churg-Strauss syndrome during pregnancy after steroid withdrawal.
Lancet 352:1499-1500; 1998.
12. F Conti, V Pittoni, P Sacerdote, R Priori, PL Meroni, G Valesini.
Decreased immunoreactive beta-endorphin in mononuclear leucocytes from patients with Chronic Fatigue Syndrome.
Clin Exp Rheumatol 16:729-732; 1998.
13. B Caronti, C Calderaro, C Alessandri, F Conti, R Tinghino, G Palladini, G Valesini.
Beta2-glycoprotein I (β2-GPI) mRNA is expressed by several cell types involved in antiphospholipid syndrome-related tissue damage.
Clin Exp Immunol 115:214-219; 1999.
14. Praticò D, Ferro D, Iuliano L, Rokach J, Conti F, Valesini G, FitzGerald GA, Violi F.
Ongoing prothrombotic state in patients with antiphospholipid antibodies: a role for increased lipid peroxidation.
Blood 93:3401-3407; 1999.
15. F Conti, R Priori, V Pittoni, P Pivetti-Pezzi, G Valesini.
Antiphospholipid antibody syndrome in Behçet’s disease.
Lancet 354:73; 1999.
16. Arpino C, Carrieri MP, Valesini G, Pizzigallo E, Rovere P, Tirelli U, Conti F, Dialmi P, Barberio A, Rusconi N, Bosco O, Lazzarin A, Saracco A, Moro ML, Vlahov D.
Idiopathic chronic fatigue and chronic fatigue syndrome: a comparison of two case-definitions.
Ann Ist Super Sanità 35:435-441; 1999.
17. R Priori, F Conti, V Pittoni, T Garofalo, M Sorice, G Valesini.
Is there a role for anti-phospholipid-binding protein antibodies in the pathogenesis of thrombosis in Behçet’s disease?
Thromb Haemost 83:173-174; 2000.
18. U Ramenghi, S Bonissoni, G Migliaretti, S De Franco, F Bottarel, D Buonfiglio, C Gambaruto, R Priori, F Conti, I Dianzani, G Valesini, F Merletti, U Dianzani.
Deficiency of the FAS apoptosis pathway without gene mutations is a familial trait predisposing to the development of autoimmune disease and cancer.
Blood 95:3176-3182; 2000.
19. F Conti, R Priori, C Alessandri, FR Spinelli, E Medda, G Valesini.
Safety profile and causes of withdrawal due to adverse events in Systemic Lupus Erythematosus patients treated long-term with Cyclosporine A.
Lupus 9:676-680; 2000.
20. S Morelli, AM Gurgo Di Castelmenardo, F Conti, A Sgreccia, C Alessandri, ML Bernardo, G Valesini.
Cardiac involvement in patients with Wegener’s granulomatosis.
Rheumatol Int 19:209-212; 2000.
21. F Conti, FR Spinelli, A Ossandon, G Valesini.
Selective cyclooxygenase-2 inhibition: biological and clinical effects.
Isr Med Assoc J 2:841-847; 2000.
22. RS Shacterle, F Conti, L Magrini, AL Komaroff, G Valesini.
Increased Eosinophil Protein X levels in Chronic Fatigue Syndrome.
Journal of Chronic Fatigue Syndrome 9:21-30; 2001.
23. Pittoni V, Bombardieri M, Spinelli FR, Scrivo R, Alessandri C, Conti F, Spadaro A, Valesini G.
Anti-tumour necrosis factor (TNF) alpha treatment of rheumatoid arthritis (infliximab) selectively down regulates the production of interleukin (IL) 18 but not of IL12 and IL13.
Ann Rheum Dis 61:723-725; 2002.
24. Ferro D, Iuliano L, Violi F, Valesini G, Conti F.
Antioxidant treatment decreases the titer of circulating anticardiolipin antibodies: comment on the article by Sambo et al.
Arthritis Rheum 46:3110-3112; 2002.
25. Conti F, Sorice M, Circella A, Alessandri C, Pittoni V, Caronti B, Calderaro C, Griggi T, Misasi R, Valesini G.
Beta-2-glycoprotein I expression on monocytes is increased in anti-phospholipid antibody syndrome and correlates with tissue factor expression.
Clin Exp Immunol 132:509-516; 2003.
26. Alessandri C, Bombardieri M, Scrivo R, Viganego F, Conti F, De Luca N, Riccieri V, Valesini G.
Anti-carbonic anhydrase II antibodies in systemic sclerosis: association with lung involvement.
Autoimmunity 36:85-89; 2003.
27. Priori R, Medda E, Conti F, Cassarà EA, Danieli MG, Gerli R, Giacomelli R, Franceschini F, Manfredi A, Pietrogrande M, Stazi MA, Valesini G.
Familial autoimmunity as a risk factor for systemic lupus erythematosus and vice versa: a case-control study.
Lupus 12:735-740; 2003.
28. Magrini L, Rotiroti G, Conti F, Viganego F, Alessandri C, Picardo V, Valesini G.
Orbital myositis in a patient with primary biliary cirrhosis: successful treatment with methotrexate and corticosteroids.
Isr Med Assoc J 5:825-826; 2003.
29. Morelli S, Bernardo ML, Viganego F, Sgreccia A, De Marzio P, Conti F, Priori R, Valesini G.
Left-sided heart valve abnormalities and risk of ischemic cerebrovascular accidents in patients with systemic lupus erythematosus.
Lupus 12:805-812; 2003.
30. Ferro D, Pignatelli P, Loffredo L, Conti F, Valesini G, D'Angelo A, Violi F.
Soluble CD154 plasma levels in patients with systemic lupus erythematosus: modulation by antiphospholipid antibodies.
Arthritis Rheum 50:1693-1694; 2004.
31. Alessandri C, Conti F, Valesini G.
Role of anti-glial fibrillary acidic protein antibodies in the pathogenesis of neuropsychiatric systemic lupus erythematosus should be clarified: comment on the article by Trysberg et al.
Arthritis Rheum 50:1698-1699; 2004.
32. Conti F, Alessandri C, Bompane D, Bombardieri M, Spinelli FR, Rusconi AC, Valesini G.
Autoantibody profile in systemic lupus erythematosus with psychiatric
manifestations: a role for anti-endothelial-cell antibodies.
Arthritis Res Ther 6:R366-72. Jun 17; 2004.
33. Iagnocco A, Ossandon A, Coari G, Conti F, Priori R, Alessandri C, Valesini G.
Wrist joint involvement in systemic lupus erythematosus. An ultrasonographic study.
Clin Exp Rheumatol 22:621-624; 2004.
34. Alessandri C, Bombardieri M, Di Prospero L, Conigliaro P, Conti F, Labbadia G, Misasi R, Sorice M, Valesini G.
Anti-lysobisphosphatidic acid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus.
Clin Exp Immunol 140:173-180; 2005.
35. F Conti, R Priori, M S Chimenti, G Coari, A Annovazzi, G Valesini, A Signore.
Successful intrarticular infliximab for resistant knee monoarthritis in a patient with spondyloarthropathy: a role for scintigraphy with 99mTc- infliximab.
Arthritis Rheum 52:1224-1226; 2005.
36. Margutti P, Sorice M, Conti F, Delunardo F, Racaniello M, Alessandri C, Siracusano A, Riganò R, Profumo E, Valesini G, Ortona E.
Screening of an endothelial cDNA library identifies the C-terminal region of Nedd5 as a novel autoantigen in systemic lupus erythematosus with psychiatric manifestations.
Arthritis Res Ther 7:R896-903; 2005.
37. Conti F, Borrelli O, Anania C, Marocchi E, Romeo EF, Paganelli M, Valesini G, Cucchiara S.
Chronic intestinal inflammation and seronegative spondyloarthropathy in children.
Dig Liver Dis 37:761-767; 2005.
38. Delunardo F, Conti F, Margutti P, Alessandri C, Priori R, Siracusano A, Rigano
R, Profumo E, Valesini G, Sorice M, Ortona E.
Identification and characterization of the carboxy-terminal region of Sip-1, a
novel autoantigen in Behçet's disease.
Arthritis Res Ther 8:R71; 2006.
39. Ossandon A, Bompane D, Alessandri C, Marocchi E, Conti F, Valesini G.
Leishmania in SLE mimicking an exacerbation.
Clin Exp Rheumatol 24:186-190: 2006.
40. Valesini G, Alessandri C, Celestino D, Conti F.
Anti-endothelial antibodies and neuropsychiatric systemic lupus erythematosus.
Ann N Y Acad Sci 1069:118-128; 2006.
41. Chianelli M, D'Alessandria C, Conti F, Priori R, Valesini G, Annovazzi A,
Signore A.
New radiopharmaceuticals for imaging rheumatoid arthritis.
Q J Nucl Med Mol Imaging 50:217-225; 2006.
42. Alessandri C, Sorice M, Bombardieri M, Conigliaro P, Longo A, Garofalo T,
Manganelli V, Conti F, Esposti MD, Valesini G.
Antiphospholipid reactivity against cardiolipin metabolites occurring during
endothelial cell apoptosis.
Arthritis Res Ther 8:R180; 2006.
43. F Conti, S Rezai, G Valesini.
Vaccination and rheumatic diseases: is there still a dilemma?
Curr Rheumatol Review 13:79-91; 2007.
44. Priori R, Medda E, Conti F, Cassarà EA, Sabbadini MG, Antonioli CM, Gerli R,
Danieli MG, Giacomelli R, Pietrogrande M, Valesini G, Stazi MA.
Risk factors for Sjogren's syndrome: a case-control study.
Clin Exp Rheumatol 25:378-384; 2007.
45. Margutti P, Delunardo F, Colasanti T, Piro E, Profumo E, Riganò R, Siracusano A, Buttari B, Conti F, Alessandri C, Capozzi A, Sorice M, Ortona E.
Screening of endothelial expression libraries for the identification of novel
autoantigens involved in distinct autoimmune diseases characterized by
endothelial dysfunction.
Ann N Y Acad Sci 1109:178-184; 2007.
46. Sorice M, Longo A, Capozzi A, Garofalo T, Misasi R, Alessandri C, Conti F,
Buttari B, Riganò R, Ortona E, Valesini G.
Anti-beta2-glycoprotein I antibodies induce monocyte release of tumor necrosis
factor alpha and tissue factor by signal transduction pathways involving lipid
rafts.
Arthritis Rheum 56:2687-2697; 2007.
47. Conti F, Ceccarelli F, Marocchi E, Magrini L, Spinelli FR, Spadaro A, Scrivo R,
Valesini G.
Switching tumour necrosis factor α antagonists in patients with ankylosing
spondylitis and psoriatic arthritis: an observational study over a 5-year period.
Ann Rheum Dis 66:1393-1397; 2007.
48. Accorinti M, Pirraglia MP, Paroli MP, Priori R, Conti F, Pivetti-Pezzi P.
Infliximab treatment for ocular and extraocular manifestations of Behcet's
disease.
Jpn J Ophthalmol 51:191-196; 2007.
49. Delunardo F, Margutti P, Pontecorvo S, Colasanti T, Conti F, Rigano R, Profumo
E, Siracusano A, Capozzi A, Prencipe M, Sorice M, Francia A, Ortona E.
Screening of a microvascular endothelial cDNA library identifies rabaptin 5 as a
novel autoantigen in Alzheimer's disease.
J Neuroimmunol 192:105-112; 2007.
50. Margutti P, Matarrese P, Conti F, Colasanti T, Delunardo F, Capozzi A,
Garofalo T, Profumo E, Rigano R, Siracusano A, Alessandri C, Salvati B, Valesini
G, Malorni W, Sorice M, Ortona E.
Autoantibodies to the C-terminal subunit of RLIP76 induce oxidative stress and
endothelial cell apoptosis in immune-mediated vascular diseases and
atherosclerosis.
Blood 111:4559-4570; 2008.
51. Atzeni F, Bendtzen K, Bobbio-Pallavicini F, Conti F, Cutolo M, Montecucco C,
Sulli A, Valesini G, Sarzi-Puttini P.
Infections and treatment of patients with rheumatic diseases.
Clin Exp Rheumatol 26 (1 Suppl 48):S67-73; 2008.
52. F Conti, F Ceccarelli, R Priori, A Iagnocco, A Signore, G Valesini.
Intraarticular infliximab in patients with rheumatoid arthritis and psoriatic arthritis with monoarthritis resistant to local glucocorticoids. Clinical efficacy extended to patients on systemic anti-TNFα.
Ann Rheum Dis 67:1787-1790; 2008.
53. Conti F, Rezai S, Valesini G.
Vaccination and autoimmune rheumatic diseases.
Autoimmun Rev 8:124-128; 2008.
54. A Ossandon, A Iagnocco, C. Alessandri, R Priori, F Conti, G Valesini.
Clin Ultrasonographic depiction of knee joint alterations in systemic lupus erythematosus.
Clin Exp Rheumatol 27:329-32; 2009.
55. C Alessandri, F Conti, P Conigliaro, R Mancini, L Massaro, G Valesini.
Seronegative autoimmune disease.
Ann NY Acad Sci 1173:52-9; 2009.
56. Conti F, Scrivo R, Spinelli FR, Truglia S, Magrini L, Di Franco M, Ceccarelli F,
Valesini G.
Outcome in patients with rheumatoid arthritis switching TNF-alpha antagonists: a
single center, observational study over an 8-year period.
Clin Exp Rheumatol 27:540-1; 2009.
57. Scrivo R, Conti F, Spinelli FR, Truglia S, Magrini L, Di Franco M, Ceccarelli F,
Valesini G.
Switching between TNFalpha antagonists in rheumatoid arthritis: personal
experience and review of the literature.
Reumatismo 61:107-17; 2009.
58. Malviya G, Conti F, Chianelli M, Scopinaro F, Dierckx RA, Signore A.
Molecular imaging of rheumatoid arthritis by radiolabelled monoclonal antibodies:
new imaging strategies to guide molecular therapies.
Eur J Nucl Med Mol Imaging 37:386-398; 2010.
59. Profumo E, Buttari B, Alessandri C, Conti F, Capoano R, Valesini G, Salvati B,
Riganò R.
Beta2-glycoprotein I is a target of T cell reactivity in patients with advanced carotid atherosclerotic plaques.
Int J Immunopathol Pharmacol 23:73-80; 2010.
60. Conti F, Ceccarelli F, Perricone C, Massaro L, Spinelli FR, Valesini G.
Low incidence of flare and persistent active disease in a cohort of Italian patients with systemic lupus erythematosus: comment on the article by Nikpour et al.
Arthritis Care Res 62:899–900; 2010.
61. Ortona E, Capozzi A, Colasanti T, Conti F, Alessandri C, Longo A, Garofalo T,
Margutti P, Misasi R, Khamashta MA, Hughes GR, Valesini G, Sorice M.
Vimentin/cardiolipin complex as a new antigenic target of the antiphospholipid
syndrome.
Blood 116:2960-7; 2010.
62. MA Khamashta, GRV Hughes, E Ortona, A Capozzi, T Colasanti, F Conti, C Alessandri, A Longo, T Garofalo, P Margutti, R Misasi, G Valesini, M Sorice.
Anti-vimentin/cardiolipin antibodies in “seronegative” Antiphospholipid syndrome
Blood e-Letters (17 September 2010).
63. Conti F, Perricone C, Ceccarelli F, Valesini G.
Rituximab treatment of systemic lupus erythematosus in controlled trials and in clinical practice: Two sides of the same coin.
Autoimmun Rev 9:716-20; 2010.
64. Valesini G, Conti F.
The Persistent Challenge of Lupus Nephritis.
Clin Rev Allergy Immunol 40:135-7; 2011.
65. Conti F, Spinelli FR, Alessandri C, Valesini G.
Toll-like Receptors and Lupus Nephritis.
Clin Rev Allergy Immunol 40:192-8; 2011.
66. Conti F, Ceccarelli F, Perricone C, Alessandri C, Conti V, Massaro L, Truglia S, Spinelli F R, Spadaro A, Valesini G.
Rituximab infusion-related adverse event rates are lower in patients with systemic lupus erythematosus than in those with rheumatoid arthritis.
Rheumatology (Oxford) 50:1148-52; 2011.
67. Mosca M, Govoni M, Tomietto P, Aringer M, Boumpas D, Cervera R, Conti F, D'Cruz D, Doria A, De La Fuente D, Galeazzi M, Houssiau F, Huizinga TW, Khamashta MA, Ines L, Catia D, Couto M, Meroni P, Montecucco C, Norkuviene E, Riemekasten G, Rios V, Schneider M, Shoenfeld Y, Steup-Beekman G, Szmyrka-Kaczmarek M, Tani C, Tincani A, Tzioufas A, Voll R, Bencivelli W, Salaffi F, Bombardieri S.
The development of a simple questionnaire to screen SLE patients for the presence of neuropsychiatric (NP) symptoms in routine clinical practice.
Lupus 20:485-92; 2011.
68. Alessandri C, Conti F, Pendolino M, Mancini R, Valesini G.
New autoantigens in the antiphospholipid syndrome.
Autoimmun Rev 10:609-16; 2011.
69. Matarrese P, Colasanti T, Ascione B, Margutti P, Franconi F, Alessandri C, Conti F, Riccieri V, Rosano G, Ortona E, Malorni W.
Gender disparity in susceptibility to oxidative stress and apoptosis induced by autoantibodies specific to RLIP76 in vascular cells.
Antioxid Redox Signal 15:2825-36; 2011.
70. Caporali R, Conti F, Alivernini S, Atzeni F, Seriolo B, Cutolo M, Valesini G, Ferraccioli G, Sarzi-Puttini P, Salvarani C, Guiducci S, Zampogna G, Gremese E, Pipitone N, Scrivo R, Bugatti S, Montecucco C, Matucci-Cerinic M; Italian Society for Rheumatology.
Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology I. Efficacy.
Clin Exp Rheumatol 29 (3 Suppl 66):S7-14; 2011.
71. Cervera R, Conti F, Doria A, Iaccarino L, Valesini G.
Does seronegative antiphospholipid syndrome really exist?
Autoimmun Rev 11(8):581-4; 2012.
72. Colasanti T, Maselli A, Conti F, Sanchez M, Alessandri C, Barbati C, Vacirca D,
Tinari A, Chiarotti F, Giovannetti A, Franconi F, Valesini G, Malorni W,
Pierdominici M, Ortona E.
Autoantibodies to estrogen receptor α interfere with T lymphocyte homeostasis and are associated with disease activity in systemic lupus erythematosus.
Arthritis Rheum 64:778-87; 2012.
73. M Govoni, S Bombardieri, A Bortoluzzi, L Caniatti, C Casu, F Conti, S De
Vita, A Doria, I Farina, G Ferraccioli, E Gremese, E Mansutti, M Mosca, M
Padovan, M Piga, A Tincani, MR Tola, P Tomietto, M Taglietti, F Trotta, G
Valesini, M Zen, A Mathieu.
Factors and comorbidities associated with first neuropsychiatric event in
systemic lupus erythematosus: does a risk profile exist? A large multicentre
retrospective cross-sectional study on 959 Italian patients.
Rheumatology (Oxford) 51:157-68; 2012.
74. Conti F, Alessandri C, Sorice M, Capozzi A, Longo A, Garofalo T, Misasi R, Bompane D, Hughes GRV, Khamashta MA, Valesini G.
Thin-layer chromatography immunostaining in detecting anti-phospholipid antibodies in seronegative anti-phospholipid syndrome.
Clin Exp Immunol 167:429-437; 2012.
75. Conti F, Alessandri C, Perricone C, Scrivo R, Rezai S, Ceccarelli F, Spinelli FR, Ortona E, Marianetti M, Mina C, Valesini G.
Neurocognitive dysfunction in systemic lupus erythematosus: association with antiphospholipid antibodies, disease activity and chronic damage.
PLoS ONE 7 e33824; 2012.
76. Conti F, Malviya G, Ceccarelli F, Priori R, Iagnocco A, Valesini G, Signore A.
Role of scintigraphy with (99m)Tc-infliximab in predicting the response of
intraarticular infliximab treatment in patients with refractory monoarthritis.
Eur J Nucl Med Mol Imaging 39:1339-47; 2012.
77. De Angelis F, Di Rocco A, Minotti C, Valesini G, Cartoni C, Riminucci M, Conti F,
Finolezzi E, Armiento D, Grammatico S, Massaro L, Fama A, Colafigli G, Viccarone C, Foà R, Martelli M.
Atypical presentation of anaplastic large T-cell lymphoma mimicking an articular
relapse of rheumatoid arthritis in a patient treated with etanercept. A case
report and literature review.
Leuk Res 36:e199-201; 2012.
78. Conti F, Ceccarelli F, Perricone C, Miranda F, Truglia S, Massaro L, Pacucci V A, Conti V, Bartosiewicz I, Spinelli F R, Alessandri C, Valesini G.
Flare, Persistently Active Disease, and Serologically Active Clinically Quiescent Disease in Systemic Lupus Erythematosus: A 2-Year Follow-Up Study.
PLoS ONE 7:e45934; 2012.
79. Alessandri C, Barbati C, Vacirca D, Piscopo P, Confaloni A, Sanchez M, Maselli A, Colasanti T, Conti F, Truglia S, Perl A, Valesini G, Malorni W, Ortona E,
Pierdominici M.
T lymphocytes from patients with systemic lupus erythematosus are resistant to
induction of autophagy.
FASEB J 26:4722-32; 2012.
80. Colasanti T, Alessandri C, Capozzi A, Sorice M, Delunardo F, Longo A,
Pierdominici M, Conti F, Truglia S, Siracusano A, Valesini G, Ortona E, Margutti P.
Autoantibodies specific to a peptide of β2-glycoprotein I cross-react with
TLR4 inducing a pro-inflammatory phenotype in endothelial cells and monocytes.
Blood 120:3360-70; 2012.
81. Iannuccelli C, Spinelli FR, Guzzo MP, Priori R, Conti F, Ceccarelli F, Pietropaolo M, Olivieri M, Minniti A, Alessandri C, Gattamelata A, Valesini G, Di Franco M.
Fatigue and widespread pain in Systemic Lupus Erythematosus and Sjogren's Syndrome: symptoms of the inflammatory disease or associated Fibromyalgia?
Clin Exp Rheumatol 2012; 30 (Suppl. 74): S117-S121.
82. Perricone C, Ciccacci C, Ceccarelli F, Di Fusco D, Spinelli FR, Cipriano E,
Novelli G, Valesini G, Conti F, Borgiani P.
TRAF3IP2 gene and systemic lupus erythematosus: association with disease
susceptibility and pericarditis development.
Immunogenetics 65:703-9; 2013.
83. F Conti, F Ceccarelli, L Massaro, V A Pacucci, F Miranda, S Truglia, E Cipriano, F Martinelli, I Leccese, F R Spinelli, C Alessandri, C Perricone, G Valesini.
Evaluation of the patient acceptable symptom state (pass) in Italian patients affected by Systemic Lupus Erythematosus: association with disease activity indices.
PLoS ONE 8:e73517; 2013.
84. Conti F, Ceccarelli F, Massaro L, Cipriano E, Di Franco M, Alessandri C, Spinelli
FR, Scrivo R, Valesini G.
Biological therapies in rheumatic diseases.
Clin Ter 164:e413-28; 2013.
85. Iagnocco A, Ceccarelli F, Rizzo C, Truglia S, Massaro L, Spinelli F R, Vavala C, Valesini G, Conti F.
Ultrasound evaluation of hand, wrist and foot joint synovitis in systemic lupus erythematosus.
Rheumatology (Oxford) 53:465-72; 2014. First published online: November 14, 2013.
86. Conti F, Spinelli FR, Alessandri C, Pacelli M, Ceccarelli F, Marocchi E, Montali
A, Capozzi A, Buttari B, Profumo E, Sorice M, Arca M, Valesini G, Riganò R. Subclinical Atherosclerosis in Systemic Lupus Erythematosus and Antiphospholipid Syndrome: focus on β2GPI-specific T cell response.
Arterioscler Thromb Vasc Biol 34:661-8; 2014.
87. Conti F, Alessandri C, Spinelli F R, Capozzi A, Martinelli F, Recalchi S, Misasi R, Valesini G, Sorice M.
TLC immunostaining for the detection of “anti-phospholipid antibodies”.
Methods Mol Biol 1134:95-101; 2014.
88. Segni M, Pucarelli I, Truglia S, Turriziani I, Serafinelli C, Conti F.
High prevalence of antinuclear antibodies in children with thyroid autoimmunity.
J Immunol Res 2014:150239; 2014.
89. Conti F, Perricone C, Reboldi G, Gawlicki M, Bartosiewicz I, Pacucci V, Massaro L, Miranda F, Truglia S, Alessandri C, Spinelli F, Teh LS, Ceccarelli F, Valesini G.
Validation of a disease-specific health-related quality of life measure in adult Italian patients with systemic lupus erythematosus: LupusQoL-IT.
Lupus 23:743–751; 2014.
90. Di Franco M, Gerardi MC, Lucchino B, Conti F.
Mavrilimumab: an evidence based review of its potential in the treatment of rheumatoid arthritis.
Core Evid 9:41–48; 2014.
91. Conti F, Capozzi A, Truglia S, Lococo E, Longo A, Misasi R, Alessandri C, Valesini G, Sorice M.
The mosaic of “seronegative” antiphospholipid syndrome
J Immunol Res 2014:389601; 2014.
92. Cervera R, Rodríguez-Pintó I, Colafrancesco S, Conti F, Valesini G, Rosário C, Agmon-Levin N, Shoenfeld Y, Ferrão C, Faria R, Vasconcelos C, Signorelli F, Espinosa G.
14th International Congress on Antiphospholipid Antibodies Task Force Report on Catastrophic Antiphospholipid Syndrome.
Autoimmun Rev 13:699-707; 2014.
93. T Colasanti, M Vomero, C Alessandri, C Barbati, A Maselli, C Camperio, F Conti, A Tinari, C Carlostella, L Tuosto, G Valesini, W Malorni, M Pierdominici, E Ortona, D Benincasa.
Role of α-synuclein in autophagy modulation of primary human T lymphocytes.
Cell Death Dis 5:e1265; 2014.
94. Di Franco M, Guzzo MP, Spinelli FR, Atzeni F, Sarzi-Puttini P, Conti F,
Iannuccelli C.
Pain and systemic lupus erythematosus.
Reumatismo 66:33-38; 2014.
95. Caporali R, Conti F, Covelli M, Govoni M, Salaffi F, Ventriglia G.
Treating rheumatoid arthritis to target: an Italian rheumatologists' survey on the acceptance of the treat-to-target recommendations.
Clin Exp Rheumatol 32:471-6; 2014.
96. Conti F, Ceccarelli F, Gigante A, Barbano B, Perricone C, Massaro
L, Martinelli F, Spinelli FR, Giannakakis K, Valesini G, Cianci R.
Ultrasonographic Evaluation of Renal Resistive Index in Patients with Lupus
Nephritis: Correlation with Histologic Findings.
Ultrasound Med Biol 40:2573-80; 2014.
97. Bortoluzzi A, Scirè CA, Bombardieri S, Caniatti L, Conti F, De
Vita S, Doria A, Ferraccioli G, Gremese E, Mansutti E, Mathieu
A, Mosca M, Padovan M, Piga M, Tincani A, Tola MR, Tomietto
P, Valesini G, Zen M, Govoni M; on behalf of the Study Group on
Neuropsychiatric Systemic Lupus Erythematosus of the Italian Society of
Rheumatology.
Development and validation of a new algorithm for attribution of neuropsychiatric events in systemic lupus erythematosus.
Rheumatology (Oxford) 54:891-8; 2015. Epub 2014 Oct 21
98. Perricone C, Rinkevich-Shop S, Blank M, Landa-Rouben N, Alessandri C,
Conti F, Leor J, Shoenfeld Y, Valesini G.
The Autoimmune Side of Rheumatic Fever.
IMAJ 16:654–655; 2014.
99. Ceccarelli F, Perricone C, Massaro L, Pacucci VA, Cipriano E, Truglia S, Miranda F, Spinelli FR, Alessandri C, Valesini G, Conti F.
The role of Disease Activity Score 28 in the evaluation of articular involvement in systemic lupus erythematosus.
ScientificWorldJournal Volume 2014, Article ID 236842, 6 pages; 2014.
100. Ciccacci C, Perricone C, Ceccarelli F, Rufini S, Di Fusco D, Alessandri C,
Spinelli FR, Cipriano E, Novelli G, Valesini G, Borgiani P, Conti F.
A multilocus genetic study in a cohort of Italian SLE patients confirms the association with STAT4 gene and describes a new association with HCP5 gene. PLoS One Nov 4;9(11):e111991; 2014.
101. Conti F, Spinelli FR, Colafrancesco S, Truglia S, Ceccarelli F, Fattapposta F, Sorice M, Capozzi A, Ferretti G, Priori R, Martinelli F, Pirone C, Alessandri C, Valesini G.
Acute longitudinal myelitis following Cryptococcus laurentii pneumonia in a
patient with systemic lupus erythematosus.
Lupus 24:94-7; 2015. Epub 2014 Oct 8.
102. Spinelli FR, Di Franco M, Metere A, Conti F, Iannuccelli C, Agati L, Valesini
G.
Decrease of asymmetric dimethyl arginine after anti-TNF therapy in patients with
rheumatoid arthritis.
Drug Dev Res. 2014 Nov;75 Suppl 1:S67-9.
103. Chimenti MS, Spinelli FR, Giunta A, Martinelli F, Saraceno R, Conti F,
Perricone R, Valesini G.
Emergence of antinuclear antibodies in psoriatic patients treated with
infliximab: personal experience and literature review.
Drug Dev Res. 2014 Nov;75 Suppl 1:S61-3.
104. Perricone C, Ceccarelli F, Nesher G, Borella E, Odeh Q, Conti F, Shoenfeld Y,
Valesini G.
Immune thrombocytopenic purpura (ITP) associated with vaccinations: a review of reported cases.
Immunol Res 60:226-35; 2014.
105. Conti F, Ceccarelli F, Perricone C, Massaro L, Cipriano E, Pacucci VA, Truglia
S, Miranda F, Morello F, Alessandri C, Spinelli FR, Valesini G.
Mycophenolate mofetil in systemic lupus erythematosus: results from a
retrospective study in a large monocentric cohort and review of the literature.
Immunol Res 60:270-6; 2014.
106. Artenjak A, Locatelli I, Brelih H, Simonič DM, Ulcova-Gallova Z, Swadzba J,
Musial J, Iwaniec T, Stojanovich L, Conti F, Valesini G, Avčin T, Cohen Tervaert
JW, Shoenfeld Y, Blank M, Ambrožič A, Sodin-Semrl S, Božič B, Cučnik S.
Immunoreactivity and avidity of IgG anti-β2-glycoprotein I antibodies from
patients with autoimmune diseases to different peptide clusters of
β2-glycoprotein I.
Immunol Res 61:35-44; 2015.
107. Barbati C, Alessandri C, Vomero M, Vona R, Colasanti T, Vacirca D, Camerini S, Crescenzi M, Pendolino M, Truglia S, Conti F, Garofalo T, Sorice M, Pierdominici M, Valesini G, Malorni W, Ortona E.
Autoantibodies specific to D4GDI modulate Rho GTPase mediated cytoskeleton remodeling and induce autophagy in T lymphocytes.
J Autoimmun 58:78-89; 2015.
108. Ceccarelli F, Perricone C, Massaro L, Cipriano E, Alessandri C, Spinelli FR, Valesini G, Conti F.
Assessment of disease activity in Systemic Lupus Erythematosus: lights and
shadows.
Autoimmun Rev 14:601-8; 2015.
109. Misasi R, Capozzi A, Longo A, Recalchi S, Emanuela Lococo E, Alessandri C, Conti F, Valesini G, Sorice M.
“New” antigenic targets and methodological approaches for refining laboratory diagnosis of antiphospholipid syndrome.
J Immunol Res 2015:858542; 2015.
110. Perricone C, Pendolino M, Olivieri M, Conti F, Valesini G, Alessandri C. Neuropsychiatric manifestations associated with anti-endothelial cell antibodies
in systemic lupus erythematosus.
Isr Med Assoc J 17:171-8; 2015.
111. Conti F, Ceccarelli F, Gigante A, Perricone C, Barbano B, Massaro L, Spinelli FR, Alessandri C, Valesini G, Cianci R.
Ultrasonographic evaluation of resistive index and renal artery stenosis in
patients with anti-phospholipid syndrome: two distinct mechanisms?
Ultrasound Med Biol 41:1814-20; 2015.
112. Mastrangelo A, Colasanti T, Barbati C, Pecani A, Sabatinelli D, Pendolino M,
Truglia S, Massaro L, Mancini R, Miranda F, Spinelli FR, Conti F, Alessandri C.
The role of posttranslational protein modifications in rheumatological diseases: focus on Rheumatoid Arthritis.
J Immunol Res 2015:712490; 2015.
113. Spinelli FR, Pecani A, Ceccarelli F, Alessandri C, Conti F.
Effect of Etanercept on Anti-Carbamylated Protein Antibodies in Patients with Rheumatoid Arthritis.
J Rheum Dis Treat 1:013; 2015.
114. Iaccarino L, Bartoloni E, Carli L, Ceccarelli F, Conti F, De Vita
S, Ferraccioli G, Galeazzi M, Gatto M, Gerli R, Govoni M, Gremese E, Iuliano A, Mansutti E, Moroni G, Mosca M, Nalli C, Naretto C, Padovan M, Palma , Raffiotta F, Roccatello D, Tincani A, Valesini G, Zen M, Doria A.
Efficacy and safety of off-label use of rituximab in refractory lupus: data from The Italian Multicentre Registry.
Clin Exp Rheumatol 33:449-56; 2015.
115. Conti F, Ceccarelli F, Perricone C, Massaro L, Marocchi E, Miranda F, Spinelli FR, Truglia S, Alessandri C, Valesini G.
Systemic Lupus Erythematosus with and without anti-dsDNA antibodies: analysis
from a large monocentric cohort.
Mediators Inflamm 2015:328078; 2015.
116. Foltyn Zadura A, Memon AA, Stojanovich L, Perricone C, Conti F, Valesini G,
Bogdanovic G, Hillarp A, Shoenfeld Y, Sundquist J, Leffler J, Svensson PJ, Trouw LA, Blom AM.
Factor H Autoantibodies in Patients with Antiphospholipid Syndrome
and Thrombosis.
J Rheumatol 42:1786-93; 2015.
117. Alessandri C, Bartosiewicz I, Pendolino M, Mancini R, Colasanti T, Pecani A, Morello F, Mastrangelo A, Sabatinelli D, Riccieri V, Di Franco M, Ceccarelli F, Perricone C, Conti F, Valesini G.
Anti-carbamylated protein antibodies in unaffected first-degree relatives of rheumatoid arthritis patients: lack of correlation with anti-cyclic citrullinated protein antibodies and rheumatoid factor.
Clin Exp Rheumatol 33:824-30; 2015.
118. Cipriano E, Ceccarelli F, Massaro L, Spinelli FR, Alessandri C, Perricone C,
Valesini G, Conti F.
Joint involvement in patients affected by systemic lupus erythematosus: application of the swollen to tender joint count ratio.
Reumatismo 67:62-7; 2015.
119. Spinelli FR, Ceccarelli F, Alessandri C, Sili Scavalli A, Conti F, Valesini G.
Developing new evaluation methods in systemic lupus erythematosus.
International Journal of Clinical Rheumatology 10:479-488; 2015.
120. Ceccarelli F, Perricone C, Borgiani P, Ciccacci C, Rufini S, Cipriano E, Alessandri C, Spinelli FR, Sili Scavalli A, Novelli G, Valesini G, Conti F.
Genetic Factors in Systemic Lupus Erythematosus: Contribution to Disease Phenotype.
J Immunol Res 2015:745647; 2015.
121. Sorice M, Buttari B, Capozzi A, Profumo E, Facchiano F, Truglia S, Recalchi S, Alessandri C, Conti F, Misasi R, Valesini G, Riganò R.
Antibodies to age-β2 glycoprotein i in patients with antiphospholipid antibody
syndrome.
Clin Exp Immunol 184:174-82; 2016. Epub 2016 Feb 15.
122. Maselli A, Conti F, Alessandri C, Colasanti T, Barbati C, Vomero M, Ciarlo L, Patrizio M, Spinelli FR, Ortona E, Valesini G, Pierdominici M.
Low expression of estrogen receptor β in T lymphocytes and high serum levels of
anti-estrogen receptor α antibodies impact disease activity in female patients
with systemic lupus erythematosus.
Biol Sex Differ 12;7:3. 2016.
123. Vadasz Z, Goldeberg Y, Halasz K, Rosner I, Valesini G, Conti F, Perricone C, Sthoeger Z, Bezalel SR, Tzioufas AG, Levin N, Shoenfeld Y, Toubi E.
Increased soluble CD72 in systemic lupus erythematosus is in association with
disease activity and lupus nephritis.
Clin Immunol 13;164:114-8; 2016.
124. Perricone C, Versini M, Ben-Ami D, Gertel S, Watad A, Segel MJ, Ceccarelli F, Conti F, Cantarini L, Bogdanos DP, Antonelli A, Amital H, Valesini G, Shoenfeld Y.
Smoke and autoimmunity: The fire behind the disease.
Autoimmun Rev 15:354-74; 2016.
125. Conti F, Ceccarelli F, Perricone C, Leccese I, Massaro L, Pacucci VA, Truglia S, Miranda F, Spinelli FR, Alessandri C, Valesini G.
The chronic damage in systemic lupus erythematosus is driven by flares,
glucocorticoids and antiphospholipid antibodies: results from a monocentric
cohort.
Lupus 25:719-26; 2016.
126. Gigante A, Barbano B, Di Mario F, Rosato E, Simonelli M, Rocca
AR, Conti F, Ceccarelli F, Giannakakis K, Valesini G, Cianci R.
Renal parenchymal resistance in patients with biopsy proven glomerulonephritis:
correlation with histological findings.
Int J Immunopathol Pharmacol 29:469-74; 2016.
127. Delunardo F, Soldati D, Bellisario V, Berry A, Camerini S, Crescenzi M, Alessandri C, Conti F, Ceccarelli F, Francia A, Valesini G, Cirulli F, Siracusano A, Siracusano A, Niolu C, Alex Rubino I, Ortona E, Margutti P.
Anti-GAPDH autoantibodies as a pathogenic determinant and potential biomarker of neuropsychiatric diseases.
Arthritis Rheumatol 68:2708-16; 2016.
128. Conti F, Ceccarelli F, Iaiani G, Perricone C, Giordano A, Amori L, Miranda F, Massaro L, Pacucci VA, Truglia S, Girelli G, Fakeri A, Taliani G, Temperoni C, Spinelli FR, Alessandri C, Valesini G.
Association between Staphylococcus aureus nasal carriage and disease phenotype in patients affected by systemic lupus erythematosus.
Arthritis Res Ther 30;18:177; 2016.
129. F Conti, FR Spinelli, S Truglia, F Miranda, C Alessandri, F Ceccarelli, M Bombardieri, K Giannakakis, G Valesini.
Kidney expression of Toll Like Receptors in lupus nephritis: quantification and clinicopathological correlations.
Mediators Inflamm 2016:7697592; 2016.
130. Spinelli FR, Pecani A, Conti F, Mancini R, Alessandri C, Valesini G.
Post-translational modifications in rheumatoid arthritis and atherosclerosis:
Focus on citrullination and carbamylation.
J Int Med Res 44(1 suppl):81-84; 2016.
131. Ciccacci C, Perricone C, Politi C, Rufini S, Ceccarelli F, Cipriano E, Alessandri C, Latini A, Valesini G, Novelli G, Conti F, Borgiani P.
A polymorphism upstream MIR1279 gene is associated with pericarditis development in Systemic Lupus Erythematosus and contributes to definition of a genetic risk profile for this complication.
Lupus 26:841-848; 2017. Epub 2016 Nov 23.
132. Pecani A, Alessandri C, Spinelli FR, Priori R, Riccieri V, Di Franco M, Ceccarelli F, Colasanti T, Pendolino M, Mancini R, Truglia S, Barbati C, Vomero M, Sabatinelli D, Morello F, Valesini G, Conti F.
Prevalence, sensitivity and specificity of antibodies against carbamylated
proteins in a monocentric cohort of patients with rheumatoid arthritis and other
autoimmune rheumatic diseases.
Arthritis Res Ther 25;18:276; 2016.
133. Alessandri C, Agmon-Levin N, Conti F, Perricone C, Ortona E, Pendolino M, Capozzi A, Delunardo F, Mancini R, Truglia S, Spinelli FR, Ceccarelli F, Sorice M, Shoenfeld Y, Valesini G.
Anti-mutated citrullinated vimentin antibodies in antiphospholipid syndrome:
diagnostic value and relationship with clinical features.
Immunol Res 65:524-531; 2017.
134. Caporali R, Carletto A, Conti F, D'Angelo S, Foti R, Gremese E, Govoni M, Iannone F, Pellerito R, Sinigaglia L.
Using a modified Delphi process to establish clinical consensus for the
diagnosis, risk assessment and abatacept treatment in patients with aggressive
rheumatoid arthritis.
Clin Exp Rheumatol 35:772-776; 2017.
135. Ceccarelli F, Sciandrone M, Perricone C, Galvan G, Morelli F, Vicente LN, Leccese I, Massaro L, Cipriano E, Spinelli FR, Alessandri C, Valesini G, Conti F.
Prediction of chronic damage in systemic lupus erythematosus by using
machine-learning models.
PLoS One 12(3):e0174200; 2017.
136. Ceccarelli F, Massaro L, Perricone C, Pendolino M, Cipriano E, Truglia S, Miranda, F, Spinelli FR, Alessandri C, Valesini G, Conti F.
Jaccoud's arthropathy in systemic lupus erythematosus: clinical, laboratory and
ultrasonographic features.
Clin Exp Rheumatol 35:674-677; 2017.
137. Ceccarelli F, Perricone C, Cipriano E, Massaro L, Natalucci F, Capalbo G, Leccese I, Bogdanos D, Spinelli FR, Alessandri C, Valesini G, Conti F.
Joint involvement in systemic lupus erythematosus: From pathogenesis to clinical
assessment.
Semin Arthritis Rheum 47:53-64; 2017.
138. Bartalesi F, Scirè C, Requena-Méndez A, Abad MA, Buonfrate D, Caporali R, Conti F, Diaz-Gonzalez F, Fernández-Espartero C, Martinez-Fernandez C, Mascarello M, Generali E, Minisola G, Morrone A, Muñoz J, Richi P, Sakellariou G, Salas Coronas J, Spinicci M, Castelli F, Bartoloni A, Bisoffi Z, Gimenez-Sanchez F, Muñoz-Fernandez S, Matucci-Cerinic M
Recommendations for infectious disease screening in migrants to Western Europe with inflammatory arthropathies before starting biologic agents. Results from a multidisciplinary task force of four European societies (SIR, SER, SIMET, SEMTSI) facing the largest impact of the flow of migrants today.
Clin Exp Rheumatol 35:752-765; 2017.
139. Conti F, Priori R, Alessandri C, Misasi R, Capozzi A, Pendolino M, Truglia S, Frisenda S, Sorice M, Valesini G
Diagnosis of catastrophic anti-phospholipid syndrome in a patient tested negative
for conventional tests.
Clin Exp Rheumatol 35:678-680; 2017.
140. Spinelli FR, Pecani A, Ciciarello F, Colasanti T, Di Franco M, Miranda F, Conti F, Valesini G, Alessandri C
Association between antibodies to carbamylated proteins and subclinical
atherosclerosis in rheumatoid arthritis patients.
BMC Musculoskelet Disord 18:214; 2017.
141 Massaro L, Ceccarelli F, Colasanti T, Pendolino M, Perricone C, Cipriano E, Natalucci F, Capalbo G, Lucchetti R, Pecani A, Vomero M, Mancini R, Spinelli FR, Alessandri C, Valesini G, Conti F.
Anti-carbamylated protein antibodies in systemic lupus erythematosus patients
with articular involvement.
Lupus 27:105-111; 2018. Epub 2017 Jun 7.
142. Alessandri C, Ciccia F, Priori R, Astorri E, Guggino G, Alessandro R, Rizzo A, Conti F, Minniti A, Barbati C, Vomero M, Pendolino M, Finucci A, Ortona E, Colasanti T, Pierdominici M, Malorni W, Triolo G, Valesini G.
CD4 T lymphocyte autophagy is upregulated in the salivary glands of primary Sjögren's syndrome patients and correlates with focus score and disease activity.
Arthritis Res Ther 19:178; 2017.
143. Giacomelli R, Afeltra A, Alunno A, Baldini C, Bartoloni-Bocci E, Berardicurti O, Carubbi F, Cauli A, Cervera R, Ciccia F, Cipriani P, Conti F, De Vita S, Di Benedetto P, Doria A, Drosos AA, Favalli EG, Gandolfo S, Gatto M, Grembiale RD, Liakouli V, Lories R, Lubrano E, Lunardi C, Margiotta DPE, Massaro L, Meroni P, Minniti A, Navarini L, Pendolino M, Perosa F, Pers
JO, Prete M, Priori R, Puppo F, Quartuccio L, Ruffatti A, Ruscitti P, Russo B, Sarzi-Puttini P, Shoenfeld Y, Somarakis GA, Spinelli FR, Tinazzi E, Triolo G, Ursini F, Valentini G, Valesini G, Vettori S, Vitali C, Tzioufas AG.
International consensus: what else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management.
Autoimmun Rev 16:911-924; 2017.
144. González-Gay MA, Montecucco C, Selva-O'Callaghan A, Trallero-Araguas E, Molberg O, Andersson H, Rojas-Serrano J, Perez-Roman DI, Bauhammer J, Fiehn C, Neri R, Barsotti S, Lorenz HM, Doria A, Ghirardello A, Iannone F, Giannini M, Franceschini F, Cavazzana I, Triantafyllias K, Benucci M, Infantino M, Manfredi M, Conti F, Schwarting A, Sebastiani G, Iuliano A, Emmi G, Silvestri E, Govoni M, Scirè CA, Furini F, Lopez-Longo FJ, Martínez-Barrio J, Sebastiani M, Manfredi A, Bachiller-Corral J, Sifuentes Giraldo WA, Cimmino MA, Cosso C, Belotti Masserini A, Cagnotto G, Codullo V, Romano M, Paolazzi G, Pellerito R, Saketkoo LA, Ortego-Centeno N, Quartuccio L, Batticciotto A, Bartoloni Bocci E, Gerli R, Specker C, Bravi E, Selmi C, Parisi S, Salaffi F, Meloni F, Marchioni E, Pesci A, Dei G, Confalonieri M, Tomietto P, Nuno L, Bonella F, Pipitone N, Mera-Valera A, Perez-Gomez N, Gerzeli S, Lopez-Mejias R, Matos-Costa CJ, Pereira da Silva JA, Cifrian J, Alpini C, Olivieri I, Blázquez Cañamero MÁ, Rodriguez Cambrón AB, Castañeda S, Cavagna L; AENEAS (American and European NEtwork of Antisynthetase Syndrome) collaborative group. Timing of onset affects arthritis presentation pattern in antisyntethase syndrome.
Clin Exp Rheumatol 36:44-49; 2018. Epub 2017 Jul 26.
145. Scrivo R, Massaro L, Barbati C, Vomero M, Ceccarelli F, Spinelli FR, Riccieri V, Spagnoli A, Alessandri C, Desideri G, Conti F, Valesini G.
The role of dietary sodium intake on the modulation of T helper 17 cells and regulatory T cells in patients with rheumatoid arthritis and systemic lupus erythematosus.
PLoS One 6;12(9):e0184449; 2017.
146. Iaccarino L, Andreoli L, Bocci EB, Bortoluzzi A, Ceccarelli F, Conti F, De Angelis R, De Marchi G, De Vita S, Di Matteo A, Emmi G, Emmi L, Gatto M, Gerli R, Gerosa M, Govoni M, Larosa M, Meroni PL, Mosca M, Pazzola G, Reggia R, Saccon F, Salvarani C, Tani C, Zen M, Frigo AC, Tincani A, Doria A.
Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide study.
J Autoimmun 86:1-8; 2018. Epub 2017 Sep 19.
147. Arnaud L, Conti F, Massaro L, Denas G, Chasset F, Pengo V.
Primary thromboprophylaxis with low-dose aspirin and antiphospholipid antibodies: Pro's and Con's.
Autoimmun Rev 16:1103-1108; 2017.
148. Del Giudice E, Dilillo A, Tromba L, La Torre G, Blasi S, Conti F, Viola F, Cucchiara S, Duse M.
Aortic, carotid intima-media thickness and flow-mediated dilation as markers of early atherosclerosis in a cohort of pediatric patients with rheumatic diseases.
Clin Rheumatol 37:1675-1682; 2018. Epub 2017 Oct 12.
149. Manganelli V, Capozzi A, Truglia S, Alessandri C, Lococo E, Garofalo T, De Carolis C, Conti F, Valesini G, Sorice M, Longo A, Misasi R.
Elevated Serum Level of HMGB1 in Patients with the Antiphospholipid Syndrome.
J Immunol Res 2017:4570715; 2017.
150. Di Franco M, Lucchino B, Conti F, Valesini G, Spinelli FR.
Asymmetric Dimethyl Arginine as a Biomarker of Atherosclerosis in Rheumatoid Arthritis.
Mediators Inflamm 2018:3897295; 2018.
151. Conti F, Pontikaki I, D'Andrea M, Ravelli A, De Benedetti F.
Patients with juvenile idiopathic arthritis become adults: the role of transitional care.
Clin Exp Rheumatol 36:1086-1094; 2018. Epub 2018 Apr 13.
152. Ceccarelli F, Perricone C, Pirone C, Massaro L, Alessandri C, Mina C, Marianetti M, Spinelli FR, Valesini G, Conti F.
Cognitive dysfunction improves in systemic lupus erythematosus: Results of a 10 years prospective study.
PLoS One 3;13(5):e0196103; 2018.
153. Scrivo R, Gerardi MC, Rutigliano I, Sessa P, Mipatrini D, Stricchiola GMG, Pacella E, Altobelli A, Castellani C, Alessandri C, Ceccarelli F, Di Franco M, Priori R, Riccieri V, Sili Scavalli A, Spinelli FR, La Torre G, Conti F, Valesini G.
Polymyalgia rheumatica and diverticular disease: just two distinct age-related disorders or more? Results from a case-control study.
Clin Rheumatol 37:2573-2577; 2018.
154. Ciccacci C, Perricone C, Alessandri C, Latini A, Politi C, Delunardo F, Pierdominici M, Conti F, Novelli G, Ortona E, Borgiani P.
Evaluation of ATG5 polymorphisms in Italian patients with systemic lupus erythematosus: contribution to disease susceptibility and clinical phenotypes.
Lupus 27:1464-1469; 2018
155. Sebastiani GD, Prevete I, Iuliano A, Piga M, Iannone F, Coladonato L, Govoni M, Bortoluzzi A, Mosca M, Tani C, Doria A, Iaccarino L, Tincani A, Fredi M, Conti F, Spinelli FR, Galeazzi M, Bellisai F, Zanetti A, Carrara G, Scirè CA, Mathieu A.
Early Lupus Project: one-year follow-up of an Italian cohort of patients with
systemic lupus erythematosus of recent onset.
Lupus 27:1479-1488; 2018
156. Ceccarelli F, Lucchetti R, Spinelli FR, Perricone C, Truglia S, Miranda F, Scrivo R, Alessandri C, Valesini G, Conti F.
Early response to apremilast treatment in psoriatic arthritis: a real-life ultrasonographic follow-up study.
Rheumatology (Oxford) 1;57:1490-1491; 2018.
157. Ceccarelli F, Perricone C, Colasanti T, Massaro L, Cipriano E, Pendolino M, Natalucci F, Mancini R, Spinelli FR, Valesini G, Conti F, Alessandri C.
Anti-carbamylated protein antibodies as a new biomarker of erosive joint damage in systemic lupus erythematosus.
Arthritis Res Ther 14;20:126; 2018.
158. Spinelli FR, Moscarelli E, Ceccarelli F, Miranda F, Perricone C, Truglia S, Garufi C, Massaro L, Morello F, Alessandri C, Valesini G, Conti F.
Treating lupus patients with antimalarials: analysis of safety profile in a single-center cohort.
Lupus 27:1616-1623; 2018.
159. Ceccarelli F, Orrù G, Pilloni A, Bartosiewicz I, Perricone C, Martino E, Lucchetti R, Fais S, Vomero M, Olivieri M, di Franco M, Priori R, Riccieri V, Scrivo R, Shoenfeld Y, Alessandri C, Conti F, Polimeni A, Valesini G.
Porphyromonas gingivalis in the tongue biofilm is associated with the clinical outcome in rheumatoid arthritis patients.
Clin Exp Immunol 194:244-252; 2018.
160. Favalli EG, Conti F, Atzeni F, Selmi C, D'Angelo S, Caporali R, Iannone F.
COMMENTS ON "Short-term reasons for withdrawal and adverse events associated with apremilast therapy for psoriasis in real-world practice compared with in clinical trials: A multicenter retrospective study".
J Am Acad Dermatol 9:e119-e120; 2018.
161. Dupuis ML, Conti F, Maselli A, Pagano MT, Ruggieri A, Anticoli S, Fragale A, Gabriele L, Gagliardi MC, Sanchez M, Ceccarelli F, Alessandri C, Valesini G, Ortona E, Pierdominici M.
The Natural Agonist of Estrogen Receptor β Silibinin Plays an Immunosuppressive Role Representing a Potential Therapeutic Tool in Rheumatoid Arthritis.
Front Immunol 17;9:1903; 2018.
162. Vomero M, Barbati C, Colasanti T, Perricone C, Novelli L, Ceccarelli F, Spinelli FR, Di Franco M, Conti F, Valesini G, Alessandri C.
Autophagy and Rheumatoid Arthritis: Current Knowledges and Future Perspectives.
Front Immunol 18;9:1577; 2018.
163. Truglia S, Capozzi A, Mancuso S, Recalchi S, Spinelli FR, Perricone C, De Carolis C, Manganelli V, Riitano G, Garofalo T, Longo A, De Carolis S, Alessandri C, Misasi R, Valesini G, Sorice M, Conti F.
A Monocentric Cohort of Obstetric Seronegative Anti-Phospholipid Syndrome.
Front Immunol Jul 20;9:1678; 2018.
164. Mackay M, Dall'Era M, Fishbein J, Kalunian K, Lesser M, Sanchez Guerrero J, Levy DM, Silverman E, Petri M, Arriens C, Lewis EJ, Korbet SM, Conti F, Tesar V, Hruskova Z, Borba EF, Bonfa E, Chan TM, Rathi M, Gupta KL, Jha V, Hasni S, West MR, Silverman E, Solomons N, Houssiau FA, Romera Diaz J, Mejia-Vilet J, Rovin BH.
Establishing Surrogate Kidney Endpoints for Lupus Nephritis Clinical Trials: Development and Validation of a Novel Approach to Predict Future Kidney Outcomes.
Arthritis Rheumatol 71:411-419; 2019. 2018 Sep 17. [Epub ahead of print]
165. Frasca L, Palazzo R, Chimenti MS, Alivernini S, Tolusso B, Bui L, Botti E, Giunta A, Bianchi L, Petricca L, Auteri SE, Spadaro F, Fonti GL, Falchi M, Evangelista A, Marinari B, Pietraforte I, Spinelli FR, Colasanti T, Alessandri C, Conti F, Gremese E, Costanzo A, Valesini G, Perricone R, Lande R.
Anti-LL37 Antibodies Are Present in Psoriatic Arthritis (PsA) Patients: New Biomarkers in PsA.
Front Immunol 12;9:1936; 2018.
166. Ceccarelli F, Orrù G, Pilloni A, Bartosiewicz I, Perricone C, Martino E, Lucchetti R, Fais S, Vomero M, Olivieri M, di Franco M, Priori R, Riccieri V, Scrivo R, Shoenfeld Y, Alessandri C, Conti F, Polimeni A, Valesini G.
Porphyromonas gingivalis in the tongue biofilm is associated with clinical outcome in rheumatoid arthritis patients.
Clin Exp Immunol 194:244-252; 2018.
167. Colasanti T, Fiorito S, Alessandri C, Serafino A, Andreola F, Barbati C, Morello F, Alfè M, Di Blasio G, Gargiulo V, Vomero M, Conti F, Valesini G.
Diesel exhaust particles induce autophagy and citrullination in Normal Human Bronchial Epithelial cells.
Cell Death Dis 19;9:1073; 2018.
168. Barbati C, Vomero M, Colasanti T, Ceccarelli F, Marcosano M, Miranda F, Novelli L, Pecani A, Perricone C, Spinelli FR, Truglia S, Conti F, Valesini G, Alessandri C.
Microparticles and autophagy: a new frontier in the understanding of atherosclerosis in rheumatoid arthritis.
Immunol Res 7;20:273; 2018.
169. Conti F, Atzeni F, Massaro L, Chiara Gerardi M, Gremese E, Passiu G, Carletto A, Malavolta N, Foti R, Ramonda R, Sarzi-Puttini P.
The influence of comorbidities on the efficacy of tumour necrosis factor inhibitors, and the effect of tumour necrosis factor inhibitors on comorbidities in rheumatoid arthritis: report from a National Consensus Conference.
Rheumatology (Oxford) 1;57(57 Suppl 7):vii11-vii22; 2018.
170. Ceccarelli F, Sciandrone M, Perricone C, Galvan G, Cipriano E, Galligari A, Levato T, Colasanti T, Massaro L, Natalucci F, Spinelli FR, Alessandri C, Valesini G, Conti F.
Biomarkers of erosive arthritis in systemic lupus erythematosus: Application of machine learning models.
PLoS One 13(12):e0207926; 2018.
171. Barbati C, Vomero M, Colasanti T, Diociaiuti M, Ceccarelli F, Ferrigno S, Finucci A, Miranda F, Novelli L, Perricone C, Spinelli FR, Truglia S, Conti F, Valesini G, Alessandri C.
TNFα expressed on the surface of microparticles modulates endothelial cell fate in rheumatoid arthritis.
Arthritis Res Ther 20:273; 2018.
172. Tamirou F, Arnaud L, Talarico R, Scirè CA, Alexander T, Amoura Z, Avcin T, Bortoluzzi A, Cervera R, Conti F, Cornet A, Devilliers H, Doria A, Frassi M, Fredi M, Govoni M, Houssiau F, Lladò A, Macieira C, Martin T, Massaro L, Moraes-Fontes MF, Pamfili C, Paolino S, Tani C, Tas SW, Tektonidou M, Tincani A, Van Vollenhoven RF, Bombardieri S, Burmester G, Eurico FJ, Galetti I, Hachulla E, Mueller-Ladner U, Schneider M, Smith V, Cutolo M, Mosca M, Costedoat-Chalumeau N.
Systemic lupus erythematosus: state of the art on clinical practice guidelines.
RMD Open 4(2):e000793; 2018.
173. Giacomelli R, Afeltra A, Alunno A, Bartoloni-Bocci E, Berardicurti O, Bombardieri M, Bortoluzzi A, Caporali R, Caso F, Cervera R, Chimenti MS, Cipriani P, Coloma E, Conti F, D'Angelo S, De Vita S, Di Bartolomeo S, Distler O, Doria A, Feist E, Fisher BA, Gerosa M, Gilio M, Guggino G, Liakouli V, Margiotta DPE, Meroni P, Moroncini G, Perosa F, Prete M, Priori R, Rebuffi C, Ruscitti P, Scarpa R, Shoenfeld Y, Todoerti M, Ursini F, Valesini G, Vettori S, Vitali C, Tzioufas AG.
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis.
Autoimmun Rev 18:93-106; 2019.
174. Vomero M, Manganelli V, Barbati C, Colasanti T, Capozzi A, Finucci A, Spinelli FR, Ceccarelli F, Perricone C, Truglia S, Morrone S, Maggio R, Misasi R, Bombardieri M, Di Franco M, Conti F, Sorice M, Valesini G, Alessandri C.
Reduction of autophagy and increase in apoptosis correlates with a favorable clinical outcome in patients with rheumatoid arthritis treated with anti-TNF drugs.
Arthritis Res Ther 21:39; 2019.
175. Capozzi A, Manganelli V, Riitano G, Recalchi S, Truglia S, Alessandri C, Longo A, Garofalo T, Misasi R, Valesini G, Conti F, Sorice M.
Tissue Factor overexpression in platelets of patients with Antiphospholipid Syndrome: induction role of anti-β2-GPI antibodies
Clin Exp Immunol 196:59-66; 2019.
176. Manganelli V, Truglia S, Capozzi A, Alessandri C, Riitano G, Spinelli FR, Ceccarelli F, Mancuso S, Garofalo T, Longo A, Valesini G, Sorice M, Conti F, Misasi R.
Alarmin HMGB1 and Soluble RAGE as New Tools to Evaluate the Risk Stratification in Patients With the Antiphospholipid Syndrome.
Front Immunol 14;10:460; 2019.
177. Novelli L, Barbati C, Ceccarelli F, Perricone C, Spinelli FR, Alessandri C, Valesini G, Perricone R, Conti F.
CD44v3 and CD44v6 isoforms on T cells are able to discriminate different disease activity degrees and phenotypes in systemic lupus erythematosus patients.
Lupus 28:621-628; 2019.
178. Ceccarelli F, Perricone C, Cipriano E, Massaro L, Natalucci F, Spinelli FR, Alessandri C, Valesini G, Conti F.
Usefulness of composite indices in the assessment of joint involvement in systemic lupus erythematosus patients: correlation with ultrasonographic score.
Lupus 28:383-388; 2019.
179. Perricone C, Ceccarelli F, Matteo S, Di Carlo G, Bogdanos DP, Lucchetti R, Pilloni A, Valesini G, Polimeni A, Conti F.
Porphyromonas gingivalis and rheumatoid arthritis.
Curr Opin Rheumatol 31:517-524; 2019.
180. Barbati C, Stefanini L, Colasanti T, Cipriano E, Celia A, Gabriele G, Vomero M, Ceccarelli F, Spinelli FR, Finucci A, Speziali M, Orso G, Margiotta DPE, Conti F, Violi F, Afeltra A, Valesini G, Alessandri C.
Anti-D4GDI antibodies activate platelets in vitro: a possible link with thrombocytopenia in primary antiphospholipid syndrome.
Arthritis Res Ther 21:161; 2019.
181. Favalli EG, Becciolini A, Carletto A, Conti F, Amato G, Fusaro E, Quartuccio L, Egan CG, Lo Monaco A, Benucci M, Salaffi F, Semeraro A, Parisi S, Ceccarelli F, Piazza I, Foti R.
Efficacy and retention rate of adalimumab in rheumatoid arthritis and psoriatic arthritis patients after first-line etanercept failure: the FEARLESS cohort.
Rheumatol Int. 2019 Aug 21. doi: 10.1007/s00296-019-04416-3. [Epub ahead of print].
182. Reggia R, Andreoli L, Sebbar H, Canti V, Ceccarelli F, Favaro M, Hoxha A, Inversetti A, Larosa M, Ramoni V, Caporali R, Conti F, Doria A, Montecucco C, Rovere-Querini P, Ruffatti A, Valesini G, Zatti S, Fallo L, Lojacono A, Tincani A.
An observational multicentre study on the efficacy and safety of assisted reproductive technologies in women with rheumatic diseases.
Rheumatol Adv Pract. 2019 Feb 22;3(1):rkz005. doi: 10.1093/rap/rkz005. eCollection 2019.
183. Spinelli FR, Garufi C, Truglia S, Pacucci VA, Morello F, Miranda F, Perricone C, Ceccarelli F, Valesini G, Conti F.
The role of osteopontin as a candidate biomarker of renal involvement in systemic lupus erythematosus.
Clin Exp Rheumatol. 37:899-905; 2019.
184 Scrivo R, Perricone C, Altobelli A, Castellani C, Tinti L, Conti F, Valesini G.
Dietary Habits Bursting into the Complex Pathogenesis of Autoimmune Diseases: The Emerging Role of Salt from Experimental and Clinical Studies.
Nutrients 2019 May 5;11(5) pii: E1013.
185. Favalli EG, Conti F, Selmi C, Iannone F, Bucci R, D'Onofrio F, Carlino G, Santo L, Semeraro A, Zuccaro C, D'Angelo S, Atzeni F, Marino F, Monti S, Guidelli GM, Spinelli FR, Biggioggero M, Caporali R.
Retrospective evaluation of patient profiling and effectiveness of apremilast in an
Italian multicentric cohort of psoriatic arthritis patients.
Clin Exp Rheumatol. 38:19-26; 2020. Accepted in revised form on February 25, 2019.
186. Conti F, Ceccarelli F, Spinelli FR.
Comment on: 'Temporal relationships between systemic lupus erythematosus and comorbidities'.
Rheumatology (Oxford). 2019 Jul 10. pii: kez271. doi: 10.1093/rheumatology/kez271. [Epub ahead of print]
187. Ravelli A, Sinigaglia L, Cimaz R, Alessio M, Breda L, Cattalini M, Consolaro A, Conti F, Cortis E, D'Angelo S, De Benedetti F, Doria A, Ferrari C, Gallizzi R, Govoni M, Gremese E, Iannone F, La Torre F, Maggio MC, Perricone R, Pontikaki I, Rossi F, Salaffi F, Simonini G, Caporali R; Italian Paediatric Rheumatology Study Group and the Italian Society of Rheumatology.
Transitional care of young people with juvenile idiopathic arthritis in Italy: results of a Delphi consensus survey.
Clin Exp Rheumatol. 37:1084-1091; 2019.
188. Ceccarelli F, Lucchetti R, Perricone C, Spinelli FR, Cipriano E, Truglia S, Miranda F, Riccieri V, Di Franco M, Scrivo R, Alessandri C, Valesini G, Conti F.
Musculoskeletal ultrasound in monitoring response to apremilast in psoriatic arthritis patients: results from a longitudinal study.
Clin Rheumatol. 38:3145-3151; 2019.
189. F Ceccarelli, C Perricone, G Olivieri, E Cipriano, F R Spinelli, G Valesini, F Conti.
Staphylococcus aureus Nasal Carriage and Autoimmune Diseases: From Pathogenic Mechanisms to Disease Susceptibility and Phenotype.
Int J Mol Sci 20, 5624; 2019.
190. S Parisi, A Bortoluzzi, GD Sebastiani, F Conti, R Caporali, N Ughi, I Prevete, A Ariani, M. Manara, G Carrara, CA Scirè.
The Italian Society for Rheumatology clinical practice guidelines for rheumatoid arthritis.
Reumatismo. 71 S1:22-49; 2019.
191. Conti F, Andreoli L, Crisafulli F, Mancuso S, Truglia S, Tektonidou MG.
Does seronegative obstetric APS exist? "pro" and "cons".
Autoimmun Rev. 18:102407; 2019.
192. Ciccacci C, Latini A, Perricone C, Conigliaro P, Colafrancesco S, Ceccarelli F, Priori R, Conti F, Perricone R, Novelli G, Borgiani P.
TNFAIP3 Gene Polymorphisms in Three Common Autoimmune Diseases: Systemic Lupus Erythematosus, Rheumatoid Arthritis, and Primary Sjogren Syndrome-Association with Disease Susceptibility and Clinical Phenotypes in Italian Patients.
J Immunol Res. 2019:6728694; 2019.
193. Perricone C, Katz D, Ciccacci C, Ceccarelli F, Valesini G, Shoenfeld Y, Borgiani P, Conti F.
The Heart Matters: Contribution of Genetic Factors in Recurrent Pericarditis.
Isr Med Assoc J. 21:487-490; 2019. PMID: 31507126.
194. Cavagna L, Trallero-Araguás E, Meloni F, Cavazzana I, Rojas-Serrano J, Feist E, Zanframundo G, Morandi V, Meyer A, Pereira da Silva JA, Matos Costa CJ, Molberg O, Andersson H, Codullo V, Mosca M, Barsotti S, Neri R, Scirè C, Govoni M, Furini F, Lopez-Longo FJ, Martinez-Barrio J, Schneider U, Lorenz HM, Doria A, Ghirardello A, Ortego-Centeno N, Confalonieri M, Tomietto P, Pipitone N, Rodriguez Cambron AB, Blázquez Cañamero MÁ, Voll RE, Wendel S, Scarpato S, Maurier F, Limonta M, Colombelli P, Giannini M, Geny B, Arrigoni E, Bravi E, Migliorini P, Mathieu A, Piga M, Drott U, Delbrueck C, Bauhammer J, Cagnotto G, Vancheri C, Sambataro G, De Langhe E, Sainaghi PP, Monti C, Gigli Berzolari F, Romano M, Bonella F, Specker C, Schwarting A, Villa Blanco I, Selmi C, Ceribelli A, Nuno L, Mera-Varela A, Perez Gomez N, Fusaro E, Parisi S, Sinigaglia L, Del Papa N, Benucci M, Cimmino MA, Riccieri V, Conti F, Sebastiani GD, Iuliano A, Emmi G, Cammelli D, Sebastiani M, Manfredi A, Bachiller-Corral J, Sifuentes Giraldo WA, Paolazzi G, Saketkoo LA, Giorgi R, Salaffi F, Cifrian J, Caporali R, Locatelli F, Marchioni E, Pesci A, Dei G, Pozzi MR, Claudia L, Distler J, Knitza J, Schett G, Iannone F, Fornaro M, Franceschini F, Quartuccio L, Gerli R, Bartoloni E, Bellando Randone S, Zampogna G, Gonzalez Perez MI, Mejia M, Vicente E, Triantafyllias K, Lopez-Mejias R, Matucci-Cerinic M, Selva-O'Callaghan A, Castañeda S, Montecucco C, Gonzalez-Gay MA.
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course.
J Clin Med. 8(11):E2013; 2019.
195. Ceccarelli F, Pirone C, Mina C, Mascolo A, Perricone C, Massaro L, Spinelli FR, Alessandri C, Valesini G, Conti F.
Pragmatic language dysfunction in systemic lupus erythematosus patients: Results from a single center Italian study.
PLoS One. 14:e0224437; 2019.
196. Spinelli FR, Barbati C, Cecarelli F, Morello F, Colasanti T, Vomero M, Massaro L, Orefice V, Alessandri C, Valesini G, Conti F.
B lymphocyte stimulator modulates number and function of endothelial progenitor cells in systemic lupus erythematosus.
Arthritis Res Ther. 21:245; 2019.
197. Piga M, Floris A, Sebastiani GD, Prevete I, Iannone F, Coladonato L, Govoni M, Bortoluzzi A, Mosca M, Tani C, Doria A, Iaccarino L, Franceschini F, Fredi M, Conti F, Spinelli FR, Galeazzi M, Bellisai F, Zanetti A, Carrara G, Scirè CA, Mathieu A.
Risk factors of damage in early diagnosed systemic lupus erythematosus: results of the Italian multicentre Early Lupus Project inception cohort.
Rheumatology (Oxford). kez584; 2019.
198. Lucchino B, Spinelli FR, Iannuccelli C, Guzzo MP, Conti F, Di Franco M.
Mucosa-Environment Interactions in the Pathogenesis of Rheumatoid Arthritis.
Cells. 8(7):700; 2019.
199. Ceccarelli F, Botticelli A, Gelibter AJ, Leccese I, Lucchetti R, Cortesi E,
Valesini G, Marchetti P, Conti F.
'Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation' by Braaten et al: another point of view.
Ann Rheum Dis. 216867; 2020 doi: 10.1136/annrheumdis-2019-216867.
200. Quartuccio L, Bond M, Isola M, Monti S, Felicetti M, Furini F, Murgia S,
Berti A, Silvestri E, Pazzola G, Bozzolo E, Leccese P, Raffeiner B, Parisi S,
Leccese I, Cianci F, Bettio S, Sainaghi P, Ianniello A, Ravagnani V, Bellando
Randone S, Faggioli P, Lomater C, Stobbione P, Ferro F, Colaci M, Alfieri G,
Carubbi F, Erre GL, Giollo A, Franzolini N, Ditto MC, Balduzzi S, Padoan R,
Bortolotti R, Bortoluzzi A, Cariddi A, Padula A, Di Scala G, Gremese E, Conti F,
D'Angelo S, Matucci Cerinic M, Dagna L, Emmi G, Salvarani C, Paolazzi G,
Roccatello D, Govoni M, Schiavon F, Caporali R, De Vita S; Italian Study Group
on Lung Involvement in Rheumatic Diseases and the Italian Vasculitis Study
Group.
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and
mortality predictors.
J Autoimmun. 102397; 2020.
201. Prevete I, Espinosa G, Bellisai F, Bortoluzzi A, Conti F, Fredi M, Fonseca-
Aizpuru EM, García de Viedma V, González-García A, González-León R, Iaccarino L, Iannone F, Marín-Ballvé A, Mitjavila F, Pallarés L, Piga M, Ríos-Garcés R, Suárez S, Tani C, Zanetti A, Ruiz-Irastorza G, Sebastiani GD; Gruppo di Studio SIR sul Lupus Eritematoso Sistemico di recente insorgenza-Early Lupus and Registro Español de pacientes con Lupus Eritematoso Sistémico (RELES), Autoimmune Diseases Study Group (GEAS).
Comparative study between two European inception cohorts of patients with early systemic lupus erythematosus.
Clin Exp Rheumatol. 2020 Jan 20. Epub ahead of print. PMID: 31969225.
202. Ceccarelli F, Orefice V, Perrone G, Pirone C, Perricone C, Truglia S, Miranda
F, Pacucci VA, Spinelli FR, Galoppi P, Alessandri C, Valesini G, Conti F.
Premature ovarian failure in patients affected by systemic lupus erythematosus:
a cross-sectional case control study.
Clin Exp Rheumatol. 2020 Feb 14. Epub ahead of print. PMID: 32083540.
203. Lande R, Palazzo R, Gestermann N, Jandus C, Falchi M, Spadaro F, Riccieri V, James EA, Butera A, Boirivant M, Feldmeyer L, Surbeck I, Di Lucca J, Stuber F, Spinelli FR, Botti E, Marinari B, Bianchi L, Pica R, Cerbelli B, Giannakakis K, Auteri SE, Daniels I, Durrant LG, Horstman S, Costanzo A, Romero P, Alessandri C, Conti F, Valesini G, Gilliet M, Chizzolini C, Frasca L.
Native/citrullinated LL37-specific T-cells help autoantibody production in Systemic Lupus Erythematosus.
Sci Rep. 10:5851; 2020.
204. Spinelli FR, Ceccarelli F, Di Franco M, Conti F.
To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic.
Ann Rheum Dis. 2020 Apr 2:annrheumdis-2020-217367. doi: 10.1136/annrheumdis-2020-217367. Online ahead of print.
205. Spinelli FR, Ceccarelli F, Di Franco M, Conti F.
Response to 'Is there a future for hydroxychloroquine/chloroquine in prevention of SARS-CoV-2 infection (COVID-19)?' by Moiseev et al.
Ann Rheum Dis., annrheumdis-2020-217636 [April, 28]. https://doi.org/10.1136/annrheumdis-2020-217636
206. Spinelli FR, Ceccarelli F, Di Franco M, Conti F.
Response to 'To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic' by Parperis.
Ann Rheum Dis. 2020 May 4:annrheumdis-2020-217634. doi: 10.1136/annrheumdis-2020-217634. Online ahead of print.
207. Gatto M, Saccon F, Zen M, Regola F, Fredi M, Andreoli L, Tincani A, Urban ML, Emmi G, Ceccarelli F, Conti F, Bortoluzzi A, Govoni M, Tani C, Mosca M, Ubiali T, Gerosa M, Bozzolo E, Canti V, Cardinaletti P, Gabrielli A, Tanti G, Gremese E, De Marchi G, De Vita S, Fasano S, Ciccia F, Pazzola G, Salvarani C, Negrini S, Puppo F, Di Matteo A, De Angelis R, Orsolini G, Rossini M, Faggioli P, Laria A, Piga M, Mathieu A, Scarpato S, Rossi FW, de Paulis A, Brunetta E, Ceribelli A, Selmi C, Prete M, Racanelli V, Vacca A, Bartoloni E, Gerli R, Larosa M, Iaccarino L, Doria A.
Early disease and low baseline damage predict response to belimumab in
patients with systemic lupus erythematosus.
Arthritis Rheumatol. 2020 Apr 10. doi: 10.1002/art.41253. Online ahead of print
208. Spinelli FR, Conti F, Gadina M.
HiJAKing SARS-CoV-2? The potential role of JAK inhibitors in the management of COVID-19
Sci Immunol. 5, 10.1126/sciimmunol.abc5367 2020.
209. Lucchino B, Di Franco M, Conti F.
COVID-19: an unexpected indication for anti-rheumatic therapies?
Rheumatology (Oxford). 59:1200-1203; 2020.
209. Chimenti MS, Fonti GL, Conigliaro P, Sunzini F, Scrivo R, Navarini L, Triggianese P, Peluso G, Scolieri P, Caccavale R, Picchianti Diamanti A, De Martino E, Salemi S, Birra D, Altobelli A, Paroli M, Bruzzese V, Laganà B, Gremese E, Conti F, Afeltra A, Perricone R.
One-year effectiveness, retention rate, and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis: a real-life multicenter study.
Expert Opin Biol Ther. 2020 May 13:1-9. doi: 10.1080/14712598.2020.1761957.
[Epub ahead of print].
210. Colasanti T, Sabatinelli D, Mancone C, Giorgi A, Pecani A, Spinelli FR, Di Giamberardino A, Navarini L, Speziali M, Vomero M, Barbati C, Perricone C, Ceccarelli F, Finucci A, Celia AI, Currado D, Afeltra A, Schininà ME, Barnaba V, Conti F, Valesini G, Alessandri C.
Homocysteinylated alpha 1 antitrypsin as an antigenic target of autoantibodies in
seronegative rheumatoid arthritis patients.
J Autoimmun. 2020 May 27:102470.
211. Colafrancesco S, Alessandri C, Conti F, Priori R.
COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome?
Autoimmun Rev. 2020 Jul;19(7):102573. doi: 10.1016/j.autrev.2020.102573. Epub 2020 May 5.
212. Saccon F, Zen M, Gatto M, Margiotta DPE, Afeltra A, Ceccarelli F, Conti F, Bortoluzzi A, Govoni M, Frontini G, Moroni G, Dall'Ara F, Tincani A, Signorini V, Mosca M, Frigo AC, Iaccarino L, Doria A.
Remission in systemic lupus erythematosus: testing different definitions in a large multicentre cohort.
Ann Rheum Dis. 2020 Apr 22:annrheumdis-2020-217070. doi: 10.1136/annrheumdis-2020-217070. Online ahead of print.
213. Garufi C, Mancuso S, Spinelli FR, Truglia S, Ceccarelli F, Alessandri C, Conti F.
Janus kinases inhibitors for treating patients with rhupus.
Joint Bone Spine. 2020 Jun 10:S1297-319X(20)30106-8. doi: 10.1016/j.jbspin.2020.05.010. Online ahead of print.
214. Orefice V, Ceccarelli F, Perrone G, Perricone C, Galoppi P, Pacucci VA, Spinelli FR, Alessandri C, Brunelli R, Conti F.
Treatment with Gonadotropin Releasing Hormone Agonists in Systemic Lupus Erythematosus Patients Receiving Cyclophosphamide: A Long-term Follow-up Study.
Isr Med Assoc J. 2020 Jun;22(6):343-347.
215. Scrivo R, Silvestri V, Ciciarello F, Sessa P, Rutigliano I, Sestili C, La Torre G, Barbati C, Altobelli A, Alessandri C, Ceccarelli F, Di Franco M, Priori R, Riccieri V, Sili Scavalli A, Spinelli FR, Agati L, Fedele F, Gossetti B, Conti F, Valesini G.
An exploratory cross-sectional study of subclinical vascular damage in patients with polymyalgia rheumatica.
Sci Rep. 2020 Jul 9;10(1):11407.
216. Rosato E, Gigante A, Cianci R, Spinelli FR, Ceccarelli F, Conti F.
Evaluation of renal resistive index in different autoimmune diseases.
Clin Exp Rheumatol. 2020 Jun 4. Online ahead of print.
217. Piga M, Floris A, Sebastiani GD, Prevete I, Iannone F, Coladonato L, Govoni M, Bortoluzzi A, Mosca M, Tani C, Doria A, Iaccarino L, Franceschini F, Fredi M, Conti F, Spinelli FR, Galeazzi M, Bellisai F, Zanetti A, Carrara G, Scirè CA, Mathieu A.
Risk factors of damage in early diagnosed systemic lupus erythematosus: results of the Italian multicentre Early Lupus Project inception cohort.
Rheumatology (Oxford). 2020 Sep 1;59(9):2272-2281.
218. Ceccarelli F, Cipriano E, Natalucci F, Perricone C, Olivieri G, Orefice V, Morello F, Alessandri C, Spinelli FR, Conti F.
Belimumab is Able to Induce a Significant Improvement of Joint Activity Status in Patients Diagnosed with Systemic Lupus Erythematosus: Results From a 12-Month Longitudinal Study.
Isr Med Assoc J. 2020 Jul;7(22):349-353.
219. Ceccarelli F, Mancuso S, Lucchetti R, Conti F.
Systemic lupus erythematosus onset in patient receiving anti-PD1 treatment with pembrolizumab: a case report.
Rheumatology (Oxford). 2020 Aug 25:keaa389.
220. Iannone F, Favalli EG, Caporali R, D'Angelo S, Cantatore FP, Sarzi-Puttini P, Foti R, Conti F, Carletto A, Gremese E, Cauli A, Ramonda R, Palermo A, Epis O, Priora M, Bergossi F, Frediani B, Salaffi F, Lopalco G, Cacciapaglia F, Marchesoni A, Biggioggiero M, Bugatti S, Balduzzi S, Carriero A, Corrado A, Bongiovanni S, Benenati A, Miranda F, Fracassi E, Perra D, Ferraccioli G, Lapadula G.
Golimumab effectiveness in biologic inadequate responding patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis in real-life from the Italian registry GISEA.
Joint Bone Spine. 2020 Aug 2:S1297-319X(20)30147-0.
221. Orefice V, Ceccarelli F, Barbati C, Lucchetti R, Olivieri G, Cipriano E, Natalucci F, Perricone C, Spinelli FR, Alessandri C, Valesini G, Conti F.
Caffeine intake influences disease activity and clinical phenotype in systemic lupus erythematosus patients.
Lupus. 2020 Jul 23:961203320941920.
222. Gandolfo S, Fabro C, Kapsogeorgou E, Colafrancesco S, Ferro F, Bartoloni E, Quartuccio L, Goules A, Priori R, Alunno A, Conti F, Valesini G, Giacomelli R, Baldini C, Gerli R, Tzioufas AG, De Vita S.
Validation of thymic stromal lymphopoietin as a biomarker of primary Sjögren's syndrome and related lymphoproliferation: results in independent cohorts.
Clin Exp Rheumatol. 2020 Jul-Aug;38 Suppl 126(4):189-194. Epub 2020 Oct 23
223. Ceccarelli F, Presti AL, Olivieri G, Angeletti S, Perricone C, Garufi C, Iaiani G, De Florio L, Antonelli F, De Cesaris M, Giordano A, Amori L, Spinelli FR, Alessandri C, Valesini G, Ciccozzi M, Conti F.
Genetic diversity of Staphylococcus aureus influences disease phenotype of systemic lupus erythematosus.
Rheumatology (Oxford). 60:958-966; 2020.
224. Barbati C, Colasanti T, Vomero M, Ceccarelli F, Celia AI, Perricone C, Spinelli FR, Conti F, Valesini G, Alessandri C.
Up-regulation of autophagy by etanercept treatment results in TNF-induced apoptosis reduction in EA.hy926 endothelial cell line.
Clin Exp Rheumatol. 2020 Sep 3. Online ahead of print.
225. Vomero M, Finucci A, Barbati C, Colasanti T, Ceccarelli F, Novelli L, Massaro L, Truglia S, Pensa C, Mauro FR, Foà R, Valesini G, Conti F, Alessandri C.
Increased eryptosis in patients with primary antiphospholipid syndrome (APS): a new actor in the pathogenesis of APS.
Clin Exp Rheumatol. 2020 Oct 29. Online ahead of print.
226. Ugolini A, Zizzari IG, Ceccarelli F, Botticelli A, Colasanti T, Strigari L, Rughetti A, Rahimi H, Conti F, Valesini G, Marchetti P, Nuti M.
IgM-Rheumatoid factor confers primary resistance to anti-PD-1 immunotherapies in NSCLC patients by reducing CD137+T-cells.
EBioMedicine. 2020 Nov 6;62:103098. doi: 10.1016/j.ebiom.2020.103098. Online ahead of print.
227. Pellegrino G, Mohammad Reza Beigi D, Angelelli C, Stefanantoni K, Cadar M, Mancuso S, Conti F, Riccieri V.
COVID-19 and systemic sclerosis: analysis of lifestyle changes during the SARS-CoV-2 pandemic in an Italian single-center cohort.
Clin Rheumatol. 2020 Nov 14:1-5. doi: 10.1007/s10067-020-05504-7. Online ahead of print.
228. Vomero M, Barbati C, Colasanti T, Celia AI, Speziali M, Ucci FM, Ciancarella C, Conti F, Alessandri C.
Autophagy Modulation in Lymphocytes From COVID-19 Patients: New Therapeutic Target in SARS-COV-2 Infection.
Front Pharmacol. 2020 Nov 19;11:569849. doi: 10.3389/fphar.2020.569849. eCollection 2020.
229. Orefice V, Ceccarelli F, Barbati C, Perricone C, Alessandri C, Conti F.
The Impact of Caffeine Intake on Patients with Systemic Lupus Erythematosus: Protect Yourself, Drink More Coffee!
Mediterr J Rheumatol. 2020 Dec 28;31(4):374-375. doi: 10.31138/mjr.31.4.374. eCollection 2020 Dec.
230. Pacella I, Spinelli FR, Severa M, Timperi E, Tucci G, Zagaglioni M, Ceccarelli F, Rizzo F, Coccia EM, Patel RS, Martin-Fernandez M, Bogunovic D, Conti F, Barnaba V, Piconese S.
ISG15 protects human Tregs from interferon alpha-induced contraction in a cell-intrinsic fashion.
Clin Transl Immunology. 2020 Dec 23;9(12):e1221. doi: 10.1002/cti2.1221. eCollection 2020.
231. Spinelli FR, Ceccarelli F, Garufi C, Duca I, Mancuso S, Cipriano E, Dell'Unto E, Alessandri C, Di Franco M, Perricone C, Priori R, Riccieri V, Scrivo R, Sili Scavalli A, Truglia S, Valesini G, Conti F.
Effectiveness and safety of baricitinib in rheumatoid arthritis: a monocentric, longitudinal, real-life experience.
Clin Exp Rheumatol. 39:525-531; 2021.
232. Giacomelli R, Afeltra A, Bartoloni E, Berardicurti O, Bombardieri M, Bortoluzzi A, Carubbi F, Caso F, Cervera R, Ciccia F, Cipriani P, Coloma-Bazán E, Conti F, Costa L, D'Angelo S, Distler O, Feist E, Foulquier N, Gabini M, Gerber V, Gerli R, Grembiale RD, Guggino G, Hoxha A, Iagnocco A, Jordan S, Kahaleh B, Lauper K, Liakouli V, Lubrano E, Margiotta D, Naty S, Navarini L, Perosa F, Perricone C, Perricone R, Prete M, Pers JO, Pitzalis C, Priori R, Rivellese F, Ruffatti A, Ruscitti P, Scarpa R, Shoenfeld Y, Triolo G, Tzioufas A.
The growing role of precision medicine for the treatment of autoimmune diseases; results of a systematic review of literature and Experts' Consensus.
Autoimmun Rev. 2021 Feb;20(2):102738. doi: 10.1016/j.autrev.2020.102738. Epub 2020 Dec 14
233. Natalucci F, Ceccarelli F, Cipriano E, Perricone C, Olivieri G, Pirone C, Mettola G, Truglia S, Spinelli FR, Alessandri C, Conti F.
Joint involvement influences quality of life in systemic lupus erythematosus patients.
Lupus. 2020 Dec 15:961203320979039. doi: 10.1177/0961203320979039. Online ahead of print.
234. Celia AI, Priori R, Cerbelli B, Diomedi-Camassei F, Leuzzi V, Scrivo R, Alessandri C, d'Amati G, Conti F.
"Protenuria in SLE: is it always lupus?".
Lupus. 2021 Jan 7:961203320983458. doi: 10.1177/0961203320983458. Online ahead of print.
235. Ceccarelli F, Olivieri G, Sortino A, Dominici L, Arefayne F, Celia AI, Cipriano E, Garufi C, Lapucci M, Mancuso S, Natalucci F, Orefice V, Perricone C, Pirone C, Pacucci VA, Spinelli FR, Truglia S, Alessandri C, Sciandrone M, Conti F.
Comprehensive disease control in systemic lupus erythematosus.
Semin Arthritis Rheum. 2021 Feb 19;51(2):404-408. doi: 10.1016/j.semarthrit.2021.02.005. Online ahead of print.
236. Klionsky DJ, … Conti F, … Tong CK.
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition).
Autophagy. 2021 Feb 8:1-382. doi: 10.1080/15548627.2020.1797280. Online ahead of print.
237. Priori R, Pellegrino G, Colafrancesco S, Alessandri C, Ceccarelli F, Di Franco M, Riccieri V, Scrivo R, Sili Scavalli A, Spinelli FR, Conti F.
SARS-CoV-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases: a message for rheumatologists.
Ann Rheum Dis. 2021 Feb 23:annrheumdis-2021-220059. doi: 10.1136/annrheumdis-2021-220059. Online ahead of print.
238. Spinelli FR, Garufi C, Mancuso S, Ceccarelli F, Conti F.
Comment on: Real-world single centre use of JAK inhibitors across the rheumatoid arthritis pathway.
Rheumatology (Oxford). 2021 Mar 2:keab195. doi: 10.1093/rheumatology/keab195. Online ahead of print.
239. Ceccarelli F, Botticelli A, Natalucci F, Olivieri G, Cirillo A, Alessandri C, Marchetti P, Conti F.
Immune checkpoint inhibitors and pre-existing antinuclear antibodies: the rheumatologist point of view.
Clin Transl Oncol. 2021 Mar 17. doi: 10.1007/s12094-021-02584-y. Online ahead of print.
240. Orefice V, Ceccarelli F, Pirone C, Galoppi P, Spinelli FR, Alessandri C, Brunelli R, Perrone G, Conti F.
Breastfeeding in women affected by systemic lupus erythematosus: Rate, duration and associated factors.
Lupus. 2021 May;30(6):913-920.
241. Ceccarelli F, Pirone C, Perricone C, Selntigia A, Orefice V, Pacucci VA, Truglia S, Spinelli FR, Galoppi P, Alessandri C, Valesini G, Brunelli R, Perrone G, Conti F.
Pregnancy outcome in systemic lupus erythematosus patients: a monocentric cohort analysis.
Rheumatology (Oxford). 2021 Apr 6;60(4):1747-1754.
242. Bettiol A, Sinico RA, Schiavon F, Monti S, Bozzolo EP, Franceschini F, Govoni M, Lunardi C, Guida G, Lopalco G, Paolazzi G, Vacca A, Gregorini G, Leccese P, Piga M, Conti F, Fraticelli P, Quartuccio L, Alberici F, Salvarani C, Bettio S, Negrini S, Selmi C, Sciascia S, Moroni G, Colla L, Manno C, Urban ML, Vannacci A, Pozzi MR, Fabbrini P, Polti S, Felicetti M, Marchi MR, Padoan R, Delvino P, Caporali R, Montecucco C, Dagna L, Cariddi A, Toniati P, Tamanini S, Furini F, Bortoluzzi A, Tinazzi E, Delfino L, Badiu I, Rolla G, Venerito V, Iannone F, Berti A, Bortolotti R, Racanelli V, Jeannin G, Padula A, Cauli A, Priori R, Gabrielli A, Bond M, Tedesco M, Pazzola G, Tomietto P, Pellecchio M, Marvisi C, Maritati F, Palmisano A, Dejaco C, Willeit J, Kiechl S, Olivotto I, Willeit P, Prisco D, Vaglio A, Emmi G; Italian EGPA Consortium.
Risk of acute arterial and venous thromboembolic events in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss syndrome).
Eur Respir J. 2021 Apr 8:2004158. doi: 10.1183/13993003.04158-2020. Online ahead of print.
243. Picchianti-Diamanti A, Spinelli FR, Rosado MM, Conti F, Laganà B.
Inhibition of Phosphodiesterase-4 in Psoriatic Arthritis and Inflammatory Bowel Diseases.
Int J Mol Sci. 2021 Mar 5;22(5):2638. doi: 10.3390/ijms22052638.
244. Capozzi A, Riitano G, Mancuso S, Recalchi S, Manganelli V, Garofalo T, Alessandri C, Longo A, Misasi R, Conti F, Truglia S, Sorice M.
Anti-vimentin/cardiolipin IgA in the Antiphospholipid Syndrome: a new tool for "seronegative" diagnosis.
Clin Exp Immunol. 205:326-332; 2021.
245. Truglia S, Mancuso S, Capozzi A, Recalchi S, Riitano G, Longo A, De Carolis S, Spinelli FR, Alessandri C, Ceccarelli F, De Carolis C, Misasi R, Sorice M, Conti F.
“Non-criteria antiphospholipid antibodies": bridging the gap between seropositive and seronegative Antiphospholipid Syndrome.
Rheumatology (Oxford). 61:826-833; 2022.
246. Sebastiani GD, Spinelli FR, Bartoloni E, Bortoluzzi A, Bozzolo E, Canofari C, Canti V, Conigliaro P, Ditto MC, Emmi G, Franceschini F, Frassi M, Iaccarino L, Iuliano A, Manfredi A, Pacucci V, Parisi S, Pazzola G, Perricone R, Prevete I, Ramirez GA, Scarpato S, Scirocco C, Silvagni E, Zen M, Zanetti A, Carrara G, Scirè CA, Conti F, Doria A.
Baseline characteristics of systemic lupus erythematosus patients included in the Lupus Italian Registry of the Italian Society for Rheumatology.
Lupus. 2021 Jul;30(8):1233-1243. doi: 10.1177/09612033211012470. Epub 2021 Apr 22.
247. Nalli C, Lini D, Andreoli L, Crisafulli F, Fredi M, Lazzaroni MG, Bitsadze V, Calligaro A, Canti V, Caporali R, Carubbi F, Chighizola CB, Conigliaro P, Conti F, De Carolis C, Del Ross T, Favaro M, Gerosa M, Iuliano A, Khizroeva J, Makatsariya A, Meroni PL, Mosca M, Padovan M, Perricone R, Rovere-Querini P, Sebastiani GD, Tani C, Tonello M, Truglia S, Zucchi D, Franceschini F, Tincani A.
Low Preconception Complement Levels Are Associated with Adverse Pregnancy Outcomes in a Multicenter Study of 260 Pregnancies in 197 Women with Antiphospholipid Syndrome or Carriers of Antiphospholipid Antibodies.
Biomedicines. 2021 Jun 11;9(6):671. doi: 10.3390/biomedicines9060671
248. Latini A, Novelli L, Ceccarelli F, Barbati C, Perricone C, De Benedittis G, Conti F, Novelli G, Ciccacci C, Borgiani P.
mRNA expression analysis confirms CD44 splicing impairment in systemic lupus erythematosus patients.
Lupus. 2021 Jun;30(7):1086-1093. doi: 10.1177/09612033211004725. Epub 2021 Apr 1
249. Carpino G, Cardinale V, Di Giamberardino A, Overi D, Donsante S, Colasanti T, Amato G, Mennini G, Franchitto M, Conti F, Rossi M, Riminucci M, Gaudio E, Alvaro D, Mancone C.
Thrombospondin 1 and 2 along with PEDF inhibit angiogenesis and promote lymphangiogenesis in intrahepatic cholangiocarcinoma.
J Hepatol. 2021 Jul 28:S0168-8278(21)01947-4. doi: 10.1016/j.jhep.2021.07.016. Online ahead of print.
250. Ceccarelli F, Spinelli FR, Garufi C, Mancuso S, Alessandri C, Di Franco M, Orefice V, Pacucci VA, Pirone C, Priori R, Riccieri V, Sili Scavalli A, Scrivo R, Truglia S, Conti F.
The role of musculoskeletal ultrasound in predicting the response to JAK inhibitors: results from a monocentric cohort.
Clin Exp Rheumatol. 2021 Jun 26. Online ahead of print.
251. Lucchetti R, Ceccarelli F, Cipriano E, Perricone C, Spinelli FR, Alessandri C, Conti F.
Application of Ultrasound in the Assessment of Oligoarticular Psoriatic Arthritis Subset: Results from Patients Treated with Apremilast.
Isr Med Assoc J. 2021 Jul;23(7):412-415.
252. Ceccarelli F, Covelli V, Olivieri G, Natalucci F, Conti F.
Systemic Lupus Erythematosus before and after COVID-19 Lockdown: How the Perception of Disease Changes through the Lenses of Narrative Medicine.
Healthcare (Basel). 2021 Jun 12;9(6):726. doi: 10.3390/healthcare9060726.
253. Ceccarelli F, Olivieri G, Natalucci F, Alessandri C, Conti F.
SARS-CoV-2 vaccination efficacy and B-cell depletion therapy in systemic lupus erythematosus: Description of a case.
Lupus. 2021 Jul 1:9612033211027940. doi: 10.1177/09612033211027940. Online ahead of print.
254. Olivieri G, Ceccarelli F, Natalucci F, Pirone C, Orefice V, Pacucci VA, Garufi C, Truglia S, Spinelli FR, Alessandri C, Conti F.
Five-years drug survival of mycophenolate mofetil therapy in patients with systemic lupus erythematosus: Comparison between renal and non-renal involvement.
Joint Bone Spine. 2021 Jun 24;88(6):105246. doi: 10.1016/j.jbspin.2021.105246. Online ahead of print.
255. Ceccarelli F, Lapucci M, Olivieri G, Sortino A, Natalucci F, Spinelli FR, Alessandri C, Sciandrone M, Conti F.
Can Machine Learning models support physicians in Systemic Lupus Erythematosus diagnosis? Results from a monocentric cohort.
Joint Bone Spine. 2021 Oct 13:105292.
256. Gatto M, Saccon F, Andreoli L, Bartoloni E, Benvenuti F, Bortoluzzi A, Bozzolo E, Brunetta E, Canti V, Cardinaletti P, Ceccarelli F, Ciccia F, Conti F, De Marchi G, de Paulis A, De Vita S, Emmi G, Faggioli P, Fasano S, Fredi M, Gabrielli A, Gasparotto M, Gerli R, Gerosa M, Govoni M, Gremese E, Laria A, Larosa M, Mosca M, Orsolini G, Pazzola G, Petricca L, Ramirez GA, Regola F, Rossi FW, Rossini M, Salvarani C, Scarpato S, Tani C, Tincani A, Ubiali T, Urban ML, Zen M, Doria A, Iaccarino L.
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort.
J Autoimmun. 2021 Nov;124:102729.
257. Ceccarelli F, Natalucci F, Olivieri G, Perricone C, Pirone C, Spinelli FR, Alessandri C, Conti F.
Erosive arthritis in systemic lupus erythematosus: not only Rhupus.
Lupus. 2021 Oct 19:9612033211051637. doi: 10.1177/09612033211051637. Online ahead of print.
258. Colafrancesco S, Barbati C, Priori R, Putro E, Giardina F, Gattamelata A, Monosi B, Colasanti T, Celia AI, Cerbelli B, Giordano C, Scarpa S, Fusconi M, Cavalli G, Berardicurti O, Gandolfo S, Nayar S, Barone F, Giacomelli R, De Vita S, Alessandri C, Conti F.
Maladaptive autophagy in the pathogenesis of autoimmune epithelitis in Sjӧgren's Syndrome.
Arthritis Rheumatol. 2022 74:654-664.
259. Duca I, Lucchino B, Spinelli FR, Altobelli A, Pirone C, Gioia C, Valesini G, Conti F, Di Franco M.
Perceived Disease Activity in Rheumatoid Arthritis: When the Physician's Gender Matters.
Isr Med Assoc J. 2021 Nov;23(11):693-698.
260. Cavalli G, Colafrancesco S, De Luca G, Rizzo N, Priori R, Conti F, Dagna L.
Cutaneous vasculitis following COVID-19 vaccination.
Lancet Rheumatol. 2021 Nov;3(11):e743-e744. doi: 10.1016/S2665-9913(21)00309-X. Epub 2021 Sep 30.
261. Latini A, De Benedittis G, Perricone C, Colafrancesco S, Conigliaro P, Ceccarelli F, Chimenti MS, Novelli L, Priori R, Conti F, Ciccacci C, Borgiani P.
VDR Polymorphisms in Autoimmune Connective Tissue Diseases: Focus on Italian Population.
J Immunol Res. 2021 Dec 23;2021:5812136. doi: 10.1155/2021/5812136. eCollection 2021.
262. Capozzi A, Truglia S, Buttari B, Recalchi S, Riitano G, Manganelli V, Mancuso S, Alessandri C, Longo A, Mattei V, Profumo E, Garofalo T, Misasi R, Conti F, Sorice M.
Carbamylation of β2-GPI generates new autoantigens for Antiphospholipid Syndrome: a new tool for diagnosis of "seronegative" patients.
Rheumatology (Oxford). 2022 Feb 2:keac045. doi: 10.1093/rheumatology/keac045. Online ahead of print. PMID: 35108369.
263. Scrivo R, D'Angelo S, Carriero A, Castellani C, Perrotta FM, Conti F, Vecellio M, Selmi C, Lubrano E.
The Conundrum of Psoriatic Arthritis: a Pathogenetic and Clinical Pattern at the Midpoint of Autoinflammation and Autoimmunity.
Clin Rev Allergy Immunol. 2022 Jan 18. doi: 10.1007/s12016-021-08914-w.
264. Spinelli FR, Favalli EG, Garufi C, Cornalba M, Colafrancesco S, Conti F*, Caporali R.
Low frequency of disease flare in patients with rheumatic musculoskeletal diseases who received SARS-CoV-2 mRNA vaccine.
Arthritis Res Ther. 2022 Jan 11;24(1):21. doi: 10.1186/s13075-021-02674-w.
265. Olivieri G, Ceccarelli F, Perricone C, Ciccacci C, Pirone C, Natalucci F, Spinelli FR, Alessandri C, Borgiani P, Conti F.
Fever in systemic lupus erythematosus: associated clinical features and genetic factors.
Clin Exp Rheumatol. 2022 Mar 23. doi: 10.55563/clinexprheumatol/7x37pf. Online ahead of print.
266. Nissen M, Delcoigne B, Di Giuseppe D, Jacobsson L, Hetland ML, Ciurea A, Nekvindova L, Iannone F, Akkoc N, Sokka-Isler T, Fagerli KM, Santos MJ, Codreanu C, Pombo-Suarez M, Rotar Z, Gudbjornsson B, van der Horst-Bruinsma I, Loft AG, Möller B, Mann H, Conti F, Yildirim Cetin G, Relas H, Michelsen B, Ribeiro PA, Ionescu R, Sanchez-Piedra C, Tomsic M, Geirsson ÁJ, Askling J, Glintborg B, Lindström U.
The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondylarthritis.
Rheumatology (Oxford). 2022 Mar 22:keac174. doi: 10.1093/rheumatology/keac174. Online ahead of print.
267. Iannuccelli C, Lucchino B, Gioia C, Dolcini G, Rabasco J, Venditto T, Ioppolo F, Santilli V, Conti F, Di Franco M.
Gender influence on clinical manifestations, depressive symptoms and brain-derived neurotrophic factor (BDNF) serum levels in patients affected by fibromyalgia.
Clin Rheumatol. 2022 Mar 28. doi: 10.1007/s10067-022-06133-y. Online ahead of print.
268. Scrivo R, Anastasi E, Castellani C, Conti F, Angeloni A, Granato T.
Ovarian reserve in patients with spondyloarthritis: impact of biological disease-modifying anti-rheumatic drugs on fertility status.
Clin Exp Rheumatol. 40:1738-1743; 2022.
269. Pellegrino G, Mancuso S, Colasanti T, Mieli S, Gioia C, Izzo R, Pignatelli P, Ciardi MR, Alessandri C, Conti F, Riccieri V.
Lack of cross-reactivity between rheumatoid factor IgM and anti-S1 receptor binding domain of SARS-CoV-2 IgM: a case-control study.
Clin Exp Rheumatol. 2022 Apr 29. doi: 10.55563/clinexprheumatol/irb45o. Online ahead of print.
270. Ceccarelli F, Saccucci M, Natalucci F, Olivieri G, Bruni E, Iacono R, Colasanti T, Di Carlo G, Alessandri C, Uccelletti D, Russo P, Pilloni A, Conti F, Polimeni A.
Porphyromonas gingivalis amount in the tongue biofilm is associated with erosive arthritis in systemic lupus erythematosus.
Lupus. 2022 Apr 28:9612033221098528. doi: 10.1177/09612033221098528. Online ahead of print.
271. Celia AI, Colafrancesco S, Barbati C, Alessandri C, Conti F.
Autophagy in Rheumatic Diseases: Role in the Pathogenesis and Therapeutic Approaches.
Cells. 2022 Apr 15;11(8):1359. doi: 10.3390/cells11081359.
272. Riitano G, Capozzi A, Recalchi S, Caissutti D, Longo A, Mattei V, Conti F, Misasi R, Garofalo T, Sorice M, Manganelli V.
Anti-β2-GPI Antibodies Induce Endothelial Cell Expression of Tissue Factor by LRP6 Signal Transduction Pathway Involving Lipid Rafts.
Cells. 2022 Apr 11;11(8):1288. doi: 10.3390/cells11081288.
273. Mancuso S, Spinelli FR, Agati L, Ciardi MR, Garufi C, Natalucci F, Molteni E, Truglia S, Riccieri V, Priori R, Mastroianni CM, Conti F.
Hydroxychloroquine cardiotoxicity: a case-control study comparing patients with COVID-19 and patients with systemic lupus erythematosus.
Clin Exp Rheumatol. 2022 May;40(5):890-896. doi: 10.55563/clinexprheumatol/7ullgb. Epub 2022 Mar 30.
274. Iannone F, Conti F, Cauli A, Farina A, Caporali R.
Subcutaneously-Administered Infliximab in the Management of Rheumatoid Arthritis: A Short Narrative Review of Current Clinical Evidence.
J Inflamm Res. 2022 Jun 1;15:3259-3267. doi: 10.2147/JIR.S240593. eCollection 2022.
275. Conticini E, d'Alessandro M, Grazzini S, Fornaro M, Sabella D, Lopalco G, Giardina F, Colafrancesco S, Rizzo C, Guggino G, Priori R, Conti F, Iannone F, Bargagli E, Cantarini L, Frediani B.
Relapses of idiopathic inflammatory myopathies after vaccination against COVID-19: a real-life multicenter Italian study.
Intern Emerg Med. 2022 Jun 26:1-8. doi: 10.1007/s11739-022-03028-3. Online ahead of print.
276. Ceccarelli F, Olivieri G, Pirone C, Ciccacci C, Picciariello L, Natalucci F, Perricone C, Spinelli FR, Alessandri C, Borgiani P, Conti F.
The Impacts of the Clinical and Genetic Factors on Chronic Damage in Caucasian Systemic Lupus Erythematosus Patients.
J Clin Med. 2022 Jun 12;11(12):3368. doi: 10.3390/jcm11123368.
277. Barbati C, Celia AI, Colasanti T, Vomero M, Speziali M, Putro E, Buoncuore G, Savino F, Colafrancesco S, Ucci FM, Ciancarella C, Balbinot E, Scarpa S, Natalucci F, Pellegrino G, Ceccarelli F, Spinelli FR, Mastroianni CM, Conti F, Alessandri C.
Autophagy Hijacking in PBMC From COVID-19 Patients Results in Lymphopenia.
Front Immunol. 2022 May 30;13:903498. doi: 10.3389/fimmu.2022.903498. eCollection
2022.
278. Scrivo R, Castellani C, Mancuso S, Sciarra G, Giardina F, Bevignani G, Ceccarelli F, Spinelli FR, Alessandri C, Di Franco M, Riccieri V, Priori R, Conti F.
Effectiveness of non-medical switch from adalimumab bio-originator to SB5 biosimilar and from ABP501 adalimumab biosimilar to SB5 biosimilar in patients with chronic inflammatory arthropathies: a monocentric observational study.
Clin Exp Rheumatol. 2022 Jul 28. doi: 10.55563/clinexprheumatol/bf00j9.
279. Prevete I, Iuliano A, Cauli A, Piga M, Iannone F, Coladonato L, Bortoluzzi A, Silvagni E, Tani C, Elefante E, Doria A, Iaccarino L, Franceschini F, Fredi M, Conti F, Spinelli FR, Frediani B, Gonzales Garcìa E, Scirè CA, Zanetti A, Rozza D, Carrara G, Sebastiani GD
Similarities and differences between younger and older disease onset patients with newly diagnosed systemic lupus erythematosus.
Clin Exp Rheumatol. 2022 Jul 26. doi: 10.55563/clinexprheumatol/oo5ymg. Online ahead of print.
280. Truglia S, Capozzi A, Mancuso S, Manganelli V, Rapino L, Riitano G, Recalchi S, Colafrancesco S, Ceccarelli F, Garofalo T, Alessandri C, Longo A, Misasi R, Conti F, Sorice M.
Relationship Between Gender Differences and Clinical Outcome in Patients With the Antiphospholipid Syndrome.
Front Immunol. 2022 Jul 4;13:932181. doi: 10.3389/fimmu.2022.932181. eCollection 2022.
281. Mohammad Reza Beigi D, Pellegrino G, Cadar M, Bisconti I, Di Ciommo FR, Stefanantoni K, Conti F, Riccieri V.
Psychological Fragility in an Italian Cohort of Systemic Sclerosis Patients During COVID-19 Pandemic Category: Short Communication.
Open Access Rheumatol. 2022 Jul 11;14:133-139. doi: 10.2147/OARRR.S367424. eCollection 2022.
282. Campagna G, Anzola LK, Varani M, Lauri C, Gentiloni Silveri G, Chiurchioni L, Spinelli FR, Priori R, Conti F, Signore A.
Imaging Activated-T-Lymphocytes in the Salivary Glands of Patients with Sjögren's Syndrome by 99mTc-Interleukin-2: Diagnostic and Therapeutic Implications.
J Clin Med. 2022 Jul 27;11(15):4368. doi: 10.3390/jcm11154368.
283. Colombo D, Frassi M, Pagano Mariano G, Fusaro E, Lomater C, Del Medico P, Iannone F, Foti R, Limonta M, Marchesoni A, Raffeiner B, Viapiana O, Grassi W, Grembiale RD, Guggino G, Mazzone A, Tirri E, Perricone R, Sarzi Puttini PC, De Vita S, Conti F, Ori A, Simoni L, Fiocchi M, Orsenigo R, Zagni E; and the CHRONOS Study Group.
Real-world evidence of biologic treatments in psoriatic arthritis in Italy: results of the CHRONOS (EffeCtiveness of biologic treatments for psoriatic artHRitis in Italy: an ObservatioNal lOngitudinal Study of real-life clinical practice) observational longitudinal study.
BMC Rheumatol. 2022 Sep 12;6(1):57. doi: 10.1186/s41927-022-00284-w.
284. Ceccarelli F, Covelli V, Olivieri G, Natalucci F, Alessandri C, Conti F.
Patients with systemic lupus erythematosus and their experience with vaccination against COVID-19: a descriptive and explanatory study.
Reumatismo. 2022 Sep 13;74(2). doi: 10.4081/reumatismo.2022.1491.
285. Scrivo R, Molteni E, Castellani C, Altobelli A, Alessandri C, Ceccarelli F, Di Franco M, Priori R, Riccieri V, Sili Scavalli A, Spinelli FR, Mastroianni CM, Conti F.
Are interferon-gamma release assays reliable to detect tuberculosis infection in patients with rheumatoid arthritis treated with Janus kinase inhibitors?
PLoS One. 2022 Sep 28;17(9):e0275329. doi: 10.1371/journal.pone.0275329. eCollection 2022.
286. Ferrara V, Perrone ME, Mina C, Ceccarelli F, Olivieri G, Fattapposta F, Conti F.
Science and visual Arts: Binomial or Dichotomy? A Pilot study in Systemic Lupus Erythematosus patients.
Lupus. 31:1744-1749; 2022.
287. Gremese E, Ciccia F, Selmi C, Cuomo G, Foti R, Matucci-Cerinic M, Conti F, Fusaro E, Guggino G, Iannone F, Delle Sedie A, Perricone R, Idolazzi L, Moscato P, Theander E, Noël W, Bergmans P, Marelli S, Gossec L, Smolen JS; Italian PsABio study.
Persistence, effectiveness and safety of ustekinumab compared to TNF inhibitors in psoriatic arthritis within the Italian PsABio cohort.
Clin Exp Rheumatol. 2022 Oct 12. doi: 10.55563/clinexprheumatol/j33pjt. Online ahead of print.
288. Vitale A, Alivernini S, Caporali R, Cassone G, Bruno D, Cantarini L, Lopalco G, Rossini M, Atzeni F, Favalli EG, Conti F, Gremese E, Iannone F, Ferraccioli GF, Lapadula G, Sebastiani M.
From Bench to Bedside in Rheumatoid Arthritis from the "2022 GISEA International Symposium".
J Clin Med. 2023 Jan 9;12(2):527. doi: 10.3390/jcm12020527.
289. Salaffi F, Siragusano C, Alciati A, Cassone G, D'Angelo S, Guiducci S, Favalli EG, Conti F, Gremese E, Iannone F, Caporali R, Sebastiani M, Ferraccioli GF, Lapadula G, Atzeni F.
Axial Spondyloarthritis: Reshape the Future-From the "2022 GISEA International Symposium".
J Clin Med. 2022 Dec 19;11(24):7537. doi: 10.3390/jcm11247537.
290. Floris A, Chessa E, Sebastiani GD, Prevete I, Iannone F, Coladonato L, Govoni M, Bortoluzzi A, Mosca M, Tani C, Doria A, Iaccarino L, Franceschini F, Fredi M, Conti F, Spinelli FR, Bellisai F, D'Alessandro R, Zanetti A, Carrara G, Scirè CA, Cauli A, Piga M; study group on Early SLE of the Italian Society of Rheumatology (SIR).
Glucocorticoid tapering and associated outcome in patients with newly diagnosed systemic lupus erythematosus: the real-world GULP prospective observational study.
RMD Open. 2022 Dec;8(2):e002701. doi: 10.1136/rmdopen-2022-002701.
291. Andreozzi V, Monaco E, Garufi C, Spinelli FR, Rossi G, Dagget M, Conti F, Ferretti A.
In-Office Needle Arthroscopic Synovial Biopsy Is an Effective Diagnostic Tool in Patients With Inflammatory Arthritis.
Arthrosc Sports Med Rehabil. 2022 Nov 29;4(6):e2099-e2106. doi: 10.1016/j.asmr.2022.10.003. eCollection 2022 Dec.
292. Priori R, Giardina F, Gioia C, Iannuccelli C, Villa M, Gattamelata A, Conti F, Di Franco M, Curcio G.
Cultural adaptation and preliminary validation of the Qualisex questionnaire for its use in patients with Sjögren's syndrome and fibromyalgia in Italy.
Clin Exp Rheumatol. 2022 Dec;40(12):2470-2471. doi: 10.55563/clinexprheumatol/9dva0x. Epub 2022 Dec 20.
293. Zagni E, Frassi M, Mariano GP, Fusaro E, Lomater C, Del Medico P, Iannone F, Foti R, Limonta M, Marchesoni A, Raffeiner B, Viapiana O, Grassi W, Grembiale RD, Guggino G, Mazzone A, Tirri E, Perricone R, Sarzi Puttini PC, De Vita S, Conti F, Zullo A, Simoni L, Fiocchi M, Orsenigo R, Colombo D.
A real-world economic analysis of biologic therapies for psoriatic arthritis in Italy: results of the CHRONOS observational longitudinal study.
BMC Health Serv Res. 2022 Dec 16;22(1):1537. doi: 10.1186/s12913-022-08954-8.
294. Ceccarelli F, Natalucci F, Pirone C, Olivieri G, Colasanti T, Picciariello L, Spinelli FR, Alessandri C, Conti F.
Erosive arthritis in systemic lupus erythematosus: application of cluster analysis.
Clin Exp Rheumatol. 2022 Nov;40(11):2175-2178. doi: 10.55563/clinexprheumatol/b8gaty. Epub 2022 Oct 28.
295. Ceccarelli F, Govoni M, Piga M, Cassone G, Cantatore FP, Olivieri G, Cauli A, Favalli EG, Atzeni F, Gremese E, Iannone F, Caporali R, Sebastiani M, Ferraccioli GF, Lapadula G, Conti F.
Arthritis in Systemic Lupus Erythematosus: From 2022 International GISEA/OEG Symposium.
J Clin Med. 2022 Oct 12;11(20):6016. doi: 10.3390/jcm11206016.
296. Ucci FM, Recalchi S, Barbati C, Manganelli V, Capozzi A, Riitano G, Buoncuore G, Garofalo T, Ceccarelli F, Spinelli FR, Balbinot E, Celia A, Longo A, Alessandri C, Misasi R, Sorice M, Conti F.
Citrullinated and carbamylated proteins in extracellular microvesicles from plasma of patients with Rheumatoid Arthritis.
Rheumatology (Oxford). 2022 Oct 18:keac598. doi: 10.1093/rheumatology/keac598. Online ahead of print.
297. Gremese E, Ciccia F, Selmi C, Cuomo G, Foti R, Matucci-Cerinic M, Conti F, Fusaro E, Guggino G, Iannone F, Delle Sedie A, Perricone R, Idolazzi L, Moscato P, Theander E, Noël W, Bergmans P, Marelli S, Gossec L, Smolen JS; Italian PsABio study.
Persistence, effectiveness and safety of ustekinumab compared to TNF inhibitors in psoriatic arthritis within the Italian PsABio cohort.
Clin Exp Rheumatol. 2022 Oct 12. doi: 10.55563/clinexprheumatol/j33pjt. Online ahead of print.
298. Schiavoni I, Olivetta E, Natalucci F, Olivieri G, Lo Presti A, Fedele G, Stefanelli P, Ceccarelli F, Conti F.
Evidence of immune response to BNT162b2 COVID-19 vaccine in systemic lupus erythematosus patients treated with Belimumab.
Lupus. 2023 Jan 6:9612033221151012. doi: 10.1177/09612033221151012. Online ahead of print.
299. Villano U, Mataj E, Dorrucci M, Farchi F, Pirone C, Valdarchi C, Equestre M, Madonna E, Bruni R, Pisani G, Martina A, Simeoni M, Iaiani G, Ciccozzi M, Ciccaglione AR, Conti F, Ceccarelli F, Lo Presti A.
Molecular Characterization of Hepatitis B Virus Infection in a Patient with Cutaneous Lupus Erythematosus.
Diagnostics (Basel). 2022 Nov 19;12(11):2866.
300. Zagni E, Frassi M, Mariano GP, Fusaro E, Lomater C, Del Medico P, Iannone F, Foti R, Limonta M, Marchesoni A, Raffeiner B, Viapiana O, Grassi W, Grembiale RD, Guggino G, Mazzone A, Tirri E, Perricone R, Sarzi Puttini PC, De Vita S, Conti F, Zullo A, Simoni L, Fiocchi M, Orsenigo R, Colombo D.
A real-world economic analysis of biologic therapies for psoriatic arthritis in Italy: results of the CHRONOS observational longitudinal study.
BMC Health Serv Res. 2022 Dec 16;22(1):1537.
301. Lo Presti A, Ceccarelli F, Dorrucci M, Farchi F, Pirone C, Garufi C, Valdarchi C, Spinelli FR, Alessandri C, Chionne P, Madonna E, Pisani G, Martina A, Simeoni M, Bruni R, Ciccozzi M, Iaiani G, Ciccaglione AR, Spada E, Conti F.
Hepatitis B and C virus infection in patients with Systemic and Cutaneous Lupus Erythematosus.
New Microbiol. 2022 Dec;45(4):296-303.
302. Novelli L, Barbati C, Capuano C, Recalchi S, Ceccarelli F, Vomero M, Alessandri C, Morrone S, Conti F.
KLRG1 is reduced on NK cells in SLE patients, inversely correlates with disease activity and is modulated by hydroxychloroquine in vitro.
Lupus. 2023 Mar 6:9612033231160979.
303. Ceccarelli F, Natalucci F, Picciariello L, Ciancarella C, Dolcini G, Gattamelata A, Alessandri C, Conti F.
Application of Machine Learning Models in Systemic Lupus Erythematosus.
Int J Mol Sci. 2023 Feb 24;24(5):4514.
304. Caporali R, Conti F, Iannone F.
Management of patients with inflammatory rheumatic diseases after treatment failure with a first TNF inhibitor: a narrative review.
Mod Rheumatol. 2023 Apr 6:road033. doi: 10.1093/mr/road033. Online ahead of print.
305. Monti S, Milanesi A, Klersy C, Tomelleri A, Dagna L, Campochiaro C, Farina N, Muratore F, Galli E, Marvisi C, Bond M, Berti A, Bortolotti R, Padoan R, Schiavon F, Felicetti M, Nannini C, Cantini F, Giollo A, Rossini M, Conticini E, Frediani B, Conti F, Priori R, Sebastiani M, Cassone G, Quartuccio L, Treppo E, Bettio S, Hoxha A, Lovisotto M, Emmi G, Mattioli I, Leccese P, Caporali R, Argolini LM, Foti R, Visalli E, Colaci M, Salvarani C, Montecucco C; Italian Society of Rheumatology Vasculitis Study Group.
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients.
Ann Rheum Dis. 2023 May 15:ard-2023-223895. doi: 10.1136/ard-2023-223895. Online ahead of print.
306. Salaffi F, Di Carlo M, Di Franco M, Bianchi G, Bazzichi L, Tirri R, Guiducci S, Gorla R, Atzeni F, Giacomelli R, Di Donato E, Guggino G, Fischetti F, Tirri E, Biasi G, Foti R, Dagna L, Carubbi F, Gremese E, Govoni M, Cutolo M, Iannone F, Lippolis I, Conti F, Tramontano G, Marino V, Farah S, Sarzi-Puttini P; Società Italiana di Reumatologia (SIR).
Determining the PASS cut-off points for the FIQR, FASmod and PSD in patients with fibromyalgia: a registry-based study.
Clin Exp Rheumatol. 2023 May 3. doi: 10.55563/clinexprheumatol/on8j9a. Online ahead of print.
307. Ceccarelli F, Natalucci F, Di Filippo A, Olivieri G, Napoletano C, Rughetti A, Nuti M, Zizzari IG, Conti F.
Membrane and Soluble CD137 in Systemic Lupus Erythematosus: Role as Biomarkers for Disease Activity.
J Immunol Res. 2023 Apr 18;2023:2344239. doi: 10.1155/2023/2344239. eCollection 2023.
308. Iagnocco A, Ciccia F, Conti F, D'Angelo S, Epis OM, Govoni M, Guiducci S, Iannone F, Mosca M, Salaffi F, Sebastiani GD, Sonnati M, Caporali RF.
Adherence to therapy in people with rheumatic and musculoskeletal diseases in Italy and the role of the digital health: results of an expert Delphi consensus survey.
Clin Exp Rheumatol. 2023 Jun 28. doi: 10.55563/clinexprheumatol/uip1u1. Online ahead of print.
309. Favretti M, Dolcini G, Iannuccelli C, Franculli D, Gioia C, Sarzi-Puttini P, Conti F, Di Franco M.
Gender differences in the revised Fibromyalgia Impact Questionnaire: a pilot study.
Clin Exp Rheumatol. 2023 Jun;41(6):1310-1316. doi: 10.55563/clinexprheumatol/4mlktj. Epub 2023 Jun 28.
310. Ceccarelli F, Perricone C, Natalucci F, Picciariello L, Olivieri G, Cafaro G, Bartoloni E, Roberto G, Conti F.
Organ damage in Systemic Lupus Erythematosus patients: A multifactorial phenomenon.
Autoimmun Rev. 2023 Aug;22(8):103374. doi: 10.1016/j.autrev.2023.103374. Epub 2023 Jun 9
311. Mohammad Reza Beigi D, Pellegrino G, Loconte M, Landini N, Mattone M, Paone G, Truglia S, Di Ciommo FR, Bisconti I, Cadar M, Stefanantoni K, Panebianco V, Conti F, Riccieri V.
Lung ultrasound compared to computed tomography detection and automated quantification of systemic sclerosis-associated interstitial lung disease: preliminary study.
Rheumatology (Oxford). 2023 Jul 3:kead324. doi: 10.1093/rheumatology/kead324. Online ahead of print.
312. Spinelli FR, Berti R, Farina G, Ceccarelli F, Conti F, Crescioli C.
Exercise-induced modulation of Interferon-signature: a therapeutic route toward management of Systemic Lupus Erythematosus.
Autoimmun Rev. 2023 Oct;22(10):103412. doi: 10.1016/j.autrev.2023.103412. Epub 2023 Aug 18.
313. Scagnellato L, Collesei A, Doria A, Cozzi G, Lorenzin M, Atzeni F, Bugatti S, Caporali R, Cauli A, Conti F, Corrado A, Carletto A, Chimenti MS, Foti R, Frediani B, Gerli R, Gorla R, Govoni M, Gremese E, Guiducci S, Iagnocco A, Iannone F, Parisi S, Rossini M, Salaffi F, Santo L, Sarzi Puttini P, Sebastiani M, Semerano A, Ferraccioli G, Lapadula G, Ramonda R; GISEA Study Group.
Comorbidities in the Spondyloarthritis GISEA Cohort: an average treatment effect analysis on patients treated with bDMARDs.
Clin Exp Rheumatol. 2023 Aug 30. doi: 10.55563/clinexprheumatol/q38lu0. Online ahead of print.
314. Ceccarelli F, Olivieri G, Orefice V, Picciariello L, Natalucci F, Conti F.
Fragility fractures in lupus patients: Associated factors and comparison of four fracture risk assessment tools.
Lupus. 2023 Sep 12:9612033231202701. doi: 10.1177/09612033231202701. Online ahead of print.
315. Hernández-Cruz B, Kiltz U, Avouac J, Treuer T, Haladyj E, Gerwien J, Gupta CD, Conti F.
Systematic Literature Review of Real-World Evidence on Baricitinib for the Treatment of Rheumatoid Arthritis.
Rheumatol Ther. 2023 Sep 16. doi: 10.1007/s40744-023-00591-9. Online ahead of print.
316. Spinelli FR, Garufi C, Mancuso S, Ceccarelli F, Truglia S, Conti F.
Tapering and discontinuation of glucocorticoids in patients with rheumatoid arthritis treated with tofacitinib.
Sci Rep. 2023 Sep 20;13(1):15537. doi: 10.1038/s41598-023-42371-z.
317. Zen M, Gatto M, Depascale R, Regola F, Fredi M, Andreoli L, Franceschini F, Urban ML, Emmi G, Ceccarelli F, Conti F, Bortoluzzi A, Govoni M, Tani C, Mosca M, Ubiali T, Gerosa M, Bozzolo EP, Canti V, Cardinaletti P, Gabrielli A, Tanti G, Gremese E, De Marchi G, De Vita S, Fasano S, Ciccia F, Pazzola G, Salvarani C, Negrini S, Di Matteo A, De Angelis R, Orsolini G, Rossini M, Faggioli P, Laria A, Piga M, Cauli A, Scarpato S, Rossi FW, De Paulis A, Brunetta E, Ceribelli A, Selmi C, Prete M, Racanelli V, Vacca A, Bartoloni E, Gerli R, Zanatta E, Larosa M, Saccon F, Doria A, Iaccarino L.
Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study-Joint and Skin (BeRLiSS-JS).
J Pers Med. 2023 Apr 20;13(4):691.
318. Bijl M, Westra J, Mancuso S, Bearzi P, Giacomelli R, Conti F.
Should we vaccinate during an active rheumatic disease?
Autoimmun Rev. 2023 Aug 25:103426. doi: 10.1016/j.autrev.2023.103426
319. Picchianti-Diamanti A, Navarra A, Aiello A, Laganà B, Cuzzi G, Salmi A, Vanini V, Maggi F, Meschi S, Matusali G, Notari S, Agrati C, Salemi S, Di Rosa R, Passarini D, Di Gioia V, Sesti G, Conti F, Spinelli FR, Corpolongo A, Chimenti MS, Ferraioli M, Sebastiani GD, Benucci M, Li Gobbi F, Santoro AP, Capri A, Puro V, Nicastri E, Goletti D.
Older Age, a High Titre of Neutralising Antibodies and Therapy with Conventional DMARDs Are Associated with Protection from Breakthrough Infection in Rheumatoid Arthritis Patients after the Booster Dose of Anti-SARS-CoV-2 Vaccine.
Vaccines (Basel). 2023 Nov 2;11(11):1684. doi: 10.3390/vaccines11111684.
320. Colasanti T, Conti F.
Autoantibody Recognition of Natural and Homocysteinylated Alpha-1 Antitrypsin: Indirect Enzyme-Linked Immunosorbent Assay (ELISA) Quantification in Sera.
Methods Mol Biol. 2024;2750:135-141. doi: 10.1007/978-1-0716-3605-3_13.
321. Spinelli FR, Conti F, Caporali R, Iannone F, Cacciapaglia F, Steering Committee Of The Italian Society Of Rheumatology OBOT.
Janus kinase inhibitors: between prescription authorization and reimbursability.
Reumatismo. 2023 Dec 19;75(4). doi: 10.4081/reumatismo.2023.1627.
322. Gioia C, Picchianti Diamanti A, Perricone R, Chimenti MS, Afeltra A, Navarini L, Migliore A, Massafra U, Bruzzese V, Scolieri P, Meschini C, Paroli M, Caccavale R, Scapato P, Scrivo R, Conti F, Laganà B, Di Franco M.
Anti-tumor necrosis factor α: originators versus biosimilars, comparison in clinical response assessment in a multicenter cohort of patients with inflammatory arthropathies.
Reumatismo. 2023 Dec 19;75(4). doi: 10.4081/reumatismo.2023.1602.
323. Riitano G, Capozzi A, Recalchi S, Augusto M, Conti F, Misasi R, Garofalo T, Sorice M, Manganelli V.
Role of Lipid Rafts on LRP8 Signaling Triggered by Anti-β2-GPI Antibodies in Endothelial Cells.
Biomedicines. 2023 Nov 24;11(12):3135. doi: 10.3390/biomedicines11123135.
324. Colafrancesco S, Celia AI, Baldini C, Quartuccio L, Bartoloni E, Carubbi F, Orlandi M, Barbati C, Pignataro MG, Cerbelli B, Giordano C, Ferro F, Gattamelata A, Giardina F, Izzo R, Longhino S, De Vita S, Gerli R, Giacomelli R, Conti F, Priori R.
Clinical and histological features of patients with primary Sjögren's syndrome and autoimmune thyroiditis: a national multicentre cross-sectional study.
Clin Exp Rheumatol. 2023 Dec;41(12):2389-2396. doi: 10.55563/clinexprheumatol/eh36vs. Epub 2023 Dec 23.
325. Gigante A, Cianci R, Villa A, Pellicano C, Giannakakis K, Rosato E, Spinelli FR, Basile U, Racco C, Di Virgilio EM, Cerbelli B, Conti F.
Kidney Biopsy and Immuno-Rheumatological Diseases: A Retrospective and Observational Study.
J Pers Med. 2024 Jan 13;14(1):92. doi: 10.3390/jpm14010092.
326. Riccieri V, Pellegrino G, Cipolletta E, Giuggioli D, Bajocchi G, Bellando-Randone S, Dagna L, Zanframundo G, Foti R, Cacciapaglia F, Cuomo G, Ariani A, Rosato E, Lepri G, Girelli F, Zanatta E, Bosello SL, Cavazzana I, Ingegnoli F, De Santis M, Murdaca G, Abignano G, Romeo N, Della Rossa A, Caminiti M, Iuliano A, Ciano G, Beretta L, Bagnato G, Lubrano E, De Andres I, Giollo A, Saracco M, Agnes C, Lumetti F, Spinella A, Magnani L, Campochiaro C, De Luca G, Codullo V, Visalli E, Di Vico C, Gigante A, Saccon F, Grazia Lazzaroni M, Franceschini F, Generali E, Mennillo G, Barsotti S, Pagano Mariano G, Calabrese F, Furini F, Vultaggio L, Parisi S, Peroni CL, Bianchi G, Conti F, Cozzi F, D'Angelo S, Doria A, Fusaro E, Govoni M, Guiducci S, Iannone F, Salvarani C, Sebastiani GD, Ferri C, Matucci-Cerinic M, De Angelis R.
Practice pattern for the use of intravenous iloprost for the treatment of peripheral vasculopathy in systemic sclerosis: A case-control study from the Italian national multicenter "SPRING" (Systemic Sclerosis Progression InvestiGation) Registry.
J Scleroderma Relat Disord. 2024 Feb;9(1):38-49. doi: 10.1177/23971983231209809. Epub 2024 Jan 11.
327. Bortoluzzi A, Fanouriakis A, Silvagni E, Appenzeller S, Carli L, Carrara G, Cauli A, Conti F, Costallat LTL, De Marchi G, Doria A, Fredi M, Franceschini F, Garaffoni C, Hanly JG, Mosca M, Murphy E, Piga M, Quartuccio L, Scirè CA, Tomietto P, Truglia S, Zanetti A, Zen M, Bertsias G, Govoni M.
Therapeutic Strategies and Outcomes in Neuropsychiatric Systemic Lupus
Erythematosus: An International Multicenter Retrospective Study.
Rheumatology (Oxford). 2024 Oct 1;63(10):2711-2720
328. Treppo E, Isola M, De Martino M, Padoan R, Giollo A, Urban ML, Monti S, Sartorelli S, Fassio A, Argolini LM, Marvisi C, Gattamelata A, Regola F, Ferro F, Cassone G, Motta F, Berti A, Conticini E, Guiducci S, Matucci-Cerinic M, Lo Gullo A, Manfredi A, Frediani B, Bortolotti R, Selmi C, Baldini C, Franceschini F, Conti F, Caporali R, Rossini M, Dagna L, Montecucco C, Emmi G, Schiavon F, Salvarani C, Quartuccio L.
Validation of the Italian version of the ANCA-associated vasculitis patient-reported outcome (AAV-PRO) questionnaire.
Rheumatol Adv Pract. 2024 Jan 22;8(1):rkae001.
329. Manfredi A, Fornaro M, Bazzani C, Perniola S, Cauli A, Rai A, Favalli EG, Bugatti S, Rossini M, Foti R, Conti F, Lopalco G, Scalvini A, Garufi C, Congia M, Gorla R, Gremese E, Atzeni F, Caporali R, Iannone F, Sebastiani M.
Retention rate of biologic and targeted synthetic anti-rheumatic drugs in elderly rheumatoid arthritis patients: data from GISEA registry.
Front Med (Lausanne). 2024 Mar 11;11:1349533.
330. Ceccarelli F, Natalucci F, Picciariello L, Cirillo A, Olivieri G, Veroli M, Pisegna S, Ciancarella C, Gelibter A, Picone V, Santini D, Botticelli A, Conti F.
Antinuclear antibodies may predict the development of immune-related adverse events in asymptomatic patients treated with immune checkpoint inhibitors: results from a single-center cohort.
Clin Exp Med. 2024 Apr 10;24(1):72.
331. Gioia C, Dolcini G, Iannuccelli C, Favretti M, Franculli D, Sarzi-Puttini P, Conti F, Priori R, Di Franco M.
Validation of Qualisex questionnaire to evaluate sexual dysfunction in women affected by fibromyalgia.
Clin Exp Rheumatol. 2024 Apr 8. doi: 10.55563/clinexprheumatol/a00yur. Online ahead of print.
332. Fornaro M, Caporali R, Biggioggero M, Bugatti S, De Stefano L, Cauli A, Congia M, Conti F, Chimenti MS, Bazzani C, Perniola S, Atzeni F, Lapadula G, Ferraccioli G, Iannone F; from the GISEA registry.
Effectiveness and safety of filgotinib in rheumatoid arthritis patients: data from the GISEA registry.
Clin Exp Rheumatol. 2024 Apr 17. doi: 10.55563/clinexprheumatol/b40rv4. Online ahead of print.
333. Latini A, Borgiani P, De Benedittis G, Ciccacci C, Novelli L, Pepe G, Helmer-Citterich M, Baldini I, Perricone C, Ceccarelli F, Conti F, Ianniciello G, Caceres J, Ottalevi R, Capulli M, Novelli G.
Large-scale DNA sequencing identifies rare variants associated with Systemic Lupus Erythematosus susceptibility in known risk genes.
Gene. 2024 May 20;907:148279. doi: 10.1016/j.gene.2024.148279. Epub 2024 Feb 13.
334. Fornaro M, Caporali R, Biggioggero M, Bugatti S, De Stefano L, Cauli A, Congia M, Conti F, Chimenti MS, Bazzani C, Perniola S, Atzeni F, Lapadula G, Ferraccioli G, Iannone F; from the GISEA registry.Effectiveness and safety of filgotinib in rheumatoid arthritis patients: data from the GISEA registry.
Clin Exp Rheumatol. 2024 May;42(5):1043-1050. doi: 10.55563/clinexprheumatol/b40rv4. Epub 2024 Apr 17.
335. Ceccarelli F, Picciariello L, Natalucci F, Moretti V, Spinelli FR, Alessandri C, Conti F.
Application of SLE-DAS to assess subcutaneous belimumab efficacy in a cohort of systemic lupus erythematosus patients.
Clin Exp Rheumatol. 2024 Jul;42(7):1491-1494. doi: 10.55563/clinexprheumatol/l5976o. Epub 2024 May 28.
336. Molteni E, Pirone C, Ceccarelli F, Castellani C, Alessandri C, Di Franco M, Riccieri V, Spinelli FR, Priori R, Scrivo R, Conti F.
Retention rate of abatacept in rheumatoid arthritis patients in a real-life setting: results from a monocentric cohort.
Reumatismo. 2024 Jun 24;76(2). doi: 10.4081/reumatismo.2024.1608.
337. Tani C, Cardelli C, Zen M, Moroni L, Piga M, Ceccarelli F, Fasano S, De Marchi G, Coladonato L, Emmi G, Gatto M, Trentin F, Ramirez GA, Chessa E, Gallina G, Picciariello L, Patrone M, Urban ML, Biancalana E, Quartuccio L, Ciccia F, Conti F, Cauli A, Dagna L, Doria A, Mosca M.
Anifrolumab in Refractory Systemic Lupus Erythematosus: A Real-World, Multicenter Study.
J Rheumatol. 2024 Nov 1;51(11):1096-1101. doi: 10.3899/jrheum.2024-0053.
338. Galosi E, Pirone C, Ceccarelli F, Esposito N, Falco P, Leopizzi M, Di Maio V, Tramontana L, De Stefano G, Di Pietro G, Di Stefano G, Garufi C, Leone C, Natalucci F, Orefice V, Alessandri C, Spinelli FR, Truini A, Conti F.
Clinical, histologic, and immunologic signatures of Small Fiber Neuropathy in Systemic Lupus Erythematosus.
J Peripher Nerv Syst. 2024 Sep;29(3):315-328. doi: 10.1111/jns.12644. Epub 2024 Jul 9.
339. Chimenti MS, Fatica M, Fornaro M, Lopalco G, Corrado A, Rotondo C, Semeraro A, Colella S, Praino E, Gorla R, Bazzani C, Babaglioni G, Foti R, Floris A, Frediani B, Atzeni F, Conti F, Cauli A, Caporali R, Iannone F, Guiducci S.
Effectiveness of ixekizumab over 24 months in different clinical scenarios in psoriatic arthritis: results from the Gruppo Italiano Studio Early Arthritis multicentric prospective registry.
Clin Exp Rheumatol. 2024 Nov;42(11):2221-2228. doi: 10.55563/clinexprheumatol/udiit0. Epub 2024 Jul 24.
340. Celia AI, Galli M, Mancuso S, Alessandri C, Frati G, Sciarretta S, Conti F.
Antiphospholipid Syndrome: Insights into Molecular Mechanisms and Clinical Manifestations.
J Clin Med. 2024 Jul 18;13(14):4191. doi: 10.3390/jcm13144191.
341. Ruscitti P, Allanore Y, Baldini C, Barilaro G, Bartoloni Bocci E, Bearzi P, Bellis E, Berardicurti O, Biaggi A, Bombardieri M, Cantarini L, Cantatore FP, Caporali R, Caso F, Cervera R, Ciccia F, Cipriani P, Chatzis L, Colafrancesco S, Conti F, Corberi E, Costa L, Currado D, Cutolo M, D'Angelo S, Del Galdo F, Di Cola I, Di Donato S, Distler O, D'Onofrio B, Doria A, Fautrel B, Fasano S, Feist E, Fisher BA, Gabini M, Gandolfo S, Gatto M, Genovali I, Gerli R, Grembiale RD, Guggino G, Hoffmann-Vold AM, Iagnocco A, Iaquinta FS, Liakouli V, Manoussakis MN, Marino A, Mauro D, Montecucco C, Mosca M, Naty S, Navarini L, Occhialini D, Orefice V, Perosa F, Perricone C, Pilato A, Pitzalis C, Pontarini E, Prete M, Priori R, Rivellese F, Sarzi-Puttini P, Scarpa R, Sebastiani G, Selmi C, Shoenfeld Y, Triolo G, Trunfio F, Yan Q, Tzioufas AG, Giacomelli R.
Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensus.
Autoimmun Rev. 2024 Jul-Aug;23(7-8):103581. doi: 10.1016/j.autrev.2024.103581. Epub 2024 Jul 26.
342. Truglia S, Riitano G, Mancuso S, Recalchi S, Rapino L, Garufi C, Manganelli V, Garofalo T, Misasi R, Alessandri C, Sorice M, Longo A, Conti F, Capozzi A.
Antibody profiles in the mosaic of 'seronegative' APS syndrome.
Clin Exp Immunol. 2024 Nov 12;218(3):275-282. doi: 10.1093/cei/uxae079.
343. Quartuccio L, Piga M, Atzeni F, Callori M, Doria A, Emmi G, Franceschini F, Gerosa M, Mosca M, Pasqualetti P, Pelissero R, Sebastiani GD, Conti F, Govoni M.
Preferences for diagnostic pathways and treatment choice in systemic lupus erythematosus: a patient-based discrete choice experiment.
Clin Exp Rheumatol. 2025 Jan;43(1):53-61. doi: 10.55563/clinexprheumatol/clx4p7. Epub 2024 Sep 10.
344. Piga M, Quartuccio L, Atzeni F, Doria A, Emmi G, Franceschini F, Gerosa M, Mosca M, Pasqualetti P, Sebastiani GD, Conti F, Govoni M.
Diagnostic pathway and treatment preferences for systemic lupus erythematosus: a physician-based discrete choice experiment.
Clin Exp Rheumatol. 2025 Jan;43(1):48-52. doi: 10.55563/clinexprheumatol/25a2qk. Epub 2024 Sep 10.
345. Mancuso S, De Michele M, Truglia S, Capozzi A, Rapino L, Berto I, Alessandri C, Toni D, Manganelli V, Sorice M, Conti F.
Cryptogenic stroke and seronegative antiphospholipid syndrome: a case series of patients with positivity for "non-criteria" antiphospholipid antibodies.
Reumatismo. 2024 Sep 25;76(4). doi: 10.4081/reumatismo.2024.1701.
346. Ceccarelli F, Natalucci F, Ciancarella C, Picciariello L, Moretti V, Spinelli FR, Alessandri C, Conti F.
Belimumab 10 years later: how drug positioning has changed.
Immunol Res. 2024 Dec;72(6):1441-1446. doi: 10.1007/s12026-024-09543-z. Epub 2024 Oct 2.
347. Orefice V, Ceccarelli F, Barbati C, Buoncuore G, Pirone C, Alessandri C, Conti F.
Caffeine improves systemic lupus erythematosus endothelial dysfunction by promoting endothelial progenitor cells survival.
Rheumatology (Oxford). 2025 Apr 1;64(4):1886-1893. doi: 10.1093/rheumatology/keae453.
348. Garufi C, Mancuso S, Ceccarelli F, Caruso L, Alessandri C, Di Franco M, Priori R, Riccieri V, Scrivo R, Truglia S, Conti F, Spinelli FR.
PASSing to the patient side: early achieving of an acceptable symptom state in patients with rheumatoid arthritis treated with Janus kinase inhibitors.
Reumatismo. 2025 Feb 13;77(1). doi: 10.4081/reumatismo.2024.1725. Epub 2024 Nov 5.
349. Lubrano E, Armuzzi A, Scriffignano S, Felice C, Perrotta FM, Venerito V, Del Vescovo S, Ramonda R, Cassone G, Atzeni F, Caporali R, Conti F, Gremese E, Iannone F, Sebastiani M, Favalli EG.
The holistic management of peripheral spondyloarthritis: focus on articular involvement in patients with inflammatory bowel disease.
Reumatismo. 2025 Feb 13;77(1). doi: 10.4081/reumatismo.2024.1688. Epub 2024 Nov 11.
350. La Gualana F, Olivieri G, Petriti B, Picciariello L, Natalucci F, Sciannamea M, Gragnani L, Basile U, Casato M, Spinelli FR, Stefanini L, Basili S, Visentini M, Ceccarelli F, Conti F.
Early decrease of T-bet+ B cells during subcutaneous belimumab predicts response to therapy in systemic lupus erythematosus patients.
Immunol Lett. 2025 Apr;272:106962. doi: 10.1016/j.imlet.2024.106962. Epub 2024 Dec 4.
351. Natalucci F, Ceccarelli F, Picciariello L, Olivieri G, Ciancarella C, Alessandri C, Conti F.
Are Tattoos Safe in Patients with Systemic Lupus Erythematosus? Results From a Single-Center Study.
Dermatol Pract Concept. 2024 Oct 30;14(4):e2024230. doi: 10.5826/dpc.1404a230.
352. Ucci FM, Scrivo R, Alessandri C, Conti F, Priori R.
Aseptic abscess syndrome: a case report of a patient achieving remission with both infliximab originator and biosimilar administered at varied intervals.
Front Immunol. 2024 Dec 3;15:1454813. doi: 10.3389/fimmu.2024.1454813. eCollection 2024.
353. Ceccarelli F, Ciancarella C, Natalucci F, Scorda A, Tripodi G, Garufi C, Mancuso S, Spinelli FR, Alessandri C, Conti F.
Rapid response to anifrolumab in lupus related joint involvement as assessed by ultrasonography: A case series study.
Joint Bone Spine. 2025 Mar;92(2):105830. doi: 10.1016/j.jbspin.2024.105830. Epub 2024 Dec 21.
354. Edwards CJ, Krönke G, Avouac J, Li Z, Conti F, Balsa A, Mo D, Haladyj E, Fischer P, Tanaka M, Takita Y, Hagimori K, Takeuchi T.
Baricitinib Dose Reduction in Patients With Rheumatoid Arthritis Achieving Sustained Disease Control: Final Results From the RA-BEYOND Study.
J Rheumatol. 2025 Apr 1;52(4):316-322. doi: 10.3899/jrheum.2024-0906.
355. Truglia S, Ciccia F, Mancuso S, Capozzi A, Rizzo A, Spinelli FR, Ceccarelli F, Colasanti T, Garufi C, Miranda F, Sorice M, Alessandri C, Conti F.
Interleukin-32 positive immune and resident cells in kidney samples from lupus patients: a pilot study.
Front Immunol. 2025 Jan 6;15:1475073. doi: 10.3389/fimmu.2024.1475073. eCollection 2024.
356. Mastromanno L, Giardina F, Gattamelata A, Colafrancesco S, Truglia S, Spinelli FR, Simoncelli E, Lucchino B, Conti F, Priori R.
Adherence to vaccination against SARS-CoV-2 and vaccine safety in patients with IgG4-related disease.
Reumatismo. 2025 Jun 10;77(2). doi: 10.4081/reumatismo.2025.1744. Epub 2025 Jan 22.
357. Lopalco G, Morrone M, Atzeni F, Bazzani C, Bianchi FP, Cantatore FP, Caporali R, Carletto A, Cauli A, Chimenti MS, Colella S, Conti F, Corrado A, Favalli EG, Floris A, Fornaro M, Foti R, Foti R, Fracassi E, Frediani B, Gentileschi S, Gorla R, Gremese E, Praino E, Ramonda R, Rotondo C, Sebastiani M, Semeraro A, Ferraccioli G, Lapadula G, Iannone F.
Efficacy and retention rate of secukinumab in psoriatic arthritis across different clinical phenotypes: insights from the Italian GISEA Registry.
Ther Adv Musculoskelet Dis. 2025 Jan 31;17:1759720X251315138. doi: 10.1177/1759720X251315138. eCollection 2025.
358. Riitano G, Spinelli F, Manganelli V, Caissutti D, Capozzi A, Garufi C, Garofalo T, Misasi R, Sorice M, Conti F, Longo A, Alessandri C.
Wnt signaling as a translational target in rheumatoid and psoriatic arthritis.
J Transl Med. 2025 Feb 4;23(1):158. doi: 10.1186/s12967-025-06174-2.
359. Buttari B, Recalchi S, Riitano G, Capozzi A, Ucci FM, Manganelli V, Fratini F, Profumo E, Garofalo T, Alessandri C, Misasi R, Conti F, Longo A, Sorice M.
Extracellular microvesicles from patients with Rheumatoid arthritis promote dendritic cell activation in vitro.
Front Immunol. 2025 Mar 5;16:1532114. doi: 10.3389/fimmu.2025.1532114. eCollection 2025.
360. Mancuso S, Caliste M, Petretto A, Corsiero E, Grinovero N, Capozzi A, Riitano G, Barbati C, Truglia S, Alessandri C, Sorice M, Bombardieri M, Conti F.
Anti-β2glycoprotein I-induced neutrophil extracellular TRAPS cause endothelial activation.
Rheumatology (Oxford). 2025 Apr 16:keaf204. doi: 10.1093/rheumatology/keaf204. Online ahead of print.
361. Ciancarella C, Ceccarelli F, Picciariello L, Natalucci F, Celia AI, Garufi C, Mancuso S, Tripodi G, Truglia S, Gattamelata A, Spinelli FR, Alessandri C, Conti F.
Evolutionary trajectory of undifferentiated connective tissue disease and impact of 2019 EULAR/ACR systemic lupus erythematosus classification criteria: insights from a longitudinal study.
Clin Exp Med. 2025 May 1;25(1):134. doi: 10.1007/s10238-025-01668-1.
362. Celia AI, Vescovo GM, Sarto G, Alessandri C, Iaconelli A, D'Amario D, Frati G, Conti F, Sciarretta S, Angiolillo DJ, Fava A, Petri MA, Bikdeli B, Galli M.
Direct oral anticoagulants versus Vitamin K antagonists in antiphospholipid syndrome: A systematic review and meta-analysis.
Semin Arthritis Rheum. 2025 Aug;73:152741. doi: 10.1016/j.semarthrit.2025.152741. Epub 2025 May 1.
363. Gómez-Bañuelos E, Celia AI, Trejo-Zambrano MI, Robles-De Anda JA, Paz M, Chaturvedi S, Conti F, Alessandri C, Tiniakou E, Goldman DW, Brodsky RA, Petri M, Andrade F.
Anti-TFAM antibodies link mitochondrial damage with antiphospholipid syndrome and thrombosis in SLE.
Ann Rheum Dis. 2025 May 10:S0003-4967(25)00904-5. doi: 10.1016/j.ard.2025.04.015. Online ahead of print.
364. Iannuccelli C, Favretti M, Dolcini G, Di Carlo M, Pellegrino G, Bazzichi L, Atzeni F, Lucini D, Varassi G, Leoni MLG, Fornasari DMM, Conti F, Salaffi F, Sarzi-Puttini P, Di Franco M.
Fibromyalgia: one year in review 2025.
Clin Exp Rheumatol. 2025 Jun;43(6):957-969. doi: 10.55563/clinexprheumatol/buhd2z. Epub 2025 Jun 3.
365. Mohammad Reza Beigi D, Pellegrino G, Landini N, Diana ME, Paone G, Bisconti I, Di Ciommo FR, Cadar M, Platania E, Landro J, Truglia S, Panebianco V, Conti F, Riccieri V.
Comparison of quantitative lung ultrasound scores with automated quantitative CT: to overcome the ultrasound limitations.
Rheumatology (Oxford). 2025 Jun 12:keaf328. doi: 10.1093/rheumatology/keaf328. Online ahead of print.
366. Atzeni F, Rotondo C, Siragusano C, Corrado A, Cauli A, Caporali R, Chimenti MS, Conti F, Picerno V, Gremese E, Camarda F, Guiducci S, Ramonda R, Idolazzi L, Semeraro A, Sebastiani M, Lapadula G, Ferraccioli G, Iannone F.
Italian Multicenter Real-World Study on the Twelve-Month Effectiveness, Safety, and Retention Rate of Guselkumab in Psoriatic Arthritis Patients.
J Clin Med. 2025 Jun 10;14(12):4111. doi: 10.3390/jcm14124111.
367. Minafò YA, Monaco N, Fiorilli V, La Gualana F, D'Ambrosi M, De Renzis C, Basili S, Sorice M, Coluzzi S, Priori R, Visentini M, Conti F, Casato M.
Concurrence of mixed cryoglobulinaemia and cold agglutinin disease, and the putative role for a stereotyped immunoglobulin light chain.
Br J Haematol. 2025 Jun 26. doi: 10.1111/bjh.20220. Online ahead of print.
368. Dolcini G, Favretti M, Franculli D, Buoncuore G, Pellegrino G, Di Carlo M, Sarzi-Puttini P, Conti F, Iannuccelli C, Di Franco M.
Vagal nerve stimulation and fibromyalgia: an additional therapeutic option.
Clin Exp Rheumatol. 2025 Jun;43(6):1095-1104. doi: 10.55563/clinexprheumatol/johqvo. Epub 2025 Jun 27.
369. Mattioli I, Gasparotto M, Bergamini A, Bortoluzzi A, Ciccia F, Conti F, D'agostino MA, Fredi M, Giacomelli R, Iannone F, Mormile I, Piga M, Quartuccio L, Sebastiani GD, Tani C, Vacca A, Zen M, Bettiol A, Emmi G; ESCULAPIO consortium.
Incidence and prevalence of systemic lupus erythematosus across Italian referral centers and its clinical burden in terms of disease severity, treatment and hospitalization: The ESCULAPIO study.
Eur J Intern Med. 2025 Jun 28:S0953-6205(25)00255-9. doi: 10.1016/j.ejim.2025.06.016. Online ahead of print.
370. Ruscitti P, Cantarini L, Ciccia F, Conti F, Dagna L, Iannone F, Montecucco C, Giovanni P, Sfriso P, Giacomelli R.
Managing the clinical heterogeneity of patients with Still's disease, from early diagnosis to timely treatment.
Autoimmun Rev. 2025 Sep 24;24(10):103880. doi: 10.1016/j.autrev.2025.103880. Epub 2025 Jul 18.PMID: 40684897
371. Lopalco G, Celletti E, Morrone M, Atzeni F, Limonta M, Rossini M, Carletto A, Cauli A, Cazzato M, Chimenti MS, Conti F, Rotondo C, Leccese P, Foti R, Gentileschi S, Gremese E, Selmi CF, Bazzani C, Guggino G, Guiducci S, Di Penta M, Lo Gullo A, Luchetti Gentiloni MM, Bugatti S, Ramonda R, Sebastiani M, Semeraro A, Santo L, Caporali RF, Iannone F.
Targeting axial and peripheral psoriatic arthritis: a retrospective observational study on the clinical relevance of upadacitinib.
Rheumatology (Oxford). 2025 Aug 4:keaf411. doi: 10.1093/rheumatology/keaf411. Online ahead of print.PMID: 40758456
372. Sota J, Mejía-Salgado G, Guerriero S, Ragab G, Costi S, Paroli MP, Hinojosa-Azaola A, Lopalco G, Breda L, Giardini HAM, Fonollosa A, Chimenti MS, Vitale A, Gaggiano C, Aguilar-Barrera B, Rodríguez-Camelo LD, Guaracha-Basañez GA, Hegazy MT, Dammacco R, Albano V, Martín-Nares E, Espinosa-Lugo S, Ghanema M, Morrone M, La Bella S, Cordeiro RA, Carubbi F, Conforti A, Ruscitti P, AlMaglouth I, Talarico R, Gentileschi S, Sfikakis PP, Caggiano V, Piga M, Civino A, Ricci F, Thabet M, Govoni M, Tufan A, Crisafulli F, Sbalchiero J, Al-Mayouf SM, Mauro A, Hashad S, Minoia F, Olivieri AN, Tharwat S, Maggio MC, Moshrif A, Sebastiani GD, Opris-Belinski D, Hatemi G, Direskeneli H, Alibaz-Öner F, Fotis L, Hernández-Rodríguez J, Conti G, Puttini PS, Viapiana O, Giardina A, Barone P, Babu K, Amin RH, Kawakami-Campos PA, Gupta V, Iagnocco A, Şahin A, Insalaco A, González-García A, Batu ED, Carreño E, Del Giudice E, Chighizola CB, Conti F, Balistreri A, Frediani B, Cantarini L, de-la-Torre A, Fabiani C.
Predictors of uveitic macular edema and functional prognostic outcomes: real-life data from the international AIDA Network uveitis registry.
Front Med (Lausanne). 2025 Jul 30;12:1609613. doi: 10.3389/fmed.2025.1609613. eCollection 2025.PMID: 40809444 Free PMC article.
373. Natalucci F, Ceccarelli F, Ciancarella C, Truglia S, Spinelli FR, Alessandri C, Conti F.
Ultrasound clusters of joint inflammation in systemic lupus erythematosus: a cross-sectional study.
Rheumatol Int. 2025 Sep 24;45(10):234. doi: 10.1007/s00296-025-05986-
374. Bortoluzzi A, Marangoni A, Silvagni E, Rozza D, Bartoloni E, Blagojevic J, Pallavicini FB, Bozzolo E, Canti V, Cavagna L, Cavazzana I, Coladonato L, Conigliaro P, Crisafulli F, Ditto MC, Emmi G, Ferrigno S, Franceschini F, Frassi M, Garaffoni C, Gerosa M, Govoni M, Guiducci S, Iaccarino L, Manfredi A, Mancuso S, Mosca M, Naclerio C, Orefice V, Parisi S, Pazzola G, Pettiti G, Prevete I, Ramirez GA, Scirocco C, Spinelli FR, Zen M, Carrara G, Scirè CA, Conti F, Doria A, Sebastiani GD.
Factors influencing the choice of non-biologic versus biologic immunosuppressive therapy in systemic lupus erythematosus.
Sci Rep. 2025 Oct 13;15(1):35721. doi: 10.1038/s41598-025-19654-8.
375. Gómez-Bañuelos E, Celia AI, Trejo-Zambrano MI, Robles-De Anda JA, Paz M, Chaturvedi S, Conti F, Alessandri C, Tiniakou E, Goldman DW, Brodsky RA, Petri M, Andrade F.
Anti-TFAM antibodies link mitochondrial damage with antiphospholipid syndrome and thrombosis in SLE.
Ann Rheum Dis. 2025 Sep;84(9):1501-1511. doi: 10.1016/j.ard.2025.04.015. Epub 2025 May 10.
376. Colangelo L, Di Ciommo FR, Palmisano B, Scrivo R, Della Monaca M, Pepe J, Cipriani C, Alessandri C, Valentini V, Riminucci M, Minisola S, Conti F, Corsi A.
Exploring the Role of FGF7 in Tumor-Induced Osteomalacia. Clinic-Pathologic Analysis in a Patient with a Sino-Nasal Phosphaturic Mesenchymal Tumor.
Calcif Tissue Int. 2025 Jun 9;116(1):82. doi: 10.1007/s00223-025-01394-6.
377. Mattioli I, Gasparotto M, Bergamini A, Bortoluzzi A, Ciccia F, Conti F, D'agostino MA, Fredi M, Giacomelli R, Iannone F, Mormile I, Piga M, Quartuccio L, Sebastiani GD, Tani C, Vacca A, Zen M, Bettiol A, Emmi G; ESCULAPIO consortium.
Incidence and prevalence of systemic lupus erythematosus across Italian referral centers and its clinical burden in terms of disease severity, treatment and hospitalization: The ESCULAPIO study.
Eur J Intern Med. 2025 Nov;141:106387. doi: 10.1016/j.ejim.2025.06.016. Epub 2025 Jun 28.
378. Lopalco G, Celletti E, Morrone M, Atzeni F, Limonta M, Rossini M, Carletto A, Cauli A, Cazzato M, Chimenti MS, Conti F, Rotondo C, Leccese P, Foti R, Gentileschi S, Gremese E, Selmi CF, Bazzani C, Guggino G, Guiducci S, Di Penta M, Lo Gullo A, Luchetti Gentiloni MM, Bugatti S, Ramonda R, Sebastiani M, Semeraro A, Santo L, Caporali RF, Iannone F.
Targeting axial and peripheral psoriatic arthritis: a retrospective observational study on the clinical relevance of upadacitinib.
Rheumatology (Oxford). 2025 Dec 1;64(12):6142-6150. doi: 10.1093/rheumatology/keaf411.
379. Mancuso S, Ciancarella C, Rapino L, Truglia S, Alessandri C, Conti F.
Proteins upregulated in thrombotic antiphospholipid syndrome linked to platelet function in contrast with non-antiphospholipid-related thrombosis: insights from two systematic reviews.
Lupus Sci Med. 2025 Nov 7;12(2):e001751. doi: 10.1136/lupus-2025-001751.
380. Jørgensen JB, Christensen KB, Michelsen B, Loft AG, Horskjær Rasmussen S, Heberg J, Hetland ML, Zavada J, Pavelka K, Iannone F, Conti F, Borges J, Codreanu C, Mogosan C, Glintborg B, Ciurea A, Nissen MJ, Nordström D, Kuusalo L, Laas K, Vorobjov S, Gudbjornsson B, Love TJ, Østergaard M, Ørnbjerg LM.
Assessing internal construct validity of DAPSA and DAPSA28 in psoriatic arthritis: a European observational study using confirmatory factor analysis and additional psychometric testing.
RMD Open. 2025 Dec 23;11(4):e006104. doi: 10.1136/rmdopen-2025-006104.
381. Bellofatto IA, Paci V, Conti F, Santoboni G, Sebastiani GD, Cattaruzza MS, Mazzanti C, Salemi S, Sesti G, Tesoriere E, Fiorilli V, Prevete I, Spinelli FR, Picchianti Diamanti A.
Coverage and Drivers of Vaccinations in Patients with Autoimmune Rheumatic Diseases: An Italian Multicentric Study.
Vaccines (Basel). 2025 Dec 6;13(12):1229. doi: 10.3390/vaccines13121229.
382. Latini A, De Benedittis G, Morgante C, Perricone C, Ceccarelli F, Conti F, Novelli G, Ciccacci C, Borgiani P.
An ETS2 Enhancer Variant May Modulate Gene Expression and Contribute to Defining a Genetic Risk Profile for SLE Susceptibility.
Genes (Basel). 2025 Dec 8;16(12):1462. doi: 10.3390/genes16121462.
383. De Lorenzis E, Natalello G, De Angelis R, Verardi L, Giuggioli D, Bajocchi G, Dagna L, Bellando-Randone S, Zanframundo G, Foti R, Cacciapaglia F, Cuomo G, Ariani A, Rosato E, Lepri G, Girelli F, Riccieri V, Zanatta E, Cavazzana I, Ingegnoli F, De Santis M, Murdaca G, Abignano G, Pettiti G, Rossa AD, Caminiti M, Iuliano A, Ciano G, Beretta L, Bagnato G, Lubrano E, De Andres MI, Giollo A, Bruni C, Orlandi M, Fornaro M, Saracco M, Agnes C, Cerasuolo PG, Alonzi G, Cipolletta E, Lumetti F, Spinella A, Magnani L, Campochiaro C, De Luca G, Codullo V, Visalli E, Iandoli C, Gigante A, Pellegrino G, Pigatto E, Lazzaroni MG, Franceschini F, Generali E, Mennillo G, Barsotti S, Mariano GP, Furini F, Vultaggio L, Parisi S, Peroni CL, Bianchi G, Fusaro E, Sebastiani GD, Govoni M, D'Angelo S, Cozzi F, Conti F, Guiducci S, Doria A, Salvarani C, Iannone F, D'Agostino MA, Ferri C, Matucci Cerinic M, Bosello SL; SPRING Italian Registry Collaborators.
Mycophenolate Mofetil Treatment Reduces the Risk of Treatment Escalation Due to Vascular Complications in Limited Cutaneous Systemic Sclerosis: Emulation of a Target Trial From the Italian Rheumatology Society SPRING Registry.
Arthritis Care Res (Hoboken). 2025 Dec 29. doi: 10.1002/acr.70039. Online ahead of print.
384. Ceccarelli F, Piga M, Spinelli FR, Prevete I, Cauli A, Iannone F, Coladonato L, Govoni M, Bortoluzzi A, Mosca M, Tani C, Doria A, Iaccarino L, Franceschini F, Fredi M, Frediani B, Bellisai F, Rozza D, Zanetti A, Carrara G, Scirè CA, Sebastiani GD, Conti F; study group on Early SLE of the Italian Society of Rheumatology.
Application of lupus comprehensive disease control in newly diagnosed systemic lupus erythematosus patients: results from the Italian multicentre Early Lupus Project inception cohort.
Clin Exp Rheumatol. 2026 Mar;44(3):462-467. doi: 10.55563/clinexprheumatol/dagoie. Epub 2026 Jan 15.
385. Villani F, Capozzi A, Ucci FM, Truglia S, De Michele M, Mancuso S, Rapino L, Tripodi G, Manganelli V, Riitano G, Misasi R, Sorice M, Sili Scavalli A, Conti F, Alessandri C.
Antigenic assessment for the β2-glycoprotein I/Platelet factor 4 complex in thrombotic patients with antiphospholipid syndrome.
Front Immunol. 2026 Jan 12;16:1674181. doi: 10.3389/fimmu.2025.1674181. eCollection 2025.
386. Caggiano V, Sbalchiero J, Frassi M, Martín-Nares E, Hinojosa-Azaola A, Sikora M, Jahnz-Różyk K, Crisafulli F, Franceschini F, Airò P, Guaracha-Basañez GA, Torres-Ruiz J, Sfriso P, Bindoli S, Baggio C, Hernández-Rodríguez J, Caverzaschi VG, Espinosa G, Mayrink Giardini HA, Alves Cordeiro R, González-García A, Peña Rodríguez M, Lopalco G, Iannone F, Viapiana O, Tufan A, Kucuk H, Hissaria P, Beecher M, De Paulis A, Mormile I, Dagna L, Campochiaro C, Gidaro A, La Cava L, Bugatti S, Milanesi A, Ruiz-Irastorza G, Piga M, Conti F, Moscato P, Opris-Belinski D, Vitetta R, Chighizola C, Recke A, Tornero-Romero F, Prete M, Govoni M, Emmi G, Kawakami-Campos PA, Triggianese P, Gurnari C, Ragab G, Balistreri A, Ziȩtkiewicz M, Wiesik-Szewczyk E, Frediani B, Fabiani C, Sicuranza A, Bocchia M, Cantarini L, Vitale A.
Clinical and laboratory markers to distinguish VEXAS from Schnitzler's syndrome: data from the AIDA network registries.
Front Med (Lausanne). 2026 Jan 12;12:1659758. doi: 10.3389/fmed.2025.1659758. eCollection 2025.
387. Gavioli F, Caggiano V, Sbalchiero J, Frassi M, Crisafulli F, Cavazzana I, Hinojosa-Azaola A, Martín-Nares E, Guaracha-Basañez GA, Torres-Ruiz J, Wiesik-Szewczyk E, Sfriso P, Rizzo S, Schermi M, Bindoli S, Hernández-Rodríguez J, Gómez-Caverzaschi V, Araújo O, Alemanno A, Giardini HAM, González-García A, Placido F, Lopalco G, Viapiana O, Tufan A, Koksoy B, Mulayim F, Hissaria P, Beecher M, Panayiaris T, De Paulis A, Dagna L, Tomelleri A, Campochiaro C, Bugatti S, Milanesi A, Ruiz-Irastorza G, Soto-Peleteiro A, Piga M, Cauli A, Floris A, Conti F, Cardamone C, Zorzenon I, Triggianese P, Gurnari C, Vitetta R, Prete M, Racanelli V, Silvan F, Talarico R, Mayo-Juanatey A, Alegre-Sancho JJ, Renieri A, Bocchia M, Sicuranza A, Balistreri A, Sorrentino V, Frullanti E, Frediani B, Fabiani C, Cantarini L, Vitale A.
VEXAS syndrome and cancer: Insights about a possible "Tip of the Iceberg". Ambidirectional data from the international AIDA network registries.
Semin Arthritis Rheum. 2026 Apr;77:152932. doi: 10.1016/j.semarthrit.2026.152932. Epub 2026 Jan 22.
388. Tani C, Cardelli C, Moroni L, Zen M, Bottazzi F, Fredi M, Bortoluzzi A, Piga M, Riccio F, Ceccarelli F, De Marchi G, Manfredi L, Mulè R, Biancalana E, Gatto M, Coladonato L, Conigliaro P, Gerosa M, Diamanti AP, Ramirez GA, Vesentini F, Zanframundo G, Orlandi C, Silvagni E, Chessa E, Trevisani M, Palmerini M, Pilo PFG, Ferrigno S, Di Lollo AC, Noviello S, Lo Gullo A, De Andres MI, Guiducci S, Emmi G, Maiolini F, De Angelis R, Caporali RF, Iannone F, Moroncini G, Quartuccio L, Conti F, Ciccia F, Govoni M, Franceschini F, Cavagna L, Iaccarino L, Dagna L, Mosca M.
Patient profiles and early response in patients with systemic lupus erythematosus initiating anifrolumab: interim analysis from the ongoing multicentre observational REVEAL study.
Lancet Rheumatol. 2026 Mar;8(3):e181-e191. doi: 10.1016/S2665-9913(25)00316-9. Epub 2026 Feb 5.
389. Capozzi A, Riitano G, Recalchi S, Longo A, Manganelli V, Mancuso S, Alessandri C, Misasi R, Garofalo T, Sorice M, Truglia S, Conti F.
Extracellular microvesicles from patients with antiphospholipid syndrome carry antigenic targets and promote endothelial cell activation in vitro.
Haematologica. 2026 Feb 19. doi: 10.3324/haematol.2025.288860. Online ahead of print.
390. Caggiano V, Sbalchiero J, Frassi M, Crisafulli F, Cavazzana I, Hinojosa-Azaola A, Martín-Nares E, Guaracha-Basañez GA, Torres-Ruiz J, Wiesik-Szewczyk E, Nowakowska-Plaza A, Sfriso P, Bindoli S, Rizzo S, Hernández-Rodríguez J, Gómez-Caverzaschi V, Araújo O, Mayrink Giardini HA, González-García A, Lopalco G, Viapiana O, Bixio R, Tufan A, Hissaria P, Beecher M, Callisto A, De Paulis A, Dagna L, Campochiaro C, Tomelleri A, Bugatti S, Milanesi A, Ruiz-Irastorza G, Soto-Peleteiro A, Piga M, Cauli A, Conti F, Cardamone C, Triggianese P, Gurnari C, Vitetta R, Prete M, Racanelli V, Talarico R, Ferro F, di Cianni F, Cuccaro MC, Mayo-Juanatey A, Renieri A, Sorrentino V, Ergun MA, Balistreri A, Frediani B, Bocchia M, Fabiani C, Cantarini L, Vitale A.
Recurrent fever and association with severe organ involvement, mortality and treatment outcomes in VEXAS syndrome: data from the AIDA Network.
Front Immunol. 2026 Mar 13;17:1753412. doi: 10.3389/fimmu.2026.1753412. eCollection 2026.
391. Ughi N, Padoan R, Adami G, Mosca M, Conti F, Perricone C, Piga M, Fasano S, Caporali R, Bortoluzzi A, Salvarani C, Bugatti S, Guiducci S, Sebastiani GD, Sticchi L, Gabutti G, El Aoufy K, Tonolo S, Carrara G, Landolfi G, Rozza D, Doria A.
The Italian Society of Rheumatology clinical practice guidelines for the management of vaccines in adult patients with rheumatic diseases.
Reumatismo. 2026 Apr 9. doi: 10.4081/reumatismo.2026.1895. Online ahead of print.
392. Iannuccelli C, Favretti M, Dolcini G, Cauli C, Ferraro V, Franculli D, Scalese G, Scrivo R, Conti F, Di Franco M.
Lower Adherence to the Mediterranean Diet in Fibromyalgia Compared with Rheumatoid and Psoriatic Arthritis and Its Association with Disease Burden and Lifestyle Factors.
Nutrients. 2026 Mar 24;18(7):1019. doi: 10.3390/nu18071019.
393. Ciancarella C, Ucci FM, Manganelli V, Garofalo T, Fasciolo E, Priori R, Ceccarelli F, Sergi M, Montesano C, Bartolini F, Sili Scavalli A, Conti F, Sorice M, Alessandri C.
Heat-not-burn tobacco induces protein post-translational modifications and apoptosis in bronchial cells: possible role in rheumatoid arthritis.
RMD Open. 2026 May 4;12(2):e006645. doi: 10.1136/rmdopen-2025-006645.
394. Pierdominici M, Borgi M, Spinelli FR, Conti F, Wu H, Moon KW, Kiltz U, Ortona E.
Sex and gender differences in rheumatology: clinical impact and future directions.
Nat Rev Rheumatol. 2026 May 5. doi: 10.1038/s41584-026-01376-4. Online ahead of print.
395. Ahmadzay ZF, Ørnbjerg LM, Østergaard M, Jensen KY, Jørgensen JB, Heberg J, Loft AG, Michelsen B, Jones GT, Hellamand P, Møller-Bisgaard S, Shoae Kazemi M, Karimi Reikandeh P, Závada J, Horák P, Bernardes M, Vieira-Sousa E, Castrejón I, Otero-Varela L, Codreanu C, Kuusalo L, Rantalaiho V, Regierer AC, Reich A, Möller B, Micheroli R, Mielnik P, Provan SA, Lass K, Vorobjov S, Rotar Z, Pirkmajer KP, Iannone F, Conti F, Gudbjornsson B, Di Giuseppe D, van de Sande M, Macfarlane GJ, Yarkan-Tuğsal H, Glintborg B, Hetland ML.
Impact of cardiometabolic comorbidities on clinical characteristics, prescription patterns and retention rate of first b/tsDMARD treatment in 5299 European real-world patients with psoriatic arthritis.
RMD Open. 2026 May 7;12(2):e006477. doi: 10.1136/rmdopen-2025-006477.
396. Mancuso S, Rapino L, Riccieri V, Alessandri C, Spinelli FR, Ceccarelli F, Truglia S, Mohammed Reza Beigi D, Garufi C, Pecani A, Conti F.
Anti-neutrophil extracellular trap antibodies in autoimmune rheumatic diseases: a suitable biomarker of thrombosis in systemic lupus erythematosus.
Clin Exp Rheumatol. 2026 May 18. doi: 10.55563/clinexprheumatol/crnzs0. Online ahead of print.
LIBRI
F Conti, FR Spinelli, A Ossandon, G Valesini.
Effetti biologici e clinici degli inibitori della ciclossigenasi 2.
Editmabi.com, Milano; 2001.
F Conti, R Scrivo
Il follow-up del paziente con artrite reumatoide di lunga durata.
Anno XIV, N. 1, febbraio 2011
Wolters Kluwer Health, Milano.
CAPITOLI DI LIBRI
Valesini G, Priori R, Vellucci C, Conti F.
Rilevamento e quantizzazione degli immunocomplessi circolanti.
“Trattato Italiano di Medicina di Laboratorio”, Piccin Nuova Libraria; Padova, vol. IV:117-127; 1994.
G Valesini, F Conti, L Magrini, R Gerli.
La malattia di Behçet (MB).
“Linee guida per la diagnosi e terapia delle malattie immunomediate”.
Federazione Italiana delle Società di Immunologia.
Il Lavoro Editoriale, Ancona; 35-36; 1999.
R Priori, F Conti, G Valesini.
Cyclosporin and Cancer.
“The Decade of Autoimmunity”. Y Shoenfeld and ME Gershwin editors. Elsever Science B V. 429-437; 2000.
G Valesini, F Conti.
Sindrome da anticorpi anti-fosfolipidi.
“Reumatologia per studenti e medici di medicina generale”. Unireuma. Idelson-Gnocchi, Napoli, 171-175, 2008.
G Valesini, F Conti.
Sindrome da anticorpi anti-fosfolipidi.
“Reumatologia. Per le professioni sanitarie”. Unireuma. Idelson-Gnocchi, Napoli, 2009.
F Conti, R Scrivo.
Reumatoide, artrite.
“Dizionario di Medicina Treccani”. Istituto della Enciclopedia Italiana, Roma, 2010.
F Ceccarelli, C Perricone, F Conti, G Valesini
Lupus Eritematoso Sistemico. Generalità, Patogenesi, Clinica. Pagg. 283-302.
“Malattie Autoimmuni Sistemiche”. Roberto Perricone. Società Editrice Universo (SEU) Roma, 2013.
C Perricone, F Conti, E Cipriano, G Valesini
Malattie autoimmuni sistemiche, vaccini, adiuvanti e sindrome ASIA. Pagg.709-721.
“Malattie Autoimmuni Sistemiche”. Roberto Perricone. Società Editrice Universo (SEU) Roma, 2013.
F Conti, R Scrivo, G Valesini.
Artriti reattive – generalità “Reumatologia per studenti e medici di medicina generale”. Pagg. 116-119. II edizione, Unireuma. Idelson-Gnocchi, Napoli, 2014.
Perricone C, Conti F, Agmon-Levin N, Valesini G, Shoenfeld Y.
Vaccination and Autoimmunity, chapter 13, 217-240.
“Infection and autoimmunity, second edition”. Edited by Yehuda Shoenfeld, Nancy Agmon-Levin and Noel R Rose. Elsevier 2015.
F Conti, R Scrivo, G Valesini.
Artriti reattive – generalità “Reumatologia per studenti e medici di medicina generale”. Pagg. 132-135. III edizione, Unireuma. Idelson-Gnocchi, Napoli, 2018.
Carlo Perricone, Mathilde Versini, Dana Ben-Ami, Smadar Gertel, Abdulla Watad, Michael J. Segel, Fulvia Ceccarelli, Fabrizio Conti, Luca Cantarini, Dimitrios P. Bogdanos, Alessandro Antonelli, Howard Amital, Guido Valesini and Yehuda Shoenfeld.
Smoke and Autoimmunity: The Fire Behind the Disease, Chapter 37, 383-415.
Mosaic of Autoimmunity, The Novel Factors of Autoimmune Diseases. Academic Press 2019.
Alessandri C, Scrivo R, Conti F.
Sindrome da anticorpi antifosfolipidi. In “Unireuma. Reumatologia per studenti e medici di medicina generale”. IV edizione
Idelson-Gnocchi, Napoli, 2021.
Insegnamenti
| Codice insegnamento | Insegnamento | Anno | Semestre | Lingua | Corso | Codice corso | Curriculum |
|---|---|---|---|---|---|---|---|
| 10630792 | SCIENZE INTERDISCIPLINARI - REUMATOLOGIA | 1º | 2º | ITA | Tecniche di radiologia medica, per immagini e radioterapia (abilitante alla professione sanitaria di Tecnico di radiologia medica) - Corso di laurea G - Roma Ospedale S. Spirito | 29883 | Curriculum unico |
| 10606513 | PATOLOGIA INTEGRATA IV - PATOLOGIA INTEGRATA IV - IMMUNOLOGIA CLINICA | 4º | 2º | ITA | Medicina e chirurgia "C" - Roma Azienda Policlinico Umberto I | 33560 | Curriculum unico |
| 10606513 | PATOLOGIA INTEGRATA IV - PATOLOGIA INTEGRATA IV - REUMATOLOGIA | 4º | 2º | ITA | Medicina e chirurgia "C" - Roma Azienda Policlinico Umberto I | 33560 | Curriculum unico |
| 10606513 | PATOLOGIA INTEGRATA IV - PATOLOGIA INTEGRATA IV - INGLESE SCIENTIFICO | 4º | 2º | ITA | Medicina e chirurgia "C" - Roma Azienda Policlinico Umberto I | 33560 | Curriculum unico |
| 10606513 | PATOLOGIA INTEGRATA IV - PATOLOGIA INTEGRATA IV - REUMATOLOGIA | 4º | 2º | ITA | Medicina e chirurgia "C" - Roma Azienda Policlinico Umberto I | 33560 | Curriculum unico |
| 10606513 | PATOLOGIA INTEGRATA IV - PATOLOGIA INTEGRATA IV - IMMUNOLOGIA CLINICA | 4º | 2º | ITA | Medicina e chirurgia "C" - Roma Azienda Policlinico Umberto I | 33560 | Curriculum unico |
| 10596619 | APPLIED PATHOLOGY IV DISEASES OF THE BLOOD HEMATOPOIETIC ORGANS IMMUNE SYSTEM AND RHEUMATOLOGY - APPLIED PATHOLOGY IV REUMATOLOGIA | 5º | 1º | ENG | Medicine and surgery - Medicina e chirurgia "F" | 33454 | Curriculum unico |
| TPVES115 | INTERNSHIP FOR THE STATE EXAM - MEDICINE - RHEUMATOLOGY | 6º | 2º | ITA | Medicine and surgery - Medicina e chirurgia "F" | 33454 | Curriculum unico |